##gff-version 3
##sequence-region P02829 1 709
P02829	UniProtKB	Chain	1	709	.	.	.	ID=PRO_0000062957;Note=ATP-dependent molecular chaperone HSP82	
P02829	UniProtKB	Repeat	221	225	.	.	.	Note=1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10786835;Dbxref=PMID:10786835	
P02829	UniProtKB	Repeat	226	230	.	.	.	Note=2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10786835;Dbxref=PMID:10786835	
P02829	UniProtKB	Repeat	231	235	.	.	.	Note=3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10786835;Dbxref=PMID:10786835	
P02829	UniProtKB	Repeat	237	241	.	.	.	Note=4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10786835;Dbxref=PMID:10786835	
P02829	UniProtKB	Repeat	250	254	.	.	.	Note=5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10786835;Dbxref=PMID:10786835	
P02829	UniProtKB	Nucleotide binding	99	100	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:2CG9,ECO:0000269|PubMed:16625188;Dbxref=PMID:16625188	
P02829	UniProtKB	Nucleotide binding	119	124	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:1AM1,ECO:0000244|PDB:1AMW,ECO:0000244|PDB:2CG9,ECO:0000244|PDB:2WEP,ECO:0000269|PubMed:16625188,ECO:0000269|PubMed:9230303;Dbxref=PMID:16625188,PMID:9230303	
P02829	UniProtKB	Region	221	263	.	.	.	Note=5 X 5 AA repeats of [DE]-[DE]-[DE]-K-K%3B highly charged region	
P02829	UniProtKB	Motif	705	709	.	.	.	Note=TPR repeat-binding	
P02829	UniProtKB	Binding site	33	33	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:2CG9,ECO:0000269|PubMed:16625188;Dbxref=PMID:16625188	
P02829	UniProtKB	Binding site	37	37	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:1AM1,ECO:0000244|PDB:1AMW,ECO:0000244|PDB:2CG9,ECO:0000244|PDB:2WEP,ECO:0000269|PubMed:16625188,ECO:0000269|PubMed:9230303;Dbxref=PMID:16625188,PMID:9230303	
P02829	UniProtKB	Binding site	79	79	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:1AM1,ECO:0000244|PDB:1AMW,ECO:0000244|PDB:2CG9,ECO:0000244|PDB:2WEP,ECO:0000269|PubMed:16625188,ECO:0000269|PubMed:9230303;Dbxref=PMID:16625188,PMID:9230303	
P02829	UniProtKB	Binding site	84	84	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:2CG9,ECO:0000269|PubMed:16625188;Dbxref=PMID:16625188	
P02829	UniProtKB	Binding site	92	92	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:2CG9,ECO:0000269|PubMed:16625188;Dbxref=PMID:16625188	
P02829	UniProtKB	Binding site	98	98	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:2CG9,ECO:0000269|PubMed:16625188;Dbxref=PMID:16625188	
P02829	UniProtKB	Binding site	171	171	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:2CG9,ECO:0000269|PubMed:16625188;Dbxref=PMID:16625188	
P02829	UniProtKB	Binding site	380	380	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:2CG9,ECO:0000269|PubMed:16625188;Dbxref=PMID:16625188	
P02829	UniProtKB	Modified residue	657	657	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P15108	
P02829	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Induces a 6-fold increase in ATPase activity and a reduced client protein activation activity%2C leading to growth defect at high temperatures. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7791797;Dbxref=PMID:7791797	
P02829	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Causes a 98%25 reduction in ATPase activity and a reduced client protein activation activity%2C leading to growth defect at high temperatures. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7791797;Dbxref=PMID:7791797	
P02829	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Reduces client protein activation activity%2C leading to growth defect at high temperatures. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7791797;Dbxref=PMID:7791797	
P02829	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Abolishes ATPase activity. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18256191;Dbxref=PMID:18256191	
P02829	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Abolishes interaction with SBA1. A->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9632755;Dbxref=PMID:9632755	
P02829	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Causes a 90%25 reduction in ATPase activity and a reduced client protein activation activity%2C leading to growth defect at high temperatures. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7791797;Dbxref=PMID:7791797	
P02829	UniProtKB	Mutagenesis	107	107	.	.	.	Note=Induces a 6-fold increase in ATPase activity. A->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10944121;Dbxref=PMID:10944121	
P02829	UniProtKB	Mutagenesis	170	170	.	.	.	Note=Induces a total loss of function at 34 degrees Celsius. Abolishes interaction with SBA1. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7791797;Dbxref=PMID:7791797	
P02829	UniProtKB	Mutagenesis	313	313	.	.	.	Note=Reduces client protein activation activity%2C leading to growth defect at high temperatures. G->N%2CS;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7791797,ECO:0000269|PubMed:8248264;Dbxref=PMID:7791797,PMID:8248264	
P02829	UniProtKB	Mutagenesis	349	349	.	.	.	Note=Induces a loss of ATPase activity. Can be reactivated by AHA1. F->A%2CQ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12667448;Dbxref=PMID:12667448	
P02829	UniProtKB	Mutagenesis	380	380	.	.	.	Note=Induces a loss of ATPase activity. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12667448;Dbxref=PMID:12667448	
P02829	UniProtKB	Mutagenesis	381	381	.	.	.	Note=Reduces client protein activation activity. Resistant to ATPase activation by AHA1. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7791797;Dbxref=PMID:7791797	
P02829	UniProtKB	Mutagenesis	384	384	.	.	.	Note=Induces a loss of ATPase activity. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12667448;Dbxref=PMID:12667448	
P02829	UniProtKB	Mutagenesis	387	387	.	.	.	Note=Decreases AHA1 binding affinity%2C but has no effect on client protein activation activity. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14739935;Dbxref=PMID:14739935	
P02829	UniProtKB	Mutagenesis	387	387	.	.	.	Note=Decreases AHA1 binding affinity and substantially reduces client protein activation activity. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14739935;Dbxref=PMID:14739935	
P02829	UniProtKB	Mutagenesis	431	431	.	.	.	Note=Specifically reduces the activation of the exogenous ligand glucocorticoid receptor. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8248264;Dbxref=PMID:8248264	
P02829	UniProtKB	Mutagenesis	485	485	.	.	.	Note=Abolishes interaction with SBA1. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9632755;Dbxref=PMID:9632755	
P02829	UniProtKB	Mutagenesis	525	525	.	.	.	Note=Abolishes interaction with SBA1. Reduces client protein activation activity%2C leading to growth defect at high temperatures. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8248264;Dbxref=PMID:8248264	
P02829	UniProtKB	Mutagenesis	576	576	.	.	.	Note=Reduces client protein activation activity%3B when associated with K-579. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8248264;Dbxref=PMID:8248264	
P02829	UniProtKB	Mutagenesis	577	577	.	.	.	Note=Enhances ATPase activity and client protein activation. A->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19696785;Dbxref=PMID:19696785	
P02829	UniProtKB	Mutagenesis	577	577	.	.	.	Note=Reduces ATPase activity and client protein activation. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19696785;Dbxref=PMID:19696785	
P02829	UniProtKB	Mutagenesis	577	577	.	.	.	Note=Enhances homodimerization%2C ATPase activity and client protein activation. A->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19696785;Dbxref=PMID:19696785	
P02829	UniProtKB	Mutagenesis	577	577	.	.	.	Note=Reduces homodimerization%2C ATPase activity and client protein activation. A->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19696785;Dbxref=PMID:19696785	
P02829	UniProtKB	Mutagenesis	579	579	.	.	.	Note=Reduces client protein activation activity%3B when associated with T-576. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8248264;Dbxref=PMID:8248264	
P02829	UniProtKB	Mutagenesis	587	587	.	.	.	Note=No effect on ATPase activity. Reduces client protein activation activity%2C leading to growth defect at high temperatures. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7791797;Dbxref=PMID:7791797	
P02829	UniProtKB	Sequence conflict	481	481	.	.	.	Note=A->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P02829	UniProtKB	Beta strand	4	7	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	10	21	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	26	28	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ASB	
P02829	UniProtKB	Helix	29	48	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Turn	49	51	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	53	56	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Beta strand	64	69	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	70	72	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Beta strand	74	79	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	86	93	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Turn	95	97	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BRC	
P02829	UniProtKB	Helix	101	110	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	114	120	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	123	129	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Beta strand	131	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Beta strand	146	150	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Beta strand	152	160	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Beta strand	162	164	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Beta strand	168	177	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	182	185	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	187	197	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Beta strand	200	203	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2AKP	
P02829	UniProtKB	Beta strand	205	207	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2IWX	
P02829	UniProtKB	Helix	276	278	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	281	283	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	286	297	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	304	311	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	313	315	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	317	323	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Turn	329	332	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	335	337	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CG9	
P02829	UniProtKB	Beta strand	341	345	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	348	352	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	355	358	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HK7	
P02829	UniProtKB	Helix	360	362	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	366	373	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	380	383	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HK7	
P02829	UniProtKB	Helix	387	408	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	411	431	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Turn	433	435	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	436	440	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	444	447	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	450	456	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	457	462	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	470	475	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	479	483	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	488	493	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	498	501	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Helix	504	513	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Beta strand	519	523	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1USU	
P02829	UniProtKB	Turn	524	526	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HK7	
P02829	UniProtKB	Beta strand	530	533	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Helix	535	558	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Beta strand	563	567	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Beta strand	573	580	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Beta strand	582	584	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Helix	587	597	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Beta strand	600	602	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Beta strand	611	615	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Helix	620	629	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Turn	630	632	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Helix	633	635	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Helix	637	653	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
P02829	UniProtKB	Helix	661	676	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CGE	
##sequence-region P38398 1 1863
P38398	UniProtKB	Chain	1	1863	.	.	.	ID=PRO_0000055830;Note=Breast cancer type 1 susceptibility protein	
P38398	UniProtKB	Domain	1642	1736	.	.	.	Note=BRCT 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00033	
P38398	UniProtKB	Domain	1756	1855	.	.	.	Note=BRCT 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00033	
P38398	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00175	
P38398	UniProtKB	Region	1397	1424	.	.	.	Note=Interaction with PALB2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19369211;Dbxref=PMID:19369211	
P38398	UniProtKB	Compositional bias	651	654	.	.	.	Note=Poly-Lys	
P38398	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
P38398	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163	
P38398	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14990569;Dbxref=PMID:14990569	
P38398	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
P38398	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
P38398	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P38398	UniProtKB	Modified residue	434	434	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	551	551	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	694	694	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
P38398	UniProtKB	Modified residue	708	708	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	725	725	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48754	
P38398	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P38398	UniProtKB	Modified residue	840	840	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P48754	
P38398	UniProtKB	Modified residue	988	988	.	.	.	Note=Phosphoserine%3B by CHEK2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10724175,ECO:0000269|PubMed:20364141;Dbxref=PMID:10724175,PMID:20364141	
P38398	UniProtKB	Modified residue	1009	1009	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	1143	1143	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1189	1189	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	1191	1191	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P38398	UniProtKB	Modified residue	1217	1217	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P38398	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692;Dbxref=PMID:18669648,PMID:21406692	
P38398	UniProtKB	Modified residue	1280	1280	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1328	1328	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P38398	UniProtKB	Modified residue	1336	1336	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:17081983,PMID:20068231,PMID:21406692	
P38398	UniProtKB	Modified residue	1342	1342	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692;Dbxref=PMID:20068231,PMID:21406692	
P38398	UniProtKB	Modified residue	1387	1387	.	.	.	Note=Phosphoserine%3B by ATM and ATR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1394	1394	.	.	.	Note=Phosphothreonine%3B by ATR%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1423	1423	.	.	.	Note=Phosphoserine%3B by ATM and ATR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1457	1457	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Modified residue	1524	1524	.	.	.	Note=Phosphoserine%3B by ATM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21144835;Dbxref=PMID:21144835	
P38398	UniProtKB	Modified residue	1542	1542	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P38398	UniProtKB	Cross-link	109	109	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	301	301	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	339	339	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:28112733	
P38398	UniProtKB	Cross-link	443	443	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25755297,PMID:28112733	
P38398	UniProtKB	Cross-link	459	459	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
P38398	UniProtKB	Cross-link	519	519	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	583	583	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:28112733	
P38398	UniProtKB	Cross-link	654	654	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25218447;Dbxref=PMID:25218447	
P38398	UniProtKB	Cross-link	734	734	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25218447;Dbxref=PMID:25218447	
P38398	UniProtKB	Cross-link	739	739	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25218447;Dbxref=PMID:25218447	
P38398	UniProtKB	Cross-link	918	918	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	987	987	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Cross-link	1079	1079	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P38398	UniProtKB	Alternative sequence	1	47	.	.	.	ID=VSP_057569;Note=In isoform 8. Missing	
P38398	UniProtKB	Alternative sequence	1	17	.	.	.	ID=VSP_035396;Note=In isoform 4. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Alternative sequence	64	1863	.	.	.	ID=VSP_047891;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.4	
P38398	UniProtKB	Alternative sequence	224	1365	.	.	.	ID=VSP_035398;Note=In isoform 5. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Alternative sequence	264	1366	.	.	.	ID=VSP_035399;Note=In isoform 3 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:9010228;Dbxref=PMID:15489334,PMID:9010228	
P38398	UniProtKB	Alternative sequence	1453	1453	.	.	.	ID=VSP_043797;Note=In isoform 3 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:9010228;Dbxref=PMID:15489334,PMID:9010228	
P38398	UniProtKB	Alternative sequence	1453	1453	.	.	.	ID=VSP_055404;Note=In isoform 7. A->DSHIHGQRNNSMFSKRPREHIS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
P38398	UniProtKB	Alternative sequence	1778	1863	.	.	.	ID=VSP_043798;Note=In isoform 6. DQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPHSHY->GCPPNCGCAARCLDRGQWLPCNWADV;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
P38398	UniProtKB	Natural variant	4	4	.	.	.	ID=VAR_070458;Note=In BC%3B unknown pathological significance. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs786203152,PMID:23867111	
P38398	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_020679;Note=In BC and BROVCA1. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_007754;Note=Found in breast-ovarian cancer patients%3B unknown pathological significance. V->A;Dbxref=dbSNP:rs80357017	
P38398	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_063899;Note=In BC%3B unknown pathological significance. M->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356929,PMID:17924331,PMID:23867111	
P38398	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_007755;Note=Found in breast-ovarian cancer patients%3B unknown pathological significance. I->V;Dbxref=dbSNP:rs80357406	
P38398	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_007756;Note=In BC. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs80357438,PMID:9609997	
P38398	UniProtKB	Natural variant	23	23	.	.	.	ID=VAR_020680;Note=In BC and BROVCA1. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_035947;Note=In a breast cancer sample%3B somatic mutation. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P38398	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_070459;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs769650474,PMID:23867111	
P38398	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_007757;Note=In BC and ovarian cancer%3B no interaction with BAP1. C->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12938098,ECO:0000269|PubMed:14746861,ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:7894493,ECO:0000269|PubMed:8554067,ECO:0000269|PubMed:9528852,ECO:0000269|PubMed:9760198;Dbxref=dbSNP:rs28897672,PMID:12938098,PMID:14746861,PMID:23867111,PMID:7894493,PMID:8554067,PMID:9528852,PMID:9760198	
P38398	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_007758;Note=In BC%3B no interaction with BAP1. C->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:7894491,ECO:0000269|PubMed:9482581,ECO:0000269|PubMed:9528852;Dbxref=dbSNP:rs80357064,PMID:23867111,PMID:7894491,PMID:9482581,PMID:9528852	
P38398	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_007759;Note=C->Y;Dbxref=dbSNP:rs55851803	
P38398	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_070460;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357102,PMID:23867111	
P38398	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_020681;Note=In BC%3B unknown pathological significance. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs80356913,PMID:12938098	
P38398	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_070461;Note=Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897673,PMID:23867111	
P38398	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_070462;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357413,PMID:23867111	
P38398	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_070463;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. P->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs55971303,PMID:23867111	
P38398	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_070464;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs748876625,PMID:23867111	
P38398	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_052077;Note=S->R;Dbxref=dbSNP:rs28897674	
P38398	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_070465;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_070466;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357325,PMID:23867111	
P38398	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_070467;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs55688530,PMID:23867111	
P38398	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_070468;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357090,PMID:23867111	
P38398	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_008759;Note=In ovarian cancer%3B unknown pathological significance. E->K	
P38398	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_070469;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357001,PMID:23867111	
P38398	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_007760;Note=H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9010228,ECO:0000269|PubMed:9760198;Dbxref=dbSNP:rs80357396,PMID:9010228,PMID:9760198	
P38398	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_070470;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356865,PMID:23867111	
P38398	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_070471;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897675,PMID:23867111	
P38398	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_070472;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357244,PMID:23867111	
P38398	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_007761;Note=In BC. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8723683;Dbxref=dbSNP:rs80357244,PMID:8723683	
P38398	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_019944;Note=G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.6;Dbxref=dbSNP:rs8176153	
P38398	UniProtKB	Natural variant	346	346	.	.	.	ID=VAR_008760;Note=In BC%3B unknown pathological significance. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10323242;Dbxref=dbSNP:rs80357015,PMID:10323242	
P38398	UniProtKB	Natural variant	356	356	.	.	.	ID=VAR_007762;Note=Q->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7894493,ECO:0000269|Ref.5,ECO:0000269|Ref.6;Dbxref=dbSNP:rs1799950,PMID:7894493	
P38398	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_007763;Note=In BC. Missing	
P38398	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_007764;Note=I->M;Dbxref=dbSNP:rs56128296	
P38398	UniProtKB	Natural variant	461	461	.	.	.	ID=VAR_007765;Note=In BC. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs56046357,PMID:9609997	
P38398	UniProtKB	Natural variant	465	465	.	.	.	ID=VAR_007766;Note=In BC. Y->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397508869,PMID:9609997	
P38398	UniProtKB	Natural variant	507	507	.	.	.	ID=VAR_007767;Note=Found in breast-ovarian cancer patients%3B unknown pathological significance. R->I;Dbxref=dbSNP:rs80357224	
P38398	UniProtKB	Natural variant	552	552	.	.	.	ID=VAR_007768;Note=In BC. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397508893,PMID:9609997	
P38398	UniProtKB	Natural variant	656	656	.	.	.	ID=VAR_020682;Note=N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12442274;Dbxref=PMID:12442274	
P38398	UniProtKB	Natural variant	668	668	.	.	.	ID=VAR_070473;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357250,PMID:23867111	
P38398	UniProtKB	Natural variant	693	693	.	.	.	ID=VAR_007769;Note=D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15026808,ECO:0000269|Ref.6;Dbxref=dbSNP:rs4986850,PMID:15026808	
P38398	UniProtKB	Natural variant	695	695	.	.	.	ID=VAR_070474;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897681,PMID:23867111	
P38398	UniProtKB	Natural variant	723	723	.	.	.	ID=VAR_020110;Note=N->D;Dbxref=dbSNP:rs4986845	
P38398	UniProtKB	Natural variant	749	749	.	.	.	ID=VAR_020683;Note=In BC. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12442275;Dbxref=dbSNP:rs80357114,PMID:12442275	
P38398	UniProtKB	Natural variant	758	758	.	.	.	ID=VAR_035948;Note=In a breast cancer sample%3B somatic mutation. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P38398	UniProtKB	Natural variant	772	772	.	.	.	ID=VAR_007770;Note=V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7894491,ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs80357467,PMID:7894491,PMID:9482581	
P38398	UniProtKB	Natural variant	778	778	.	.	.	ID=VAR_035949;Note=In a breast cancer sample%3B somatic mutation. G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P38398	UniProtKB	Natural variant	798	798	.	.	.	ID=VAR_070475;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs876660005,PMID:23867111	
P38398	UniProtKB	Natural variant	810	810	.	.	.	ID=VAR_070476;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. N->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897682,PMID:23867111	
P38398	UniProtKB	Natural variant	820	820	.	.	.	ID=VAR_007771;Note=K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs56082113,PMID:9482581	
P38398	UniProtKB	Natural variant	826	826	.	.	.	ID=VAR_007772;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. T->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897683,PMID:23867111	
P38398	UniProtKB	Natural variant	835	835	.	.	.	ID=VAR_020684;Note=In BROVCA1%3B unknown pathological significance. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs751656678,PMID:12938098	
P38398	UniProtKB	Natural variant	841	841	.	.	.	ID=VAR_070477;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357337,PMID:23867111	
P38398	UniProtKB	Natural variant	841	841	.	.	.	ID=VAR_007773;Note=In BROVCA1%3B unknown pathological significance. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8968716,ECO:0000269|PubMed:9760198;Dbxref=dbSNP:rs1800709,PMID:8968716,PMID:9760198	
P38398	UniProtKB	Natural variant	856	856	.	.	.	ID=VAR_020685;Note=In a patient with sporadic breast cancer%3B unknown pathological significance. Y->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356892,PMID:15365993,PMID:23867111	
P38398	UniProtKB	Natural variant	866	866	.	.	.	ID=VAR_070478;Note=R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs41286300,PMID:23867111	
P38398	UniProtKB	Natural variant	866	866	.	.	.	ID=VAR_020686;Note=In BC%3B unknown pathological significance. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=PMID:12938098	
P38398	UniProtKB	Natural variant	871	871	.	.	.	ID=VAR_007774;Note=P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323242,ECO:0000269|PubMed:12442274,ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:15489334,ECO:0000269|Ref.6;Dbxref=dbSNP:rs799917,PMID:10323242,PMID:12442274,PMID:15365993,PMID:15489334	
P38398	UniProtKB	Natural variant	888	888	.	.	.	ID=VAR_020687;Note=In BC%3B unknown pathological significance. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs80357480,PMID:12938098	
P38398	UniProtKB	Natural variant	892	892	.	.	.	ID=VAR_007775;Note=In BC. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397508994,PMID:9609997	
P38398	UniProtKB	Natural variant	903	1863	.	.	.	ID=VAR_080693;Note=In FANCS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29133208;Dbxref=PMID:29133208	
P38398	UniProtKB	Natural variant	925	925	.	.	.	ID=VAR_021913;Note=I->L;Dbxref=dbSNP:rs4986847	
P38398	UniProtKB	Natural variant	960	960	.	.	.	ID=VAR_007776;Note=In BC. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397509022,PMID:9609997	
P38398	UniProtKB	Natural variant	989	989	.	.	.	ID=VAR_020111;Note=F->S;Dbxref=dbSNP:rs4986848	
P38398	UniProtKB	Natural variant	1008	1008	.	.	.	ID=VAR_007777;Note=M->I;Dbxref=dbSNP:rs1800704	
P38398	UniProtKB	Natural variant	1025	1025	.	.	.	ID=VAR_007778;Note=In BC. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397509034,PMID:9609997	
P38398	UniProtKB	Natural variant	1038	1038	.	.	.	ID=VAR_007779;Note=E->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323242,ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7894493,ECO:0000269|Ref.6;Dbxref=dbSNP:rs16941,PMID:10323242,PMID:15365993,PMID:15489334,PMID:7894493	
P38398	UniProtKB	Natural variant	1040	1040	.	.	.	ID=VAR_007780;Note=S->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15026808,ECO:0000269|PubMed:7894491,ECO:0000269|PubMed:7894493,ECO:0000269|PubMed:9482581,ECO:0000269|Ref.6;Dbxref=dbSNP:rs4986852,PMID:15026808,PMID:7894491,PMID:7894493,PMID:9482581	
P38398	UniProtKB	Natural variant	1047	1047	.	.	.	ID=VAR_007781;Note=In BC. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9609997;Dbxref=dbSNP:rs397509037,PMID:9609997	
P38398	UniProtKB	Natural variant	1060	1060	.	.	.	ID=VAR_020688;Note=E->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15026808,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357184,PMID:15026808,PMID:23867111	
P38398	UniProtKB	Natural variant	1101	1101	.	.	.	ID=VAR_070479;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs41293447,PMID:23867111	
P38398	UniProtKB	Natural variant	1139	1139	.	.	.	ID=VAR_020689;Note=In BC%3B unknown pathological significance. S->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs80357228,PMID:12938098	
P38398	UniProtKB	Natural variant	1140	1140	.	.	.	ID=VAR_019945;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23867111,ECO:0000269|Ref.6;Dbxref=dbSNP:rs2227945,PMID:23867111	
P38398	UniProtKB	Natural variant	1140	1140	.	.	.	ID=VAR_070480;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1150	1150	.	.	.	ID=VAR_007782;Note=In BC. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8723683;Dbxref=dbSNP:rs80357272,PMID:8723683	
P38398	UniProtKB	Natural variant	1183	1183	.	.	.	ID=VAR_007783;Note=K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323242,ECO:0000269|PubMed:14722926,ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7894493,ECO:0000269|Ref.6;Dbxref=dbSNP:rs16942,PMID:10323242,PMID:14722926,PMID:15365993,PMID:15489334,PMID:7894493	
P38398	UniProtKB	Natural variant	1187	1187	.	.	.	ID=VAR_020690;Note=In BC and BROVCA1. S->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1200	1200	.	.	.	ID=VAR_020691;Note=In BC and BROVCA1. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=dbSNP:rs56214134,PMID:14722926	
P38398	UniProtKB	Natural variant	1204	1204	.	.	.	ID=VAR_020692;Note=In BC. R->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1207	1207	.	.	.	ID=VAR_020693;Note=In BC. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1210	1210	.	.	.	ID=VAR_020694;Note=In BC%3B unknown pathological significance. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs1060502347,PMID:12938098	
P38398	UniProtKB	Natural variant	1214	1214	.	.	.	ID=VAR_070481;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356923,PMID:23867111	
P38398	UniProtKB	Natural variant	1217	1217	.	.	.	ID=VAR_020695;Note=In BC and BROVCA1. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1219	1219	.	.	.	ID=VAR_007784;Note=Found in breast-ovarian cancer patients%3B unknown pathological significance. E->D;Dbxref=dbSNP:rs80356876	
P38398	UniProtKB	Natural variant	1226	1226	.	.	.	ID=VAR_020696;Note=In BROVCA1. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1236	1236	.	.	.	ID=VAR_052078;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897687,PMID:23867111	
P38398	UniProtKB	Natural variant	1243	1243	.	.	.	ID=VAR_020697;Note=In BROVCA1. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14722926;Dbxref=PMID:14722926	
P38398	UniProtKB	Natural variant	1250	1250	.	.	.	ID=VAR_052079;Note=E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897686,PMID:23867111	
P38398	UniProtKB	Natural variant	1267	1267	.	.	.	ID=VAR_070482;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs587782190,PMID:23867111	
P38398	UniProtKB	Natural variant	1282	1282	.	.	.	ID=VAR_070483;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. E->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357217,PMID:23867111	
P38398	UniProtKB	Natural variant	1297	1297	.	.	.	ID=VAR_020698;Note=In BC%3B unknown pathological significance. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs1450793674,PMID:12938098	
P38398	UniProtKB	Natural variant	1297	1297	.	.	.	ID=VAR_070484;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1301	1301	.	.	.	ID=VAR_070485;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs273900719,PMID:23867111	
P38398	UniProtKB	Natural variant	1346	1346	.	.	.	ID=VAR_070486;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357407,PMID:23867111	
P38398	UniProtKB	Natural variant	1347	1347	.	.	.	ID=VAR_007785;Note=R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12215251;Dbxref=dbSNP:rs28897689,PMID:12215251	
P38398	UniProtKB	Natural variant	1378	1378	.	.	.	ID=VAR_070487;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs28897690,PMID:23867111	
P38398	UniProtKB	Natural variant	1400	1400	.	.	.	ID=VAR_070488;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357306,PMID:23867111	
P38398	UniProtKB	Natural variant	1406	1406	.	.	.	ID=VAR_008761;Note=K->N;Dbxref=dbSNP:rs1800707	
P38398	UniProtKB	Natural variant	1407	1407	.	.	.	ID=VAR_070489;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357492,PMID:23867111	
P38398	UniProtKB	Natural variant	1411	1411	.	.	.	ID=VAR_020699;Note=In BC and ovarian cancer%3B unknown pathological significance%3B decreased interaction with PALB2. M->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14746861,ECO:0000269|PubMed:19369211,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs273900729,PMID:14746861,PMID:19369211,PMID:23867111	
P38398	UniProtKB	Natural variant	1431	1431	.	.	.	ID=VAR_007786;Note=S->P	
P38398	UniProtKB	Natural variant	1443	1443	.	.	.	ID=VAR_007787;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. R->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:7894491,ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs41293455,PMID:23867111,PMID:7894491,PMID:9482581	
P38398	UniProtKB	Natural variant	1443	1443	.	.	.	ID=VAR_020112;Note=R->Q;Dbxref=dbSNP:rs4986849	
P38398	UniProtKB	Natural variant	1448	1448	.	.	.	ID=VAR_070490;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357486,PMID:23867111	
P38398	UniProtKB	Natural variant	1486	1486	.	.	.	ID=VAR_070491;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397507232,PMID:23867111	
P38398	UniProtKB	Natural variant	1495	1495	.	.	.	ID=VAR_063900;Note=In BC%3B unknown pathological significance. R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357389,PMID:17924331	
P38398	UniProtKB	Natural variant	1512	1512	.	.	.	ID=VAR_007788;Note=S->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12215251,ECO:0000269|PubMed:9482581,ECO:0000269|PubMed:9760198;Dbxref=dbSNP:rs1800744,PMID:12215251,PMID:9482581,PMID:9760198	
P38398	UniProtKB	Natural variant	1534	1534	.	.	.	ID=VAR_070492;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs55815649,PMID:23867111	
P38398	UniProtKB	Natural variant	1561	1561	.	.	.	ID=VAR_007789;Note=Found in breast cancer%3B unknown pathological significance. T->I;Dbxref=dbSNP:rs56158747	
P38398	UniProtKB	Natural variant	1589	1589	.	.	.	ID=VAR_070493;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1606	1606	.	.	.	ID=VAR_007790;Note=Found in breast cancer%3B unknown pathological significance. K->E;Dbxref=dbSNP:rs80356943	
P38398	UniProtKB	Natural variant	1613	1613	.	.	.	ID=VAR_007791;Note=S->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10323242,ECO:0000269|PubMed:12442274,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:7894493,ECO:0000269|PubMed:9010228,ECO:0000269|Ref.6;Dbxref=dbSNP:rs1799966,PMID:10323242,PMID:12442274,PMID:15489334,PMID:7894493,PMID:9010228	
P38398	UniProtKB	Natural variant	1620	1620	.	.	.	ID=VAR_019946;Note=T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.6;Dbxref=dbSNP:rs8176219	
P38398	UniProtKB	Natural variant	1623	1623	.	.	.	ID=VAR_063901;Note=Could be associated with cancer susceptibility%3B major splicing aberration identified with this mutant. A->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:20513136;Dbxref=dbSNP:rs80356862,PMID:17924331,PMID:20513136	
P38398	UniProtKB	Natural variant	1628	1628	.	.	.	ID=VAR_007793;Note=In some patients with sporadic breast cancer%3B unknown pathological significance. M->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15365993,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs4986854,PMID:15365993,PMID:23867111	
P38398	UniProtKB	Natural variant	1628	1628	.	.	.	ID=VAR_007792;Note=Found in breast and ovarian cancer patients%3B unknown pathological significance. M->V;Dbxref=dbSNP:rs80357465	
P38398	UniProtKB	Natural variant	1637	1637	.	.	.	ID=VAR_007794;Note=P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7939630,ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs80357048,PMID:7939630,PMID:9482581	
P38398	UniProtKB	Natural variant	1641	1641	.	.	.	ID=VAR_008762;Note=In ovarian cancer%3B unknown pathological significance. A->P;Dbxref=dbSNP:rs1800726	
P38398	UniProtKB	Natural variant	1651	1651	.	.	.	ID=VAR_070494;Note=In BC%3B unknown pathological significance. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356938,PMID:23867111	
P38398	UniProtKB	Natural variant	1651	1651	.	.	.	ID=VAR_070495;Note=In BC%3B unknown pathological significance. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs879254042,PMID:23867111	
P38398	UniProtKB	Natural variant	1652	1652	.	.	.	ID=VAR_007795;Note=M->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12215251,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:9482581;Dbxref=dbSNP:rs1799967,PMID:12215251,PMID:15489334,PMID:23867111,PMID:9482581	
P38398	UniProtKB	Natural variant	1655	1655	.	.	.	ID=VAR_070496;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357390,PMID:23867111	
P38398	UniProtKB	Natural variant	1662	1662	.	.	.	ID=VAR_052080;Note=F->C;Dbxref=dbSNP:rs28897695	
P38398	UniProtKB	Natural variant	1665	1665	.	.	.	ID=VAR_020700;Note=V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15026808;Dbxref=dbSNP:rs80357169,PMID:15026808	
P38398	UniProtKB	Natural variant	1685	1685	.	.	.	ID=VAR_063902;Note=In BC%3B unknown pathological significance. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80356890,PMID:17924331	
P38398	UniProtKB	Natural variant	1685	1685	.	.	.	ID=VAR_063903;Note=Could be associated with cancer susceptibility%3B multifactorial likelihood analysis provides evidence for pathogenicity. T->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:20513136;Dbxref=dbSNP:rs80357043,PMID:17924331,PMID:20513136	
P38398	UniProtKB	Natural variant	1686	1686	.	.	.	ID=VAR_070497;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397509218,PMID:23867111	
P38398	UniProtKB	Natural variant	1686	1686	.	.	.	ID=VAR_070498;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs730882166,PMID:23867111	
P38398	UniProtKB	Natural variant	1688	1688	.	.	.	ID=VAR_070499;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1689	1689	.	.	.	ID=VAR_063904;Note=In BC%3B unknown pathological significance. M->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357061,PMID:17924331	
P38398	UniProtKB	Natural variant	1690	1690	.	.	.	ID=VAR_020701;Note=In some patients with sporadic breast cancer%3B unknown pathological significance. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365993;Dbxref=dbSNP:rs397507239,PMID:15365993	
P38398	UniProtKB	Natural variant	1691	1691	.	.	.	ID=VAR_070500;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357034,PMID:23867111	
P38398	UniProtKB	Natural variant	1692	1692	.	.	.	ID=VAR_008763;Note=In ovarian cancer%3B unknown pathological significance. D->N;Dbxref=dbSNP:rs80187739	
P38398	UniProtKB	Natural variant	1697	1697	.	.	.	ID=VAR_020702;Note=In ovarian cancer. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14746861;Dbxref=dbSNP:rs80356993,PMID:14746861	
P38398	UniProtKB	Natural variant	1699	1699	.	.	.	ID=VAR_070501;Note=In BC%3B unknown pathological significance%3B strongly reduces affinity for a BRIP1 phosphopeptide%3B functionally impaired in vitro. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21473589,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs41293459,PMID:21473589,PMID:23867111	
P38398	UniProtKB	Natural variant	1699	1699	.	.	.	ID=VAR_075666;Note=In BC%2C ovarian cancer and FANCS%3B impairs protein stability%3B functionally impaired in vitro. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14746861,ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:21473589,ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:25472942;Dbxref=dbSNP:rs55770810,PMID:14746861,PMID:17924331,PMID:21473589,PMID:23867111,PMID:25472942	
P38398	UniProtKB	Natural variant	1706	1706	.	.	.	ID=VAR_070502;Note=In BC%3B unknown pathological significance. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356860,PMID:23867111	
P38398	UniProtKB	Natural variant	1706	1706	.	.	.	ID=VAR_063905;Note=In BC%3B unknown pathological significance. G->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356860,PMID:17924331,PMID:23867111	
P38398	UniProtKB	Natural variant	1708	1708	.	.	.	ID=VAR_007796;Note=In BC%3B abolishes ACACA binding. A->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:23867111,ECO:0000269|PubMed:7939630;Dbxref=dbSNP:rs28897696,PMID:17924331,PMID:23867111,PMID:7939630	
P38398	UniProtKB	Natural variant	1713	1713	.	.	.	ID=VAR_007797;Note=V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365993;Dbxref=PMID:15365993	
P38398	UniProtKB	Natural variant	1715	1715	.	.	.	ID=VAR_063906;Note=In BC%3B unknown pathological significance. S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357094,PMID:17924331	
P38398	UniProtKB	Natural variant	1718	1718	.	.	.	ID=VAR_070503;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357239,PMID:23867111	
P38398	UniProtKB	Natural variant	1720	1720	.	.	.	ID=VAR_070504;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro%3B no effect on in vitro phosphorylation by ATR. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11114888,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs56195342,PMID:11114888,PMID:23867111	
P38398	UniProtKB	Natural variant	1735	1735	.	.	.	ID=VAR_070505;Note=In BC%3B unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397509238,PMID:23867111	
P38398	UniProtKB	Natural variant	1736	1736	.	.	.	ID=VAR_070506;Note=In BC and FANCS%3B unknown pathological significance%3B Decreased localization to DNA damage sites and reduced interaction with UIMC1/RAP80. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23269703,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs45553935,PMID:23269703,PMID:23867111	
P38398	UniProtKB	Natural variant	1738	1738	.	.	.	ID=VAR_063907;Note=In BC%3B unknown pathological significance. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80356937,PMID:17924331	
P38398	UniProtKB	Natural variant	1739	1739	.	.	.	ID=VAR_070507;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357227,PMID:23867111	
P38398	UniProtKB	Natural variant	1739	1739	.	.	.	ID=VAR_070508;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357227,PMID:23867111	
P38398	UniProtKB	Natural variant	1746	1746	.	.	.	ID=VAR_070509;Note=In BC%3B unknown pathological significance. H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs786202389,PMID:23867111	
P38398	UniProtKB	Natural variant	1749	1749	.	.	.	ID=VAR_007798;Note=In ovarian cancer%3B unknown pathological significance%3B abolishes ACACA binding and strongly reduces BRIP1 binding. P->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10486320,ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:15133502;Dbxref=dbSNP:rs80357462,PMID:10486320,PMID:11301010,PMID:15133502	
P38398	UniProtKB	Natural variant	1753	1753	.	.	.	ID=VAR_070510;Note=In BC%3B unknown pathological significance. R->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397509246,PMID:23867111	
P38398	UniProtKB	Natural variant	1764	1764	.	.	.	ID=VAR_063908;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17924331,ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357281,PMID:17924331,PMID:23867111	
P38398	UniProtKB	Natural variant	1766	1766	.	.	.	ID=VAR_063909;Note=In BC%3B unknown pathological significance. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357463,PMID:17924331	
P38398	UniProtKB	Natural variant	1767	1767	.	.	.	ID=VAR_070511;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1770	1770	.	.	.	ID=VAR_070512;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs863224765,PMID:23867111	
P38398	UniProtKB	Natural variant	1775	1775	.	.	.	ID=VAR_063212;Note=In BC%3B strongly reduced transcription transactivation%3B abolishes interaction with BRIP1 and RBBP8. M->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18285836;Dbxref=dbSNP:rs41293463,PMID:18285836	
P38398	UniProtKB	Natural variant	1775	1775	.	.	.	ID=VAR_007799;Note=In BC%3B alters protein stability and abolishes ACACA and BRIP1 binding. M->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:12427738,ECO:0000269|PubMed:15133502,ECO:0000269|PubMed:7545954,ECO:0000269|PubMed:7939630;Dbxref=dbSNP:rs41293463,PMID:11301010,PMID:12427738,PMID:15133502,PMID:7545954,PMID:7939630	
P38398	UniProtKB	Natural variant	1776	1776	.	.	.	ID=VAR_008764;Note=In ovarian cancer%3B unknown pathological significance. P->S;Dbxref=dbSNP:rs1800757	
P38398	UniProtKB	Natural variant	1780	1780	.	.	.	ID=VAR_079607;Note=In BC%2C BROVCA1 and OC%3B unknown pathological significance. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28364669;Dbxref=dbSNP:rs80357474,PMID:28364669	
P38398	UniProtKB	Natural variant	1782	1782	.	.	.	ID=VAR_070513;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1786	1786	.	.	.	ID=VAR_020704;Note=In BROVCA1%3B unknown pathological significance. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12938098;Dbxref=dbSNP:rs398122697,PMID:12938098	
P38398	UniProtKB	Natural variant	1788	1788	.	.	.	ID=VAR_063910;Note=In BC%3B unknown pathological significance. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17924331;Dbxref=dbSNP:rs80357069,PMID:17924331	
P38398	UniProtKB	Natural variant	1789	1789	.	.	.	ID=VAR_070514;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357078,PMID:23867111	
P38398	UniProtKB	Natural variant	1794	1794	.	.	.	ID=VAR_070515;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs397509275,PMID:23867111	
P38398	UniProtKB	Natural variant	1804	1804	.	.	.	ID=VAR_070516;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356920,PMID:23867111	
P38398	UniProtKB	Natural variant	1812	1812	.	.	.	ID=VAR_070517;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=PMID:23867111	
P38398	UniProtKB	Natural variant	1812	1812	.	.	.	ID=VAR_008765;Note=In ovarian cancer%3B unknown pathological significance. P->S;Dbxref=dbSNP:rs1800751	
P38398	UniProtKB	Natural variant	1837	1837	.	.	.	ID=VAR_070518;Note=In BC%3B unknown pathological significance%3B functionally impaired in vitro. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80356959,PMID:23867111	
P38398	UniProtKB	Natural variant	1862	1862	.	.	.	ID=VAR_070519;Note=In BC%3B unknown pathological significance%3B functionally neutral in vitro. H->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23867111;Dbxref=dbSNP:rs80357183,PMID:23867111	
P38398	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Disrupts the interaction with E2 enzymes%2C thereby abolishing the E3 ubiquitin-protein ligase activity. I->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16818604,ECO:0000269|PubMed:20351172;Dbxref=PMID:16818604,PMID:20351172	
P38398	UniProtKB	Mutagenesis	26	26	.	.	.	Note=No ubiquitination of RBBP8. No restoration RBBP8-mediated focus formation or G2/M checkpoint control upon DNA damage. I->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16818604,ECO:0000269|PubMed:20351172;Dbxref=PMID:16818604,PMID:20351172	
P38398	UniProtKB	Mutagenesis	71	71	.	.	.	Note=No effect on interaction with BAP1. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9528852;Dbxref=PMID:9528852	
P38398	UniProtKB	Mutagenesis	308	308	.	.	.	Note=Abolishes phosphorylation by AURKA and interferes with cell cycle progression from G2 to mitosis. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14990569;Dbxref=PMID:14990569	
P38398	UniProtKB	Mutagenesis	1143	1143	.	.	.	Note=Reduces in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1239	1239	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1280	1280	.	.	.	Note=Reduces in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1298	1298	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1330	1330	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1387	1387	.	.	.	Note=Loss of IR-induced S-phase checkpoint. Reduces in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11114888,ECO:0000269|PubMed:12183412;Dbxref=PMID:11114888,PMID:12183412	
P38398	UniProtKB	Mutagenesis	1394	1394	.	.	.	Note=Reduces in vitro phosphorylation by ATR. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1423	1423	.	.	.	Note=Inhibition of the infrared-induced G2 arrest. Reduces phosphorylation by ATR. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11114888,ECO:0000269|PubMed:12183412;Dbxref=PMID:11114888,PMID:12183412	
P38398	UniProtKB	Mutagenesis	1457	1457	.	.	.	Note=Reduces in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1466	1466	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1524	1524	.	.	.	Note=No change in infrared S-phase delay%3B when associated with A-1387. No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11114888,ECO:0000269|PubMed:12183412;Dbxref=PMID:11114888,PMID:12183412	
P38398	UniProtKB	Mutagenesis	1655	1655	.	.	.	Note=Abolishes interaction with BRIP1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15133502;Dbxref=PMID:15133502	
P38398	UniProtKB	Mutagenesis	1656	1656	.	.	.	Note=No effect on affinity for a BRIP1 phosphopeptide. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21473589;Dbxref=PMID:21473589	
P38398	UniProtKB	Mutagenesis	1662	1662	.	.	.	Note=Does not abolish ABRAXAS1 binding%2C but abolishes formation of a heterotetramer with ABRAXAS1. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1663	1663	.	.	.	Note=Does not abolish ABRAXAS1 binding%2C but abolishes formation of a heterotetramer with ABRAXAS1. M->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1666	1666	.	.	.	Note=Does not abolish ABRAXAS1 binding%2C but impairs formation of a heterotetramer with ABRAXAS1. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1670	1670	.	.	.	Note=Impairs formation of a heterotetramer with ABRAXAS1. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1671	1671	.	.	.	Note=Impairs formation of a heterotetramer with ABRAXAS1. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26778126;Dbxref=PMID:26778126	
P38398	UniProtKB	Mutagenesis	1700	1700	.	.	.	Note=Strongly reduces affinity for a BRIP1 phosphopeptide. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21473589;Dbxref=PMID:21473589	
P38398	UniProtKB	Mutagenesis	1702	1702	.	.	.	Note=Abolishes interaction with BRIP1. K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15133502;Dbxref=PMID:15133502	
P38398	UniProtKB	Mutagenesis	1738	1738	.	.	.	Note=Abolishes interaction with BRIP1. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15133502;Dbxref=PMID:15133502	
P38398	UniProtKB	Mutagenesis	1755	1755	.	.	.	Note=No effect on in vitro phosphorylation by ATR. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11114888;Dbxref=PMID:11114888	
P38398	UniProtKB	Mutagenesis	1835	1835	.	.	.	Note=Mildly reduces affinity for a BRIP1 phosphopeptide. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21473589;Dbxref=PMID:21473589	
P38398	UniProtKB	Mutagenesis	1836	1836	.	.	.	Note=Slightly reduces affinity for a BRIP1 phosphopeptide. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21473589;Dbxref=PMID:21473589	
P38398	UniProtKB	Sequence conflict	89	89	.	.	.	Note=I->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	148	148	.	.	.	Note=Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	253	253	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	713	713	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	1077	1077	.	.	.	Note=G->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	1426	1426	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Sequence conflict	1527	1527	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P38398	UniProtKB	Helix	3	5	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Helix	8	21	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Beta strand	25	27	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Helix	46	53	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Beta strand	54	58	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Turn	62	64	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Turn	70	72	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Beta strand	78	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Helix	81	96	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1JM7	
P38398	UniProtKB	Beta strand	1651	1656	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1659	1671	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1675	1679	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1T29	
P38398	UniProtKB	Beta strand	1686	1689	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1695	1697	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1701	1708	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1712	1715	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1717	1725	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1731	1734	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Turn	1740	1742	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1743	1745	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1T29	
P38398	UniProtKB	Helix	1748	1754	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Turn	1755	1757	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1T29	
P38398	UniProtKB	Turn	1760	1763	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1765	1768	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1770	1772	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1T2V	
P38398	UniProtKB	Beta strand	1773	1775	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1777	1786	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1790	1794	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1795	1797	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1801	1803	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1806	1810	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1812	1814	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1817	1819	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1OQA	
P38398	UniProtKB	Helix	1820	1822	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1824	1827	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Beta strand	1828	1830	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3PXE	
P38398	UniProtKB	Beta strand	1832	1834	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1835	1844	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
P38398	UniProtKB	Helix	1851	1853	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IGK	
##sequence-region P0CG63 1 381
P0CG63	UniProtKB	Chain	1	76	.	.	.	ID=PRO_0000396306;Note=Ubiquitin	
P0CG63	UniProtKB	Chain	77	152	.	.	.	ID=PRO_0000396307;Note=Ubiquitin	
P0CG63	UniProtKB	Chain	153	228	.	.	.	ID=PRO_0000396308;Note=Ubiquitin	
P0CG63	UniProtKB	Chain	229	304	.	.	.	ID=PRO_0000396309;Note=Ubiquitin	
P0CG63	UniProtKB	Chain	305	380	.	.	.	ID=PRO_0000396310;Note=Ubiquitin	
P0CG63	UniProtKB	Propeptide	381	381	.	.	.	ID=PRO_0000396311	
P0CG63	UniProtKB	Domain	1	76	.	.	.	Note=Ubiquitin-like 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00214	
P0CG63	UniProtKB	Domain	77	152	.	.	.	Note=Ubiquitin-like 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00214	
P0CG63	UniProtKB	Domain	153	228	.	.	.	Note=Ubiquitin-like 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00214	
P0CG63	UniProtKB	Domain	229	304	.	.	.	Note=Ubiquitin-like 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00214	
P0CG63	UniProtKB	Domain	305	380	.	.	.	Note=Ubiquitin-like 5;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00214	
P0CG63	UniProtKB	Cross-link	76	76	.	.	.	Note=Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)	
P0CG63	UniProtKB	Mutagenesis	29	29	.	.	.	Note=Deficiency in ubiquitin-protein conjugate formation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7615550;Dbxref=PMID:7615550	
P0CG63	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Deficiency in ubiquitin-protein conjugate formation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7615550;Dbxref=PMID:7615550	
P0CG63	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Deficiency in ubiquitin-protein conjugate formation. Loss of DNA repair function. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7615550;Dbxref=PMID:7615550	
P0CG63	UniProtKB	Sequence conflict	352	352	.	.	.	Note=K->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P0CG63	UniProtKB	Beta strand	231	234	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Beta strand	236	238	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Beta strand	241	243	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Helix	251	256	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Helix	266	268	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Beta strand	270	272	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Beta strand	274	277	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Helix	285	287	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Beta strand	294	298	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1ZW7	
P0CG63	UniProtKB	Beta strand	306	310	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Q5E	
P0CG63	UniProtKB	Turn	312	314	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1Q0W	
P0CG63	UniProtKB	Beta strand	316	320	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Q5E	
P0CG63	UniProtKB	Beta strand	323	326	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1Q0W	
P0CG63	UniProtKB	Helix	327	338	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Q5E	
P0CG63	UniProtKB	Turn	342	344	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Q5E	
P0CG63	UniProtKB	Beta strand	345	349	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Q5E	
P0CG63	UniProtKB	Beta strand	351	353	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4NNJ	
P0CG63	UniProtKB	Beta strand	358	360	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3OLM	
P0CG63	UniProtKB	Helix	361	363	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Q5E	
P0CG63	UniProtKB	Beta strand	370	375	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Q5E	
P0CG63	UniProtKB	Helix	377	379	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2JT4	
##sequence-region Q6SJ61 1 286
Q6SJ61	UniProtKB	Signal peptide	1	23	.	.	.	Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:SignalP	
Q6SJ61	UniProtKB	Chain	24	286	.	.	.	ID=PRO_5015098494;Note=Beta-lactamase;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:SignalP	
##sequence-region P0DP23 1 149
P0DP23	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22223895,ECO:0000244|PubMed:22814378,ECO:0000244|PubMed:25944712,ECO:0000269|PubMed:7093203,ECO:0000269|Ref.7;Dbxref=PMID:19413330,PMID:22223895,PMID:22814378,PMID:25944712,PMID:7093203	
P0DP23	UniProtKB	Chain	2	149	.	.	.	ID=PRO_0000439932;Note=Calmodulin-1	
P0DP23	UniProtKB	Domain	8	43	.	.	.	Note=EF-hand 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00448	
P0DP23	UniProtKB	Domain	44	79	.	.	.	Note=EF-hand 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00448	
P0DP23	UniProtKB	Domain	81	116	.	.	.	Note=EF-hand 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00448	
P0DP23	UniProtKB	Domain	117	149	.	.	.	Note=EF-hand 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00448	
P0DP23	UniProtKB	Calcium binding	21	32	.	.	.	Note=1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:1CLL,ECO:0000244|PDB:5J03,ECO:0000269|PubMed:1474585,ECO:0000269|PubMed:27564677;Dbxref=PMID:1474585,PMID:27564677	
P0DP23	UniProtKB	Calcium binding	57	68	.	.	.	Note=2;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:1CLL,ECO:0000244|PDB:5J03,ECO:0000269|PubMed:1474585,ECO:0000269|PubMed:27564677;Dbxref=PMID:1474585,PMID:27564677	
P0DP23	UniProtKB	Calcium binding	94	105	.	.	.	Note=3;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:1CLL,ECO:0000244|PDB:5J03,ECO:0000269|PubMed:1474585,ECO:0000269|PubMed:27564677;Dbxref=PMID:1474585,PMID:27564677	
P0DP23	UniProtKB	Calcium binding	130	141	.	.	.	Note=4;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PDB:1CLL,ECO:0000244|PDB:5J03,ECO:0000269|PubMed:1474585,ECO:0000269|PubMed:27564677;Dbxref=PMID:1474585,PMID:27564677	
P0DP23	UniProtKB	Region	77	149	.	.	.	Note=Necessary and sufficient for interaction with PCP4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27876793;Dbxref=PMID:27876793	
P0DP23	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22223895,ECO:0000244|PubMed:22814378,ECO:0000244|PubMed:25944712,ECO:0000269|PubMed:7093203,ECO:0000269|Ref.7;Dbxref=PMID:19413330,PMID:22223895,PMID:22814378,PMID:25944712,PMID:7093203	
P0DP23	UniProtKB	Modified residue	22	22	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P0DP23	UniProtKB	Modified residue	45	45	.	.	.	Note=Phosphothreonine%3B by CaMK4;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P0DP29	
P0DP23	UniProtKB	Modified residue	82	82	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P0DP23	UniProtKB	Modified residue	95	95	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P0DP23	UniProtKB	Modified residue	100	100	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
P0DP23	UniProtKB	Modified residue	102	102	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:21406692,PMID:23186163,PMID:24275569	
P0DP23	UniProtKB	Modified residue	111	111	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
P0DP23	UniProtKB	Modified residue	116	116	.	.	.	Note=N6%2CN6%2CN6-trimethyllysine%3B alternate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:24129315,ECO:0000269|PubMed:7093203;Dbxref=PMID:24129315,PMID:7093203	
P0DP23	UniProtKB	Modified residue	116	116	.	.	.	Note=N6-methyllysine%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
P0DP23	UniProtKB	Modified residue	139	139	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
P0DP23	UniProtKB	Cross-link	22	22	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P0DP23	UniProtKB	Cross-link	22	22	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P62157	
P0DP23	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_069222;Note=In CPVT4%3B increased RYR2 calcium-release channel activity%3B not changed calcium-dependent inactivation of L-type calcium channel%3B not changed protein abundance%3B not changed structure%3B not changed thermal stability both in the absence and presence of calcium%3B no effect on the calcium binding affinity%3B significantly increased binding of RYR2%3B increased ryanodine-sensitive calcium-release channel activity%3B decreased of KCNN2 calcium-activated potassium channel activity%3B not changed KCNN2 expression%3B not changed KCNN2 location at membrane. N->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23040497,ECO:0000269|PubMed:26164367,ECO:0000269|PubMed:27165696,ECO:0000269|PubMed:27516456;Dbxref=dbSNP:rs267607276,PMID:23040497,PMID:26164367,PMID:27165696,PMID:27516456	
P0DP23	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_073275;Note=In LQT14%3B significantly decreased of KCNN2 calcium-activated potassium channel activity%3B not changed KCNN2 expression%3B not changed KCNN2 location at membrane. F->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24076290,ECO:0000269|PubMed:27165696;Dbxref=dbSNP:rs730882253,PMID:24076290,PMID:27165696	
P0DP23	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_078541;Note=In CPVT4%3B the mutant has significantly reduced calcium affinity compared to wild-type%3B calmodulin-RYR2 interaction is defective at low intracellular Ca(2+) concentrations and restored at moderate to high Ca(2+) concentrations%3B increased RYR2 calcium-release channel activity%3B decreased calcium-dependent inactivation of L-type calcium channel%3B not changed protein abundance%3B not changed structure%3B significantly reduced ryanodine-sensitive calcium-release channel activity%3B decreased of KCNN2 calcium-activated potassium channel activity%3B not changed KCNN2 expression%3B not changed KCNN2 location at membrane. N->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23040497,ECO:0000269|PubMed:26164367,ECO:0000269|PubMed:27165696,ECO:0000269|PubMed:27516456;Dbxref=dbSNP:rs398124647,PMID:23040497,PMID:26164367,PMID:27165696,PMID:27516456	
P0DP23	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_078542;Note=In LQT14%3B reduction in calcium affinity%3B not changed protein abundance%3B not changed structure%3B significantly decreased thermal stability in presence of calcium%3B significantly decreased RYR2 interaction%3B increased ryanodine-sensitive calcium-release channel activity%3B decreased of KCNN2 calcium-activated potassium channel activity%3B not changed KCNN2 expression%3B not changed KCNN2 location at membrane. D->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23388215,ECO:0000269|PubMed:26164367,ECO:0000269|PubMed:26969752,ECO:0000269|PubMed:27165696;Dbxref=dbSNP:rs730882252,PMID:23388215,PMID:26164367,PMID:26969752,PMID:27165696	
P0DP23	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_078263;Note=In LQT14%3B decreased calcium affinity%3B loss of CACNA1C calcium-dependent-inactivation%3B no effect on intracellular RYR2-mediated calcium release. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26969752;Dbxref=PMID:26969752	
P0DP23	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_073282;Note=In LQT14%3B reduction in calcium affinity%3B not changed protein abundance%3B not changed structure%3B significantly decreased thermal stability in presence of calcium%3B no effect on RYR2 interaction%3B significantly reduced ryanodine-sensitive calcium-release channel activity. F->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23388215,ECO:0000269|PubMed:26164367,ECO:0000269|PubMed:26969752;Dbxref=dbSNP:rs11551462,PMID:23388215,PMID:26164367,PMID:26969752	
P0DP23	UniProtKB	Helix	2	4	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5OEO	
P0DP23	UniProtKB	Helix	7	20	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Beta strand	25	28	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6DAD	
P0DP23	UniProtKB	Helix	30	39	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Helix	46	56	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Turn	57	59	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6BUT	
P0DP23	UniProtKB	Beta strand	61	64	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Helix	66	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Helix	76	78	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V7X	
P0DP23	UniProtKB	Turn	79	81	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6BUT	
P0DP23	UniProtKB	Helix	83	91	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Beta strand	97	102	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Helix	103	110	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Turn	111	114	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6HCS	
P0DP23	UniProtKB	Helix	119	129	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Beta strand	130	132	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6B8Q	
P0DP23	UniProtKB	Beta strand	133	138	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
P0DP23	UniProtKB	Helix	139	147	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V03	
##sequence-region P07550 1 413
P07550	UniProtKB	Chain	1	413	.	.	.	ID=PRO_0000069130;Note=Beta-2 adrenergic receptor	
P07550	UniProtKB	Topological domain	1	34	.	.	.	Note=Extracellular	
P07550	UniProtKB	Transmembrane	35	58	.	.	.	Note=Helical%3B Name%3D1	
P07550	UniProtKB	Topological domain	59	71	.	.	.	Note=Cytoplasmic	
P07550	UniProtKB	Transmembrane	72	95	.	.	.	Note=Helical%3B Name%3D2	
P07550	UniProtKB	Topological domain	96	106	.	.	.	Note=Extracellular	
P07550	UniProtKB	Transmembrane	107	129	.	.	.	Note=Helical%3B Name%3D3	
P07550	UniProtKB	Topological domain	130	150	.	.	.	Note=Cytoplasmic	
P07550	UniProtKB	Transmembrane	151	174	.	.	.	Note=Helical%3B Name%3D4	
P07550	UniProtKB	Topological domain	175	196	.	.	.	Note=Extracellular	
P07550	UniProtKB	Transmembrane	197	220	.	.	.	Note=Helical%3B Name%3D5	
P07550	UniProtKB	Topological domain	221	274	.	.	.	Note=Cytoplasmic	
P07550	UniProtKB	Transmembrane	275	298	.	.	.	Note=Helical%3B Name%3D6	
P07550	UniProtKB	Topological domain	299	305	.	.	.	Note=Extracellular	
P07550	UniProtKB	Transmembrane	306	329	.	.	.	Note=Helical%3B Name%3D7	
P07550	UniProtKB	Topological domain	330	413	.	.	.	Note=Cytoplasmic	
P07550	UniProtKB	Region	193	207	.	.	.	Note=Agonist and antagonist binding	
P07550	UniProtKB	Region	286	293	.	.	.	Note=Agonist and antagonist binding	
P07550	UniProtKB	Region	312	316	.	.	.	Note=Agonist and antagonist binding	
P07550	UniProtKB	Motif	410	413	.	.	.	Note=PDZ-binding	
P07550	UniProtKB	Binding site	113	113	.	.	.	Note=Agonist or antagonist	
P07550	UniProtKB	Binding site	118	118	.	.	.	Note=Agonist or antagonist	
P07550	UniProtKB	Modified residue	141	141	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8521811;Dbxref=PMID:8521811	
P07550	UniProtKB	Modified residue	246	246	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:17525332;Dbxref=PMID:17525332	
P07550	UniProtKB	Modified residue	261	261	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P07550	UniProtKB	Modified residue	262	262	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P07550	UniProtKB	Modified residue	345	345	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11146000;Dbxref=PMID:11146000	
P07550	UniProtKB	Modified residue	346	346	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11146000;Dbxref=PMID:11146000	
P07550	UniProtKB	Modified residue	355	355	.	.	.	Note=Phosphoserine%3B by BARK;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P07550	UniProtKB	Modified residue	356	356	.	.	.	Note=Phosphoserine%3B by BARK;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P07550	UniProtKB	Modified residue	382	382	.	.	.	Note=4-hydroxyproline;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19584355;Dbxref=PMID:19584355	
P07550	UniProtKB	Modified residue	395	395	.	.	.	Note=4-hydroxyproline;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19584355;Dbxref=PMID:19584355	
P07550	UniProtKB	Lipidation	341	341	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17962520,ECO:0000269|PubMed:18547522,ECO:0000269|PubMed:2540197;Dbxref=PMID:17962520,PMID:18547522,PMID:2540197	
P07550	UniProtKB	Glycosylation	6	6	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P07550	UniProtKB	Glycosylation	15	15	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P07550	UniProtKB	Disulfide bond	106	191	.	.	.	.	
P07550	UniProtKB	Disulfide bond	184	190	.	.	.	.	
P07550	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_049373;Note=N->S;Dbxref=dbSNP:rs33973603	
P07550	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_003452;Note=Common polymorphism. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:3025863,ECO:0000269|PubMed:3033609,ECO:0000269|PubMed:3034889,ECO:0000269|PubMed:7706471,ECO:0000269|PubMed:7915137,ECO:0000269|PubMed:8383511,ECO:0000269|Ref.8;Dbxref=dbSNP:rs1042713,PMID:15489334,PMID:3025863,PMID:3033609,PMID:3034889,PMID:7706471,PMID:7915137,PMID:8383511	
P07550	UniProtKB	Natural variant	27	27	.	.	.	ID=VAR_003453;Note=E->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11246467,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:2823249,ECO:0000269|PubMed:3025863,ECO:0000269|PubMed:3026848,ECO:0000269|PubMed:3033609,ECO:0000269|PubMed:3034889,ECO:0000269|PubMed:7915137,ECO:0000269|PubMed:8383511,ECO:0000269|Ref.10,ECO:0000269|Ref.11,ECO:0000269|Ref.12,ECO:0000269|Ref.8;Dbxref=dbSNP:rs1042714,PMID:11246467,PMID:15489334,PMID:2823249,PMID:3025863,PMID:3026848,PMID:3033609,PMID:3034889,PMID:7915137,PMID:8383511	
P07550	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_003454;Note=V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8383511;Dbxref=dbSNP:rs990810566,PMID:8383511	
P07550	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_009125;Note=I->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11246467;Dbxref=PMID:11246467	
P07550	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_009124;Note=I->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11246467;Dbxref=PMID:11246467	
P07550	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_003455;Note=T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8383511;Dbxref=dbSNP:rs1800888,PMID:8383511	
P07550	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_025101;Note=S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.11;Dbxref=dbSNP:rs3729943	
P07550	UniProtKB	Natural variant	375	375	.	.	.	ID=VAR_009394;Note=K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11246467;Dbxref=dbSNP:rs771585355,PMID:11246467	
P07550	UniProtKB	Mutagenesis	79	79	.	.	.	Note=Affects binding of catecholamines%2C and produces an uncoupling between the receptor and stimulatory G proteins. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2831218;Dbxref=PMID:2831218	
P07550	UniProtKB	Mutagenesis	141	141	.	.	.	Note=Abolishes insulin-induced tyrosine phosphorylation and insulin-induced receptor supersensitization. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8521811;Dbxref=PMID:8521811	
P07550	UniProtKB	Mutagenesis	341	341	.	.	.	Note=Uncoupled receptor. C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2540197;Dbxref=PMID:2540197	
P07550	UniProtKB	Mutagenesis	345	346	.	.	.	Note=Delayed agonist-promoted desensitization. SS->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11146000;Dbxref=PMID:11146000	
P07550	UniProtKB	Mutagenesis	350	350	.	.	.	Note=Does not affect insulin-induced tyrosine phosphorylation or insulin-induced receptor supersensitization. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8521811;Dbxref=PMID:8521811	
P07550	UniProtKB	Mutagenesis	354	354	.	.	.	Note=Does not affect insulin-induced tyrosine phosphorylation or insulin-induced receptor supersensitization. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8521811;Dbxref=PMID:8521811	
P07550	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Does not affect insulin-induced tyrosine phosphorylation or insulin-induced receptor supersensitization. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8521811;Dbxref=PMID:8521811	
P07550	UniProtKB	Sequence conflict	71	71	.	.	.	Note=F->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P07550	UniProtKB	Sequence conflict	216	216	.	.	.	Note=V->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P07550	UniProtKB	Sequence conflict	261	261	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P07550	UniProtKB	Sequence conflict	402	402	.	.	.	Note=Q->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P07550	UniProtKB	Beta strand	25	27	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3P0G	
P07550	UniProtKB	Helix	31	60	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	62	64	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	67	85	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	87	96	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	102	136	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Beta strand	137	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	141	144	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6MXT	
P07550	UniProtKB	Helix	147	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Turn	171	174	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	179	186	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Beta strand	187	189	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3SN6	
P07550	UniProtKB	Helix	197	207	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	209	229	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Turn	235	239	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2R4R	
P07550	UniProtKB	Helix	267	298	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Beta strand	299	303	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6MXT	
P07550	UniProtKB	Helix	305	317	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	318	320	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	322	325	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	326	328	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Helix	330	339	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2RH1	
P07550	UniProtKB	Turn	340	342	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5JQH	
P07550	UniProtKB	Turn	345	347	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2R4R	
##sequence-region Q9ES00 1 1173
Q9ES00	UniProtKB	Chain	1	1173	.	.	.	ID=PRO_0000194994;Note=Ubiquitin conjugation factor E4 B	
Q9ES00	UniProtKB	Domain	1098	1171	.	.	.	Note=U-box	
Q9ES00	UniProtKB	Site	109	110	.	.	.	Note=Cleavage%3B by caspase-3 and caspase-7;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9ES00	UniProtKB	Site	123	124	.	.	.	Note=Cleavage%3B by caspase-6 and granzyme B;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9ES00	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O95155	
Q9ES00	UniProtKB	Modified residue	23	23	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O95155	
Q9ES00	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21183079;Dbxref=PMID:21183079	
Q9ES00	UniProtKB	Modified residue	84	84	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O95155	
Q9ES00	UniProtKB	Modified residue	88	88	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21183079;Dbxref=PMID:21183079	
Q9ES00	UniProtKB	Modified residue	90	90	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21183079;Dbxref=PMID:21183079	
Q9ES00	UniProtKB	Modified residue	101	101	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21183079;Dbxref=PMID:21183079	
Q9ES00	UniProtKB	Modified residue	103	103	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21183079;Dbxref=PMID:21183079	
Q9ES00	UniProtKB	Modified residue	105	105	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O95155	
Q9ES00	UniProtKB	Modified residue	124	124	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O95155	
Q9ES00	UniProtKB	Modified residue	238	238	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O95155	
Q9ES00	UniProtKB	Modified residue	674	674	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21183079;Dbxref=PMID:21183079	
Q9ES00	UniProtKB	Modified residue	840	840	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21183079;Dbxref=PMID:21183079	
Q9ES00	UniProtKB	Modified residue	1136	1136	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O95155	
Q9ES00	UniProtKB	Mutagenesis	1140	1140	.	.	.	Note=Loss of E3 ubiquitin protein ligase activity. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11435423;Dbxref=PMID:11435423	
Q9ES00	UniProtKB	Sequence conflict	298	298	.	.	.	Note=L->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9ES00	UniProtKB	Sequence conflict	408	408	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9ES00	UniProtKB	Sequence conflict	408	408	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9ES00	UniProtKB	Sequence conflict	674	674	.	.	.	Note=S->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9ES00	UniProtKB	Sequence conflict	697	697	.	.	.	Note=C->Y;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9ES00	UniProtKB	Sequence conflict	753	753	.	.	.	Note=E->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9ES00	UniProtKB	Turn	1101	1103	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KR4	
Q9ES00	UniProtKB	Turn	1106	1108	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KR4	
Q9ES00	UniProtKB	Beta strand	1113	1117	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KR4	
Q9ES00	UniProtKB	Beta strand	1123	1125	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KR4	
Q9ES00	UniProtKB	Helix	1126	1135	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KR4	
Q9ES00	UniProtKB	Turn	1140	1142	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KR4	
Q9ES00	UniProtKB	Helix	1148	1150	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KR4	
Q9ES00	UniProtKB	Helix	1155	1170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KR4	
##sequence-region P63279 1 158
P63279	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22814378;Dbxref=PMID:19413330,PMID:22814378	
P63279	UniProtKB	Chain	2	158	.	.	.	ID=PRO_0000082454;Note=SUMO-conjugating enzyme UBC9	
P63279	UniProtKB	Region	13	18	.	.	.	Note=Interaction with SUMO1	
P63279	UniProtKB	Active site	93	93	.	.	.	Note=Glycyl thioester intermediate	
P63279	UniProtKB	Site	4	4	.	.	.	Note=Interaction with RANBP2	
P63279	UniProtKB	Site	25	25	.	.	.	Note=Interaction with RANBP2	
P63279	UniProtKB	Site	57	57	.	.	.	Note=Interaction with RANBP2	
P63279	UniProtKB	Site	100	101	.	.	.	Note=Substrate binding	
P63279	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22814378;Dbxref=PMID:19413330,PMID:22814378	
P63279	UniProtKB	Modified residue	65	65	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P63279	UniProtKB	Modified residue	71	71	.	.	.	Note=Phosphoserine%3B by CDK1;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:22509284;Dbxref=PMID:23186163,PMID:22509284	
P63279	UniProtKB	Cross-link	18	18	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P63279	UniProtKB	Cross-link	18	18	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)%3B alternate	
P63279	UniProtKB	Cross-link	48	48	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25755297,PMID:28112733	
P63279	UniProtKB	Cross-link	49	49	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25114211;Dbxref=PMID:25114211	
P63279	UniProtKB	Cross-link	49	49	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25114211,ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25114211,PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
P63279	UniProtKB	Cross-link	101	101	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P63279	UniProtKB	Mutagenesis	13	14	.	.	.	Note=Impairs binding to SUMO1 and catalytic activity. RK->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12924945;Dbxref=PMID:12924945	
P63279	UniProtKB	Mutagenesis	17	18	.	.	.	Note=Impairs binding to SUMO1 and catalytic activity. RK->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12924945;Dbxref=PMID:12924945	
P63279	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Impairs binding to RANBP2. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Impairs binding to RANBP2. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Impairs binding to RANBP2. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Slightly impairs binding to RANBP2. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Slightly impairs binding to RANBP2. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Slightly impairs binding to RANBP2. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Impairs binding to RANBP2. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Impairs binding to RANBP2. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Slightly impairs binding to RANBP2. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15608651;Dbxref=PMID:15608651	
P63279	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Impairs catalytic activity. N->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16732283;Dbxref=PMID:16732283	
P63279	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Impairs catalytic activity. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16732283;Dbxref=PMID:16732283	
P63279	UniProtKB	Mutagenesis	93	93	.	.	.	Note=Loss of enhancement of sumoylation by RWDD3. No effect on RWDD3 protein levels. C->S	
P63279	UniProtKB	Mutagenesis	100	101	.	.	.	Note=Impairs catalytic activity. DK->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12641448;Dbxref=PMID:12641448	
P63279	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Impairs catalytic activity. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16732283;Dbxref=PMID:16732283	
P63279	UniProtKB	Mutagenesis	127	127	.	.	.	Note=No effect on catalytic activity. D->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16732283;Dbxref=PMID:16732283	
P63279	UniProtKB	Sequence conflict	18	18	.	.	.	Note=K->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P63279	UniProtKB	Sequence conflict	86	89	.	.	.	Note=VYPS->GVPF;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P63279	UniProtKB	Helix	3	18	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Beta strand	25	30	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Beta strand	32	34	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2PE6	
P63279	UniProtKB	Beta strand	36	46	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Turn	52	55	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Beta strand	57	63	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Turn	66	69	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Beta strand	74	79	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Beta strand	90	92	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Helix	95	97	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Turn	99	102	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Helix	109	121	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Helix	131	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
P63279	UniProtKB	Helix	141	154	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5F6E	
##sequence-region P01112 1 189
P01112	UniProtKB	Chain	1	186	.	.	.	ID=PRO_0000042996;Note=GTPase HRas	
P01112	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.12	
P01112	UniProtKB	Chain	2	186	.	.	.	ID=PRO_0000326476;Note=GTPase HRas%2C N-terminally processed	
P01112	UniProtKB	Propeptide	187	189	.	.	.	ID=PRO_0000042997;Note=Removed in mature form	
P01112	UniProtKB	Nucleotide binding	10	17	.	.	.	Note=GTP	
P01112	UniProtKB	Nucleotide binding	57	61	.	.	.	Note=GTP	
P01112	UniProtKB	Nucleotide binding	116	119	.	.	.	Note=GTP	
P01112	UniProtKB	Region	166	185	.	.	.	Note=Hypervariable region	
P01112	UniProtKB	Motif	32	40	.	.	.	Note=Effector region	
P01112	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine%3B in GTPase HRas%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.12	
P01112	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylthreonine%3B in GTPase HRas%2C N-terminally processed;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.12	
P01112	UniProtKB	Modified residue	118	118	.	.	.	Note=S-nitrosocysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9020151;Dbxref=PMID:9020151	
P01112	UniProtKB	Modified residue	186	186	.	.	.	Note=Cysteine methyl ester;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8626715;Dbxref=PMID:8626715	
P01112	UniProtKB	Lipidation	181	181	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15705808,ECO:0000269|PubMed:16000296,ECO:0000269|PubMed:2661017,ECO:0000269|PubMed:8626715;Dbxref=PMID:15705808,PMID:16000296,PMID:2661017,PMID:8626715	
P01112	UniProtKB	Lipidation	184	184	.	.	.	Note=S-(15-deoxy-Delta12%2C14-prostaglandin J2-9-yl)cysteine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12684535;Dbxref=PMID:12684535	
P01112	UniProtKB	Lipidation	184	184	.	.	.	Note=S-palmitoyl cysteine%3B alternate;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15705808,ECO:0000269|PubMed:16000296,ECO:0000269|PubMed:2661017,ECO:0000269|PubMed:8626715;Dbxref=PMID:15705808,PMID:16000296,PMID:2661017,PMID:8626715	
P01112	UniProtKB	Lipidation	186	186	.	.	.	Note=S-farnesyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8626715;Dbxref=PMID:8626715	
P01112	UniProtKB	Cross-link	170	170	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30442762;Dbxref=PMID:30442762	
P01112	UniProtKB	Alternative sequence	152	189	.	.	.	ID=VSP_041597;Note=In isoform 2. VEDAFYTLVREIRQHKLRKLNPPDESGPGCMSCKCVLS->SRSGSSSSSGTLWDPPGPM;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14500341,ECO:0000303|PubMed:15489334;Dbxref=PMID:14500341,PMID:15489334	
P01112	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_026106;Note=In CSTLO. G->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16170316,ECO:0000269|PubMed:16329078,ECO:0000269|PubMed:16443854;Dbxref=dbSNP:rs104894230,PMID:16170316,PMID:16329078,PMID:16443854	
P01112	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_045975;Note=In CSTLO. G->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16443854,ECO:0000269|PubMed:18039947;Dbxref=dbSNP:rs104894229,PMID:16443854,PMID:18039947	
P01112	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_068816;Note=In CSTLO%3B severe mutation. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18039947;Dbxref=dbSNP:rs104894230,PMID:18039947	
P01112	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_045976;Note=In CSTLO. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16443854;Dbxref=PMID:16443854	
P01112	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_006837;Note=In CSTLO and CMEMS%3B also found in patients with oral squamous cell carcinoma. G->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1459726,ECO:0000269|PubMed:16170316,ECO:0000269|PubMed:16329078,ECO:0000269|PubMed:16443854,ECO:0000269|PubMed:17054105,ECO:0000269|PubMed:17412879;Dbxref=dbSNP:rs104894229,PMID:1459726,PMID:16170316,PMID:16329078,PMID:16443854,PMID:17054105,PMID:17412879	
P01112	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_006836;Note=In CSTLO%2C bladder carcinoma and CMEMS%3B constitutively activated%3B interacts and recruits PLCE1 to plasma membrane. G->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11022048,ECO:0000269|PubMed:15546861,ECO:0000269|PubMed:16170316,ECO:0000269|PubMed:17412879;Dbxref=dbSNP:rs104894230,PMID:11022048,PMID:15546861,PMID:16170316,PMID:17412879	
P01112	UniProtKB	Natural variant	13	13	.	.	.	ID=VAR_026107;Note=In CSTLO. G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16329078;Dbxref=dbSNP:rs104894228,PMID:16329078	
P01112	UniProtKB	Natural variant	13	13	.	.	.	ID=VAR_026108;Note=In CSTLO. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16170316;Dbxref=dbSNP:rs104894226,PMID:16170316	
P01112	UniProtKB	Natural variant	13	13	.	.	.	ID=VAR_068817;Note=In SFM%3B somatic mutation%3B shows constitutive activation of the MAPK and PI3K-AKT signaling pathways. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22683711;Dbxref=dbSNP:rs104894228,PMID:22683711	
P01112	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_045977;Note=In CMEMS. Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17412879;Dbxref=dbSNP:rs121917757,PMID:17412879	
P01112	UniProtKB	Natural variant	37	37	.	.	.	ID=VAR_068818;Note=In CSTLO. E->EE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19995790;Dbxref=PMID:19995790	
P01112	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_045978;Note=In CSTLO. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18247425;Dbxref=dbSNP:rs121917758,PMID:18247425	
P01112	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_045979;Note=In NMTC2%3B somatic mutation%3B increases transformation of cultured cell lines. Q->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12727991,ECO:0000269|PubMed:18073111;Dbxref=dbSNP:rs28933406,PMID:12727991,PMID:18073111	
P01112	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_006838;Note=In melanoma%3B strongly reduced GTP hydrolysis in the presence of RAF1%3B increases transformation of cultured cell lines. Q->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18073111;Dbxref=dbSNP:rs121913233,PMID:18073111	
P01112	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_045980;Note=In CMEMS. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17412879;Dbxref=dbSNP:rs121917756,PMID:17412879	
P01112	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_078259;Note=Found in a patient with severe fetal hydrops and pleural effusion%3B unknown pathological significance%3B decreased activation of Ras protein signal transduction. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22821884;Dbxref=dbSNP:rs755322824,PMID:22821884	
P01112	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_045981;Note=In CSTLO. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16443854;Dbxref=dbSNP:rs104894227,PMID:16443854	
P01112	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_045982;Note=In CSTLO. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17054105;Dbxref=dbSNP:rs104894231,PMID:17054105	
P01112	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_045983;Note=In CSTLO. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18247425;Dbxref=dbSNP:rs121917759,PMID:18247425	
P01112	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Dominant negative. Prevents PLCE1 EGF-induced recruitment to plasma membrane. No effect on subcellular location of isoform 2. S->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11022048,ECO:0000269|PubMed:14500341;Dbxref=PMID:11022048,PMID:14500341	
P01112	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Loss of interaction with PLCE1%3B when associated with V-12. N->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11022048;Dbxref=PMID:11022048	
P01112	UniProtKB	Mutagenesis	29	29	.	.	.	Note=No effect on interaction with PLCE1%3B when associated with V-12. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11022048;Dbxref=PMID:11022048	
P01112	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Loss of interaction and recruitment to plasma membrane of PLCE1%3B when associated with V-12. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11022048;Dbxref=PMID:11022048	
P01112	UniProtKB	Mutagenesis	34	34	.	.	.	Note=No effect on interaction with PLCE1%3B when associated with V-12. P->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11022048;Dbxref=PMID:11022048	
P01112	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Loss of interaction with PLCE1%3B when associated with V-12. T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11022048;Dbxref=PMID:11022048	
P01112	UniProtKB	Mutagenesis	37	37	.	.	.	Note=No effect on interaction with PLCE1%3B when associated with V-12. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11022048;Dbxref=PMID:11022048	
P01112	UniProtKB	Mutagenesis	38	38	.	.	.	Note=No effect on interaction with PLCE1%3B when associated with V-12. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11022048;Dbxref=PMID:11022048	
P01112	UniProtKB	Mutagenesis	39	39	.	.	.	Note=No effect on interaction with PLCE1%3B when associated with V-12. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11022048;Dbxref=PMID:11022048	
P01112	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loss of GTPase activity and creation of an autophosphorylation site. A->T	
P01112	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Moderately increased transformation of cultured cell lines. Q->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18073111;Dbxref=PMID:18073111	
P01112	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Strongly increased transformation of cultured cell lines. Q->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18073111;Dbxref=PMID:18073111	
P01112	UniProtKB	Mutagenesis	83	83	.	.	.	Note=GTP-binding activity reduced by factor of 30. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3088563;Dbxref=PMID:3088563	
P01112	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Abolishes S-nitrosylation. No stimulation of guanine nucleotide exchange. C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12740440,ECO:0000269|PubMed:9020151;Dbxref=PMID:12740440,PMID:9020151	
P01112	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Loss of GTP-binding activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3088563;Dbxref=PMID:3088563	
P01112	UniProtKB	Mutagenesis	144	144	.	.	.	Note=GTP-binding activity reduced by factor of 25. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3088563;Dbxref=PMID:3088563	
P01112	UniProtKB	Mutagenesis	164	165	.	.	.	Note=Loss of GTP-binding activity. RQ->AV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3011420;Dbxref=PMID:3011420	
P01112	UniProtKB	Mutagenesis	170	170	.	.	.	Note=Increased Ras signaling due to impaired ubiquitination. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:30442762;Dbxref=PMID:30442762	
P01112	UniProtKB	Mutagenesis	181	181	.	.	.	Note=Exclusively localized in Golgi. Non-specifically localized on all endomembranes%3B when associated with S-184. C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15705808,ECO:0000269|PubMed:8626715;Dbxref=PMID:15705808,PMID:8626715	
P01112	UniProtKB	Mutagenesis	184	184	.	.	.	Note=Loss of S-(15-deoxy-Delta12%2C14-prostaglandin J2-9-yl)cysteine stimulation of Ras-GTPase activity. Mainly localized in Golgi. Non-specifically localized on all endomembranes%3B when associated with S-181. C->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12684535,ECO:0000269|PubMed:15705808,ECO:0000269|PubMed:8626715;Dbxref=PMID:12684535,PMID:15705808,PMID:8626715	
P01112	UniProtKB	Beta strand	3	11	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Beta strand	12	15	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6D55	
P01112	UniProtKB	Helix	16	25	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Beta strand	27	31	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1XCM	
P01112	UniProtKB	Beta strand	34	37	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1XD2	
P01112	UniProtKB	Beta strand	38	46	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Beta strand	49	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Beta strand	60	63	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CLD	
P01112	UniProtKB	Helix	66	74	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Beta strand	76	83	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Turn	84	86	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1CRP	
P01112	UniProtKB	Helix	87	104	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Beta strand	105	107	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6Q21	
P01112	UniProtKB	Beta strand	111	116	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Beta strand	120	122	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CLD	
P01112	UniProtKB	Helix	127	136	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Beta strand	141	144	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Turn	146	148	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
P01112	UniProtKB	Helix	152	164	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2CE2	
##sequence-region P61073 1 352
P61073	UniProtKB	Chain	1	352	.	.	.	ID=PRO_0000069352;Note=C-X-C chemokine receptor type 4	
P61073	UniProtKB	Topological domain	1	38	.	.	.	Note=Extracellular;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Transmembrane	39	63	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Topological domain	64	77	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Transmembrane	78	99	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Topological domain	100	110	.	.	.	Note=Extracellular;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Transmembrane	111	130	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Topological domain	131	154	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Transmembrane	155	174	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Topological domain	175	195	.	.	.	Note=Extracellular;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Transmembrane	196	216	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Topological domain	217	241	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Transmembrane	242	261	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Topological domain	262	282	.	.	.	Note=Extracellular;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Transmembrane	283	302	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Topological domain	303	352	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Region	1	21	.	.	.	Note=Important for chemokine binding%2C signaling and HIV-1 coreceptor activity;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Region	94	97	.	.	.	Note=Chemokine binding;Ontology_term=ECO:0000269,ECO:0000305;evidence=ECO:0000269|PubMed:20929726,ECO:0000305|PubMed:10825158;Dbxref=PMID:20929726,PMID:10825158	
P61073	UniProtKB	Region	113	117	.	.	.	Note=Chemokine binding	
P61073	UniProtKB	Region	135	147	.	.	.	Note=Involved in dimerization%3B when bound to chemokine	
P61073	UniProtKB	Region	186	190	.	.	.	Note=Chemokine binding%2C important for signaling and HIV-1 coreceptor activity	
P61073	UniProtKB	Region	191	210	.	.	.	Note=Involved in dimerization	
P61073	UniProtKB	Region	266	268	.	.	.	Note=Involved in dimerization	
P61073	UniProtKB	Motif	133	135	.	.	.	Note=Important for signaling	
P61073	UniProtKB	Binding site	171	171	.	.	.	Note=Chemokine	
P61073	UniProtKB	Binding site	288	288	.	.	.	Note=Chemokine;Ontology_term=ECO:0000269,ECO:0000305;evidence=ECO:0000269|PubMed:20929726,ECO:0000305|PubMed:10825158;Dbxref=PMID:20929726,PMID:10825158	
P61073	UniProtKB	Modified residue	7	7	.	.	.	Note=Sulfotyrosine%3B partial;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18834145;Dbxref=PMID:18834145	
P61073	UniProtKB	Modified residue	12	12	.	.	.	Note=Sulfotyrosine%3B partial;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18834145;Dbxref=PMID:18834145	
P61073	UniProtKB	Modified residue	21	21	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12034737,ECO:0000269|PubMed:16725153,ECO:0000269|PubMed:18834145;Dbxref=PMID:12034737,PMID:16725153,PMID:18834145	
P61073	UniProtKB	Modified residue	319	319	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P61073	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:20048153;Dbxref=PMID:23186163,PMID:20048153	
P61073	UniProtKB	Modified residue	324	324	.	.	.	Note=Phosphoserine%3B by PKC and GRK6;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:19116316,ECO:0000269|PubMed:20048153;Dbxref=PMID:23186163,PMID:19116316,PMID:20048153	
P61073	UniProtKB	Modified residue	325	325	.	.	.	Note=Phosphoserine%3B by PKC and GRK6;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:19116316,ECO:0000269|PubMed:20048153;Dbxref=PMID:23186163,PMID:19116316,PMID:20048153	
P61073	UniProtKB	Modified residue	330	330	.	.	.	Note=Phosphoserine%3B by GRK6;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20048153;Dbxref=PMID:20048153	
P61073	UniProtKB	Modified residue	339	339	.	.	.	Note=Phosphoserine%3B by GRK6;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20048153;Dbxref=PMID:20048153	
P61073	UniProtKB	Modified residue	348	348	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P61073	UniProtKB	Modified residue	351	351	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20048153;Dbxref=PMID:20048153	
P61073	UniProtKB	Glycosylation	11	11	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10756055;Dbxref=PMID:10756055	
P61073	UniProtKB	Glycosylation	18	18	.	.	.	Note=O-linked (Xyl...) (chondroitin sulfate) serine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034737;Dbxref=PMID:12034737	
P61073	UniProtKB	Glycosylation	176	176	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P61073	UniProtKB	Disulfide bond	28	274	.	.	.	Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000255,ECO:0000269;evidence=ECO:0000244|PDB:3ODU,ECO:0000244|PDB:3OE0,ECO:0000244|PDB:3OE8,ECO:0000244|PDB:3OE9,ECO:0000244|PDB:4RWS,ECO:0000255|PROSITE-ProRule:PRU00521,ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Disulfide bond	109	186	.	.	.	Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000255,ECO:0000269;evidence=ECO:0000244|PDB:3ODU,ECO:0000244|PDB:3OE0,ECO:0000244|PDB:3OE6,ECO:0000244|PDB:3OE8,ECO:0000244|PDB:3OE9,ECO:0000244|PDB:4RWS,ECO:0000255|PROSITE-ProRule:PRU00521,ECO:0000269|PubMed:20929726;Dbxref=PMID:20929726	
P61073	UniProtKB	Cross-link	331	331	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:28978524;Dbxref=PMID:28978524	
P61073	UniProtKB	Alternative sequence	1	5	.	.	.	ID=VSP_001890;Note=In isoform 2. MEGIS->MSIPLPLLQ;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:10452968;Dbxref=PMID:10452968	
P61073	UniProtKB	Natural variant	333	352	.	.	.	ID=VAR_081112;Note=Found in patients with Waldenstroem macroglobulinemia%3B somatic mutation. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24553177;Dbxref=PMID:24553177	
P61073	UniProtKB	Natural variant	334	352	.	.	.	ID=VAR_081113;Note=In WHIMS%3B also found in patients with Waldenstroem macroglobulinemia%3B somatic mutation. Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12692554,ECO:0000269|PubMed:24553177;Dbxref=PMID:12692554,PMID:24553177	
P61073	UniProtKB	Natural variant	338	352	.	.	.	ID=VAR_081114;Note=In WHIMS%3B common somatic mutation in patients with Waldenstroem macroglobulinemia%3B results in decreased CXCL12-triggered receptor internalization%3B enhanced AKT and MAPK signaling activation%3B confers resistance to ibrutinib-triggered apoptosis. Missing;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15536153,ECO:0000269|PubMed:24366360,ECO:0000269|PubMed:24553177,ECO:0000269|PubMed:24912431;Dbxref=PMID:15536153,PMID:24366360,PMID:24553177,PMID:24912431	
P61073	UniProtKB	Natural variant	343	352	.	.	.	ID=VAR_081115;Note=In WHIMS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12692554;Dbxref=PMID:12692554	
P61073	UniProtKB	Mutagenesis	2	9	.	.	.	Note=Reduced CXCL12 binding. Abolishes signaling. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	4	20	.	.	.	Note=Reduced CXCL12 binding. Impaired signaling. Reduced coreceptor activity for HIV-1 isolates LAI and NDK. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	7	7	.	.	.	Note=Reduced coreceptor activity for HIV-1 isolates LAI and NDK. Greatly reduced coreceptor activity for HIV-1 isolates LAI and NDK%3B when associated with A-12. Y->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10825158,ECO:0000269|PubMed:12034737;Dbxref=PMID:10825158,PMID:12034737	
P61073	UniProtKB	Mutagenesis	7	7	.	.	.	Note=Sulfate incorporation greatly reduced%3B when associated with F-12 and F-21. Moderate reduction in sulfate incorporation%3B when associated with F-12 and A-18. No sulfate incorporation and binding SDF-1alpha greatly reduced%3B when associated with F-12%3B A-18 and F-21. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10825158,ECO:0000269|PubMed:12034737;Dbxref=PMID:10825158,PMID:12034737	
P61073	UniProtKB	Mutagenesis	8	8	.	.	.	Note=No effect on sulfate incorporation%3B when associated with A-9 and A-13. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034737;Dbxref=PMID:12034737	
P61073	UniProtKB	Mutagenesis	9	9	.	.	.	Note=No effect on sulfate incorporation%3B when associated with A-8 and A-13. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034737;Dbxref=PMID:12034737	
P61073	UniProtKB	Mutagenesis	10	20	.	.	.	Note=Reduced CXCL12 binding. No effect on signaling. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	11	11	.	.	.	Note=Reduced molecular weight. Enhanced coreceptor activity on R5 HIV-1 isolate Envs. Slight further enhancement of coreceptor activity%3B when associated with A-13. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10756055;Dbxref=PMID:10756055	
P61073	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Greatly reduced coreceptor activity for HIV-1 isolates LAI and NDK%3B when associated with A-7. Y->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10825158,ECO:0000269|PubMed:12034737;Dbxref=PMID:10825158,PMID:12034737	
P61073	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Sulfate incorporation greatly reduced%3B when associated with F-7 and F-21. Moderate reduction in sulfate incorporation%3B when associated with F-7 and A-18. No sulfate incorporation and binding SDF-1alpha greatly reduced%3B when associated with F-7%3B A-18 and F-21. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10825158,ECO:0000269|PubMed:12034737;Dbxref=PMID:10825158,PMID:12034737	
P61073	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Enhanced coreceptor activity on R5 HIV-1 isolate Envs. No effect on sulfate incorporation%3B when associated with A-8 and A-9. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10756055;Dbxref=PMID:10756055	
P61073	UniProtKB	Mutagenesis	14	15	.	.	.	Note=Reduced CXCL12 binding. Reduced coreceptor activity for HIV-1 isolate NDK. EE->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	18	18	.	.	.	Note=Sulfate incorporation greatly reduced%3B when associated with F-21. Moderate reduction in sulfate incorporation%3B when associated with F-7 and F-12. No sulfate incorporation and binding SDF-1alpha greatly reduced%3B when associated with F-7%3B F-12%3B and F-21. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12034737;Dbxref=PMID:12034737	
P61073	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Reduced CXCL12 binding. Reduced coreceptor activity for HIV-1 isolates LAI and NDk. Y->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10825158,ECO:0000269|PubMed:12034737;Dbxref=PMID:10825158,PMID:12034737	
P61073	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Sulfate incorporation greatly reduced%3B when associated with F-7 and F-12. Sulfate incorporation greatly reduced%3B when associated with A-18. No sulfate incorporation and binding SDF-1alpha greatly reduced%3B when associated with F-7%3B F-12 and A-18. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10825158,ECO:0000269|PubMed:12034737;Dbxref=PMID:10825158,PMID:12034737	
P61073	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Reduced CXCL12 binding. Abolishes signaling. Markedly reduced coreceptor activity for HIV-1 isolate LAI. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	119	119	.	.	.	Note=No reduction of agonist-induced G-protein activation. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17197449;Dbxref=PMID:17197449	
P61073	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Loss of agonist-induced G-protein activation. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17197449;Dbxref=PMID:17197449	
P61073	UniProtKB	Mutagenesis	119	119	.	.	.	Note=Constitutive G-protein activation%2C with further activation induced by agonist. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17197449;Dbxref=PMID:17197449	
P61073	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Increased thermostability. L->W	
P61073	UniProtKB	Mutagenesis	133	133	.	.	.	Note=No reduction of agonist-induced G-protein activation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17197449;Dbxref=PMID:17197449	
P61073	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Loss of agonist-induced G-protein activation. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17197449;Dbxref=PMID:17197449	
P61073	UniProtKB	Mutagenesis	135	135	.	.	.	Note=No reduction of agonist-induced G-protein activation. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17197449;Dbxref=PMID:17197449	
P61073	UniProtKB	Mutagenesis	171	171	.	.	.	Note=Reduced coreceptor activity for HIV-1 isolate NDK. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	176	176	.	.	.	Note=Enhanced coreceptor activity on R5 HIV-1 isolate Envs%3B when associated with A-11. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10756055;Dbxref=PMID:10756055	
P61073	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Reduced coreceptor activity for several HIV-1 isolates. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10074102;Dbxref=PMID:10074102	
P61073	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Reduced CXCL12 binding. Abolishes signaling. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	188	188	.	.	.	Note=Reduced coreceptor activity for several HIV-1 isolates. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10074102;Dbxref=PMID:10074102	
P61073	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Greatly reduced coreceptor activity for HIV-1 isolate NDK. Reduced coreceptor activity for several other HIV-1 isolates. D->A%2CS%2CN;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10074102,ECO:0000269|PubMed:10825158;Dbxref=PMID:10074102,PMID:10825158	
P61073	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Abolishes coreceptor activity for HIV-1 isolate NDK. Reduced coreceptor activity for several other HIV-1 isolates. D->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10074102,ECO:0000269|PubMed:10825158;Dbxref=PMID:10074102,PMID:10825158	
P61073	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Retains ligand-binding affinity but abolishes signaling. T->P	
P61073	UniProtKB	Mutagenesis	262	262	.	.	.	Note=Markedly reduced coreceptor activity for HIV-1 isolate LAI. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	268	268	.	.	.	Note=Markedly reduced coreceptor activity for HIV-1 isolate NDK. Less effect for HIV-1 isolate LAI. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	288	288	.	.	.	Note=Reduced CXCL12 binding. Impaired signaling. Reduced coreceptor activity for HIV-1 isolate LAI. Enhanced coreceptor activity for HIV-1 isolate NDK. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10825158;Dbxref=PMID:10825158	
P61073	UniProtKB	Mutagenesis	310	310	.	.	.	Note=No effect on ubiquitination by RNF113A. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28978524;Dbxref=PMID:28978524	
P61073	UniProtKB	Mutagenesis	324	324	.	.	.	Note=Moderate degradation. About 60%25 reduction in binding ITCH and no ubiquitination nor protein degradation%3B when associated with A-325. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19116316;Dbxref=PMID:19116316	
P61073	UniProtKB	Mutagenesis	324	324	.	.	.	Note=Enhanced binding to ITCH. Enhanced binding to ITCH and greatly increased protein degradation%3B when associated with D-324. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19116316;Dbxref=PMID:19116316	
P61073	UniProtKB	Mutagenesis	324	324	.	.	.	Note=Enhanced binding to ITCH. Enhanced binding to ITCH and greatly increased protein degradation%3B when associated with D-325. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19116316;Dbxref=PMID:19116316	
P61073	UniProtKB	Mutagenesis	325	325	.	.	.	Note=Moderate degradation. About 60%25 reduction in binding ITCH and no ubiquitination nor protein degradation%3B when associated with A-324. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19116316;Dbxref=PMID:19116316	
P61073	UniProtKB	Mutagenesis	330	330	.	.	.	Note=No effect on binding to ITCH. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19116316;Dbxref=PMID:19116316	
P61073	UniProtKB	Mutagenesis	331	331	.	.	.	Note=Loss of ubiquitination by RNF113A. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28978524;Dbxref=PMID:28978524	
P61073	UniProtKB	Sequence conflict	242	244	.	.	.	Note=VIL->IIP;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P61073	UniProtKB	Sequence conflict	278	278	.	.	.	Note=N->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P61073	UniProtKB	Beta strand	9	11	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2K03	
P61073	UniProtKB	Beta strand	21	23	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2K03	
P61073	UniProtKB	Beta strand	32	35	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2K05	
P61073	UniProtKB	Helix	37	62	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Turn	63	66	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Beta strand	67	69	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3OE6	
P61073	UniProtKB	Helix	72	88	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	91	99	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	105	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	141	143	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3OE0	
P61073	UniProtKB	Helix	145	153	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	155	159	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	161	166	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	169	174	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Beta strand	175	179	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Beta strand	181	188	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	193	207	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	209	225	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	226	228	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	231	266	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	274	291	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	294	301	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Turn	302	306	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
P61073	UniProtKB	Helix	313	317	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3ODU	
##sequence-region P35520 1 551
P35520	UniProtKB	Chain	1	551	.	.	.	ID=PRO_0000167133;Note=Cystathionine beta-synthase	
P35520	UniProtKB	Domain	418	476	.	.	.	Note=CBS;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00703	
P35520	UniProtKB	Region	256	260	.	.	.	Note=Pyridoxal phosphate binding;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Metal binding	52	52	.	.	.	Note=Iron (heme axial ligand);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Metal binding	65	65	.	.	.	Note=Iron (heme axial ligand);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Binding site	149	149	.	.	.	Note=Pyridoxal phosphate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Binding site	349	349	.	.	.	Note=Pyridoxal phosphate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Modified residue	27	27	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21406692;Dbxref=PMID:21406692	
P35520	UniProtKB	Modified residue	119	119	.	.	.	Note=N6-(pyridoxal phosphate)lysine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11483494,ECO:0000269|PubMed:12173932;Dbxref=PMID:11483494,PMID:12173932	
P35520	UniProtKB	Modified residue	199	199	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P35520	UniProtKB	Cross-link	211	211	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17087506;Dbxref=PMID:17087506	
P35520	UniProtKB	Alternative sequence	518	518	.	.	.	ID=VSP_001217;Note=In isoform 2. Y->SQDQAWAGVVGGPAD;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P35520	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_046921;Note=Functional polymorphism%3B associated with 1/3 to 2/3 the enzyme activity of the wild-type. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=dbSNP:rs201827340,PMID:16205833	
P35520	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_008049;Note=In CBSD%3B decreased expression%3B no effect on cystathionine beta-synthase activity%3B increased homotetramer formation. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:23974653;Dbxref=dbSNP:rs148865119,PMID:12124992,PMID:20506325,PMID:23974653	
P35520	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_008050;Note=In CBSD%3B linked with V-114%3B 18%25 of activity. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10408774;Dbxref=dbSNP:rs555959266,PMID:10408774	
P35520	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_021790;Note=In CBSD%3B decreased cystathionine beta-synthase activity%3B inhibited by AdoMet and AdoHcy%3B decreased homotetramer formation. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs1191141364,PMID:11359213,PMID:20506325	
P35520	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_046922;Note=A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs17849313,PMID:15489334	
P35520	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_002171;Note=In CBSD%3B severe form%3B associated in cis with N-102%3B decreased cystathionine beta-synthase activity%3B decreased homotetramer formation. P->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7981678;Dbxref=dbSNP:rs786204608,PMID:20506325,PMID:7981678	
P35520	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_008051;Note=In CBSD%3B loss of cystathionine beta-synthase activity. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:23981774;Dbxref=dbSNP:rs863223435,PMID:12007221,PMID:23981774	
P35520	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_074590;Note=In CBSD%3B decreased cystathionine beta-synthase activity%3B increased aggregation. T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23981774;Dbxref=PMID:23981774	
P35520	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_002172;Note=In CBSD. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7762555;Dbxref=PMID:7762555	
P35520	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_021791;Note=In CBSD%3B common mutation in Irish population%3B loss of activity. L->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs786204757,PMID:12124992,PMID:14635102,PMID:9889017	
P35520	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_002173;Note=In CBSD%3B associated in cis with R-78%3B decreased cystathionine beta-synthase activity%3B decreased homotetramer formation. K->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7981678;Dbxref=dbSNP:rs786204609,PMID:20506325,PMID:7981678	
P35520	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_008052;Note=K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11013450;Dbxref=dbSNP:rs34040148,PMID:11013450	
P35520	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_021792;Note=In CBSD%3B loss of activity. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12124992;Dbxref=dbSNP:rs778220779,PMID:12124992	
P35520	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_002174;Note=In CBSD%3B mild form%3B when linked with W-58 severe form%3B decreased cystathionine beta-synthase activity%3B decreases homotetramer formation by promoting formation of larger aggregates. A->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:8353501;Dbxref=dbSNP:rs121964964,PMID:11359213,PMID:20506325,PMID:8353501	
P35520	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_008053;Note=In CBSD. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8803779;Dbxref=dbSNP:rs760214620,PMID:8803779	
P35520	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_008054;Note=In CBSD. R->C;Dbxref=dbSNP:rs775992753	
P35520	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_008055;Note=In CBSD. R->H;Dbxref=dbSNP:rs770095972	
P35520	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_008056;Note=In CBSD%3B mild form. R->L;Dbxref=dbSNP:rs770095972	
P35520	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_046923;Note=In CBSD. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11553052;Dbxref=PMID:11553052	
P35520	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_002175;Note=In CBSD%3B severe form%3B when linked with D-131 moderate form%3B loss of cystathionine beta-synthase activity%3B decreased homotetramer formation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7762555,ECO:0000269|PubMed:7849717;Dbxref=dbSNP:rs781444670,PMID:12124992,PMID:20506325,PMID:7762555,PMID:7849717	
P35520	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_008057;Note=In CBSD%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=dbSNP:rs886057100,PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_008058;Note=In CBSD%3B loss of activity. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10408774;Dbxref=PMID:10408774	
P35520	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_008059;Note=In CBSD. E->D;Dbxref=dbSNP:rs374593242	
P35520	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_002176;Note=In CBSD%3B linked with Q-125%3B loss of activity. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7849717;Dbxref=dbSNP:rs1555875351,PMID:7849717	
P35520	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_008060;Note=In CBSD%3B mild form. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7611293;Dbxref=dbSNP:rs121964965,PMID:7611293	
P35520	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_021793;Note=In CBSD%3B 4%25 of activity%3B stable. I->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15146473;Dbxref=dbSNP:rs370167302,PMID:15146473	
P35520	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_002177;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B decreased homotetramer formation. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10215408,ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7611293,ECO:0000269|PubMed:9156316;Dbxref=dbSNP:rs121964966,PMID:10215408,PMID:11359213,PMID:12124992,PMID:20506325,PMID:7611293,PMID:9156316	
P35520	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_002178;Note=In CBSD. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8353501;Dbxref=dbSNP:rs121964963,PMID:8353501	
P35520	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_008061;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B loss of homotetramer formation. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15146473,ECO:0000269|PubMed:16429402,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs755952006,PMID:15146473,PMID:16429402,PMID:20506325	
P35520	UniProtKB	Natural variant	151	159	.	.	.	ID=VAR_008063;Note=In CBSD. Missing	
P35520	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_008062;Note=In CBSD. G->R;Dbxref=dbSNP:rs373782713	
P35520	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_008064;Note=In CBSD%3B severe form. I->M	
P35520	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_046924;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. L->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=PMID:16205833	
P35520	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_008065;Note=In CBSD%3B complete loss of activity%3B severely affects homotetramer formation by promoting formation of larger aggregates. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11359213;Dbxref=dbSNP:rs1429138569,PMID:11359213	
P35520	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_046925;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=PMID:16205833	
P35520	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_002179;Note=In CBSD%3B severe form%3B protein expression is comparable to wild-type%3B loss of cystathionine beta-synthase activity%3B no effect on homotetramer formation. C->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10215408,ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7635485;Dbxref=dbSNP:rs1347651454,PMID:10215408,PMID:11359213,PMID:12124992,PMID:20506325,PMID:7635485	
P35520	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_046926;Note=In CBSD. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15993874;Dbxref=PMID:15993874	
P35520	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_002180;Note=In CBSD. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8528202;Dbxref=dbSNP:rs121964970,PMID:8528202	
P35520	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_046927;Note=In CBSD%3B presents 40%25 of the wild-type activity%3B highly reduced capacity to form multimeric quaternary structure. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16429402;Dbxref=PMID:16429402	
P35520	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_066098;Note=In CBSD%3B loss of activity. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_008066;Note=In CBSD%3B severe form%3B loss of cystathionine beta-synthase activity%3B inhibited by AdoMet%3B severely decreases homotetramer formation by promoting formation of larger aggregates. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:9266356;Dbxref=dbSNP:rs762065361,PMID:11359213,PMID:20506325,PMID:9266356	
P35520	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_008067;Note=In CBSD%3B decreased cystathionine beta-synthase activity%3B decreases homotetramer formation. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs1555875010,PMID:20506325	
P35520	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_008068;Note=In CBSD%3B moderate and severe forms%3B loss of cystathionine beta-synthase activity%3B absent capacity to form multimeric quaternary structure. T->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:15993874,ECO:0000269|PubMed:16429402,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs121964973,PMID:12815602,PMID:15993874,PMID:16429402,PMID:20506325	
P35520	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_008069;Note=In CBSD. D->V	
P35520	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_066099;Note=In CBSD. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=dbSNP:rs758712880,PMID:21520339	
P35520	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_002181;Note=In CBSD. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8528202;Dbxref=dbSNP:rs761647392,PMID:8528202	
P35520	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_008070;Note=In CBSD%3B presents 20%25 of the wild-type activity%3B dramatically reduced capacity to form multimeric quaternary structure. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:16429402;Dbxref=dbSNP:rs763835246,PMID:14635102,PMID:16429402	
P35520	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_021794;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B decreased homotetramer formation. N->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:15146473,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs1464223176,PMID:12124992,PMID:15146473,PMID:20506325,PMID:9889017	
P35520	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_046928;Note=In CBSD%3B has significantly decreased levels of enzyme activity. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14635102;Dbxref=dbSNP:rs1555874803,PMID:14635102	
P35520	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_046929;Note=In CBSD%3B has significantly decreased levels of enzyme activity. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14635102;Dbxref=PMID:14635102	
P35520	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_008071;Note=In CBSD%3B decreased cystathionine beta-synthase activity%3B changed localization%3B decreased interaction with pyridoxal 5'-phosphate%3B no effect on homotetramer formation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23981774;Dbxref=dbSNP:rs773734233,PMID:23981774	
P35520	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_046930;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=PMID:16205833	
P35520	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_002182;Note=In CBSD. E->K	
P35520	UniProtKB	Natural variant	247	256	.	.	.	ID=VAR_046931;Note=In CBSD. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365998;Dbxref=PMID:15365998	
P35520	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_002183;Note=In CBSD%3B moderate to severe form%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16205833,ECO:0000269|PubMed:7762555;Dbxref=dbSNP:rs758236584,PMID:16205833,PMID:7762555	
P35520	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_008072;Note=In CBSD%3B moderate form. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9361025,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs149119723,PMID:9361025,PMID:9889017	
P35520	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_021795;Note=In CBSD%3B severe form%3B loss of cystathionine beta-synthase activity%3B loss of homotetramer formation. T->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11013450,ECO:0000269|PubMed:20506325;Dbxref=PMID:11013450,PMID:20506325	
P35520	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_008073;Note=In CBSD. R->G	
P35520	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_008074;Note=In CBSD%3B mild form%3B decreased cystathionine beta-synthase activity%3B decreased homotetramer formation%3B no effect on heme-binding%3B decreased stability. R->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:22738154,ECO:0000269|PubMed:9361025;Dbxref=dbSNP:rs121964969,PMID:20506325,PMID:22738154,PMID:9361025	
P35520	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_074591;Note=In CBSD%3B loss of expression. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23974653;Dbxref=PMID:23974653	
P35520	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_008075;Note=In CBSD. Missing	
P35520	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_021796;Note=In CBSD%3B severe form%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_066100;Note=In CBSD%3B loss of activity. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_002184;Note=In CBSD%3B mild to severe form%3B common mutation%3B decreased expression%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B severely affects homotetramer formation by promoting formation of larger aggregates. I->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11013450,ECO:0000269|PubMed:11359213,ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:1301198,ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:15146473,ECO:0000269|PubMed:15993874,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:21240075,ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:7506602,ECO:0000269|PubMed:7611293,ECO:0000269|PubMed:8528202,ECO:0000269|PubMed:8803779,ECO:0000269|PubMed:9156316,ECO:0000269|PubMed:9266356,ECO:0000269|PubMed:9361025,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs5742905,PMID:11013450,PMID:11359213,PMID:12007221,PMID:12124992,PMID:1301198,PMID:14635102,PMID:15146473,PMID:15993874,PMID:20506325,PMID:21240075,PMID:23974653,PMID:7506602,PMID:7611293,PMID:8528202,PMID:8803779,PMID:9156316,PMID:9266356,PMID:9361025,PMID:9889017	
P35520	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_066101;Note=In CBSD%3B loss of activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_046932;Note=In CBSD. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365998;Dbxref=PMID:15365998	
P35520	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_046933;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16205833;Dbxref=dbSNP:rs141502207,PMID:16205833	
P35520	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_002185;Note=In CBSD. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7564249,ECO:0000269|PubMed:8803779;Dbxref=dbSNP:rs760912339,PMID:7564249,PMID:8803779	
P35520	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_008076;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B inhibited by AdoHcy and impaired activation by AdoMet%3B no effect on homotetramer formation. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10408774,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs779270933,PMID:10408774,PMID:12124992,PMID:20506325	
P35520	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_008077;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B no effect on homotetramer formation. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20506325;Dbxref=PMID:20506325	
P35520	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_002186;Note=In CBSD%3B moderate to severe form%3B linked with D-534%3B common mutation%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B no effect on homotetramer formation. G->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:7506602,ECO:0000269|PubMed:8528202,ECO:0000269|PubMed:9266356,ECO:0000269|PubMed:9361025,ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs121964962,PMID:12124992,PMID:14635102,PMID:20506325,PMID:7506602,PMID:8528202,PMID:9266356,PMID:9361025,PMID:9889017	
P35520	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_008078;Note=In CBSD%3B has 36%25 of wild-type enzyme activity. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:9361025;Dbxref=dbSNP:rs781567152,PMID:14635102,PMID:9361025	
P35520	UniProtKB	Natural variant	321	321	.	.	.	ID=VAR_066102;Note=In CBSD%3B loss of activity. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_008079;Note=In CBSD. A->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:9156316;Dbxref=dbSNP:rs777919630,PMID:12124992,PMID:9156316	
P35520	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_002187;Note=In CBSD. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8528202;Dbxref=dbSNP:rs777919630,PMID:8528202	
P35520	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_002188;Note=In CBSD%3B protein expression is comparable to wild-type%3B loss of activity%3B absent capacity to form multimeric quaternary structure. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10408774,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16205833,ECO:0000269|PubMed:16429402,ECO:0000269|PubMed:21240075;Dbxref=dbSNP:rs398123151,PMID:10408774,PMID:12124992,PMID:12815602,PMID:16205833,PMID:16429402,PMID:21240075	
P35520	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_008080;Note=In CBSD%3B mild form%3B no effect on expression%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B altered stimulation by AdoMet%3B absent capacity to form multimeric quaternary structure. R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16429402,ECO:0000269|PubMed:23974653;Dbxref=dbSNP:rs760417941,PMID:16429402,PMID:23974653	
P35520	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_021797;Note=In CBSD%3B severe form%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_021798;Note=In CBSD%3B protein expression is comparable to wild-type%3B loss of activity. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:16205833;Dbxref=dbSNP:rs771298943,PMID:12124992,PMID:16205833	
P35520	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_021799;Note=In CBSD%3B severe form%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. S->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_008081;Note=In CBSD. S->N	
P35520	UniProtKB	Natural variant	353	353	.	.	.	ID=VAR_008082;Note=In CBSD%3B protein expression is comparable to wild-type%3B significant decrease of enzyme activity. T->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:14635102,ECO:0000269|PubMed:16205833,ECO:0000269|PubMed:9156316;Dbxref=dbSNP:rs121964972,PMID:12124992,PMID:14635102,PMID:16205833,PMID:9156316	
P35520	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_008083;Note=In CBSD. V->M;Dbxref=dbSNP:rs267606146	
P35520	UniProtKB	Natural variant	355	355	.	.	.	ID=VAR_021800;Note=In CBSD. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9889017;Dbxref=dbSNP:rs1192581453,PMID:9889017	
P35520	UniProtKB	Natural variant	361	361	.	.	.	ID=VAR_046934;Note=In CBSD. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11553052;Dbxref=dbSNP:rs745764562,PMID:11553052	
P35520	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_008084;Note=In CBSD%3B when linked with C-491 severe form%3B decreased cystathionine beta-synthase activity%3B decreased homotetramer formation. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:9361025;Dbxref=dbSNP:rs117687681,PMID:12124992,PMID:20506325,PMID:9361025	
P35520	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_002189;Note=In CBSD. R->H;Dbxref=dbSNP:rs11700812	
P35520	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_008085;Note=In CBSD. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10462600;Dbxref=dbSNP:rs757920190,PMID:10462600	
P35520	UniProtKB	Natural variant	371	371	.	.	.	ID=VAR_002190;Note=In CBSD. V->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:7635485;Dbxref=dbSNP:rs372010465,PMID:12124992,PMID:7635485	
P35520	UniProtKB	Natural variant	376	376	.	.	.	ID=VAR_046935;Note=In CBSD%3B has significantly decreased levels of enzyme activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14635102;Dbxref=dbSNP:rs1170128038,PMID:14635102	
P35520	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_021801;Note=In CBSD%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=dbSNP:rs763036586,PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_046936;Note=In CBSD. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15365998;Dbxref=dbSNP:rs769080151,PMID:15365998	
P35520	UniProtKB	Natural variant	384	384	.	.	.	ID=VAR_002191;Note=In CBSD%3B severe form. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8990018;Dbxref=dbSNP:rs121964967,PMID:8990018	
P35520	UniProtKB	Natural variant	384	384	.	.	.	ID=VAR_008086;Note=In CBSD%3B moderate form. K->N	
P35520	UniProtKB	Natural variant	391	391	.	.	.	ID=VAR_008087;Note=In CBSD. M->I	
P35520	UniProtKB	Natural variant	422	422	.	.	.	ID=VAR_021802;Note=In CBSD%3B changed cystathionine beta-synthase activity%3B impaired stimulation by AdoMet%3B does not affect homotetramer formation. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs28934892,PMID:12007221,PMID:20506325	
P35520	UniProtKB	Natural variant	427	427	.	.	.	ID=VAR_074592;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:25044645;Dbxref=dbSNP:rs863223434,PMID:23974653,PMID:25044645	
P35520	UniProtKB	Natural variant	434	434	.	.	.	ID=VAR_008088;Note=In CBSD. T->N;Dbxref=dbSNP:rs1555872506	
P35520	UniProtKB	Natural variant	435	435	.	.	.	ID=VAR_008089;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B does not affect homotetramer formation. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:20506325;Dbxref=PMID:12007221,PMID:20506325	
P35520	UniProtKB	Natural variant	439	439	.	.	.	ID=VAR_008090;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B increased homotetramer formation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10462600,ECO:0000269|PubMed:12124992,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:9156316;Dbxref=dbSNP:rs756467921,PMID:10462600,PMID:12124992,PMID:20506325,PMID:9156316	
P35520	UniProtKB	Natural variant	444	444	.	.	.	ID=VAR_002192;Note=In CBSD%3B decreased expression%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet%3B increased homotetramer formation. D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:25044645,ECO:0000269|PubMed:8755636;Dbxref=dbSNP:rs28934891,PMID:12007221,PMID:20506325,PMID:23974653,PMID:25044645,PMID:8755636	
P35520	UniProtKB	Natural variant	446	446	.	.	.	ID=VAR_066103;Note=In CBSD. A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21520339;Dbxref=PMID:21520339	
P35520	UniProtKB	Natural variant	449	449	.	.	.	ID=VAR_074593;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet. V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25044645;Dbxref=PMID:25044645	
P35520	UniProtKB	Natural variant	454	454	.	.	.	ID=VAR_002193;Note=In CBSD. V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8528202;Dbxref=PMID:8528202	
P35520	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_021803;Note=In CBSD%3B severe%3B exhibits an activity lower than 4%25 of the wild-type enzyme%3B absent capacity to form multimeric quaternary structure. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12815602,ECO:0000269|PubMed:16429402;Dbxref=PMID:12815602,PMID:16429402	
P35520	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_008091;Note=In CBSD%3B increased cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B decreased homotetramer formation. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12007221,ECO:0000269|PubMed:20506325;Dbxref=dbSNP:rs121964971,PMID:12007221,PMID:20506325	
P35520	UniProtKB	Natural variant	491	491	.	.	.	ID=VAR_008092;Note=In CBSD%3B linked with C-369. R->C;Dbxref=dbSNP:rs1339830457	
P35520	UniProtKB	Natural variant	500	500	.	.	.	ID=VAR_074594;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet. S->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:25044645;Dbxref=dbSNP:rs755106884,PMID:23974653,PMID:25044645	
P35520	UniProtKB	Natural variant	526	526	.	.	.	ID=VAR_046937;Note=In CBSD%3B has significantly decreased levels of enzyme activity. Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14635102;Dbxref=PMID:14635102	
P35520	UniProtKB	Natural variant	534	534	.	.	.	ID=VAR_008093;Note=In CBSD%3B linked with S-307. V->D	
P35520	UniProtKB	Natural variant	539	539	.	.	.	ID=VAR_002194;Note=In CBSD%3B loss of cystathionine beta-synthase activity%3B impaired stimulation by AdoMet and AdoHcy%3B loss of homotetramer formation. L->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20506325,ECO:0000269|PubMed:8990018;Dbxref=dbSNP:rs121964968,PMID:20506325,PMID:8990018	
P35520	UniProtKB	Natural variant	540	540	.	.	.	ID=VAR_074595;Note=In CBSD%3B no effect on cystathionine beta-synthase activity%3B altered stimulation by AdoMet. L->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23974653,ECO:0000269|PubMed:25044645;Dbxref=PMID:23974653,PMID:25044645	
P35520	UniProtKB	Natural variant	548	548	.	.	.	ID=VAR_046938;Note=Presents 60%25 of the wild-type activity%3B highly reduced capacity to form multimeric quaternary structure. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16429402;Dbxref=dbSNP:rs150828989,PMID:16429402	
P35520	UniProtKB	Mutagenesis	272	272	.	.	.	Note=Reduced heme content and cystathionine beta-synthase activity. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12173932;Dbxref=PMID:12173932	
P35520	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Reduced heme content and cystathionine beta-synthase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12173932;Dbxref=PMID:12173932	
P35520	UniProtKB	Sequence conflict	58	58	.	.	.	Note=R->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P35520	UniProtKB	Helix	60	62	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	75	79	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	80	82	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	83	85	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	89	91	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	95	98	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	103	109	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	110	112	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	113	117	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4L0D	
P35520	UniProtKB	Helix	119	132	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	141	145	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	149	161	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	164	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	175	183	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	187	191	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	193	195	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MMS	
P35520	UniProtKB	Beta strand	197	199	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4L27	
P35520	UniProtKB	Helix	203	213	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	217	219	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4L28	
P35520	UniProtKB	Turn	222	224	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	227	234	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	236	243	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Turn	244	246	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	249	254	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	256	258	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	259	271	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	272	274	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1M54	
P35520	UniProtKB	Beta strand	276	282	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	288	290	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	291	294	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	317	319	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	322	326	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	328	342	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	348	360	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	361	363	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Beta strand	369	374	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	378	381	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Turn	382	386	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	388	393	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Helix	399	404	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4COO	
P35520	UniProtKB	Turn	408	411	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	414	417	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	431	441	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	444	449	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	455	460	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	461	469	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	479	482	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	489	491	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	496	505	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	509	515	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Beta strand	526	534	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
P35520	UniProtKB	Helix	536	544	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4UUU	
##sequence-region P03612 1 130
P03612	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B by host;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P69171	
P03612	UniProtKB	Chain	2	130	.	.	.	ID=PRO_0000164843;Note=Capsid protein	
P03612	UniProtKB	Region	32	105	.	.	.	Note=Viral RNA-binding;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26608810;Dbxref=PMID:26608810	
P03612	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Loss of repression of replicase translation. 80%25 loss of binding to the operator RNA in vivo. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9469846,ECO:0000269|PubMed:9469847;Dbxref=PMID:9469846,PMID:9469847	
P03612	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Loss of repression of replicase. 20%25 loss of binding to the operator RNA in vivo. T->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9469846,ECO:0000269|PubMed:9469847;Dbxref=PMID:9469846,PMID:9469847	
P03612	UniProtKB	Mutagenesis	77	77	.	.	.	Note=No effect on the organization of the T%3D3 capsid%2C but with a loss of thermal stability. No effect on infectivity. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9469846;Dbxref=PMID:9469846	
P03612	UniProtKB	Mutagenesis	79	79	.	.	.	Note=No effect on the organization of the T%3D3 capsid%2C but with a loss of thermal stability. Complete loss of infectivity. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9469846;Dbxref=PMID:9469846	
P03612	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Complete loss of viral assembly. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7788292;Dbxref=PMID:7788292	
P03612	UniProtKB	Beta strand	8	11	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Beta strand	13	17	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZOR	
P03612	UniProtKB	Beta strand	19	27	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Beta strand	30	34	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Beta strand	38	40	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Beta strand	44	53	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Beta strand	56	65	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Beta strand	70	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Beta strand	79	83	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VTU	
P03612	UniProtKB	Beta strand	85	94	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Helix	99	112	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
P03612	UniProtKB	Helix	118	125	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1MSC	
##sequence-region P42212 1 238
P42212	UniProtKB	Chain	1	238	.	.	.	ID=PRO_0000192576;Note=Green fluorescent protein	
P42212	UniProtKB	Modified residue	66	66	.	.	.	Note=(Z)-2%2C3-didehydrotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8448132;Dbxref=PMID:8448132	
P42212	UniProtKB	Cross-link	65	67	.	.	.	Note=5-imidazolinone (Ser-Gly);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8448132;Dbxref=PMID:8448132	
P42212	UniProtKB	Natural variant	100	100	.	.	.	Note=F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1347277;Dbxref=PMID:1347277	
P42212	UniProtKB	Natural variant	108	108	.	.	.	Note=T->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1347277;Dbxref=PMID:1347277	
P42212	UniProtKB	Natural variant	141	141	.	.	.	Note=L->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1347277;Dbxref=PMID:1347277	
P42212	UniProtKB	Natural variant	219	219	.	.	.	Note=V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1347277;Dbxref=PMID:1347277	
P42212	UniProtKB	Mutagenesis	30	30	.	.	.	Note=In mut1.28%3B shifts fluorescence lifetime from 3.03 to 2.76 ns%3B when associated with H-145. In mut2.2%3B shifts fluorescence lifetime from 3.03 to 1.94 ns%3B when associated with H-69 and H-145. In mut3.3%3B shifts fluorescence lifetime from 3.03 to 1.88 ns%3B when associated with L-46%3B H-69 and H-145. In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with N-39%3B H-66%3B A-72%3B T-105%3B F-145%3B V-171%3B S-198 and V-206. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with N-39%3B H-66%3B A-72%3B T-105%3B V-128%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198%3B V-206 and V-224. S->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16201762,ECO:0000269|PubMed:22891786;Dbxref=PMID:16201762,PMID:22891786	
P42212	UniProtKB	Mutagenesis	39	39	.	.	.	Note=In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B H-66%3B A-72%3B T-105%3B F-145%3B V-171%3B S-198 and V-206. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B H-66%3B A-72%3B T-105%3B V-128%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198%3B V-206 and V-224. Y->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Mutagenesis	46	46	.	.	.	Note=In mut3.3%3B shifts fluorescence lifetime from 3.03 to 1.88 ns%3B when associated with R-30%3B H-69 and H-145. In R10-3%3B matures to the red-emitting state with excitation and emission maxima at 555 and 585 nm%2C respectively%3B when associated with L-64%3B N-68%3B Q-162%3B A-163%3B V-167 and L-171. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-64%3B G-65%3B L-68%3B A-72%3B T-153%3B A-163%3B G-175 and Y-203. F->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:16201762,ECO:0000269|PubMed:18366185;Dbxref=PMID:12370172,PMID:16201762,PMID:18366185	
P42212	UniProtKB	Mutagenesis	64	64	.	.	.	Note=In EGFP%3B increases fluoresence at warmer temperatures such as 37 degrees Celsius%3B when associated with T-65. In EBFP%3B gives rise to variants with blue fluorescence%3B when associated with T-65 and H-66. In ECFP%3B leads to cyan fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with T-65%3B W-66%3B I-146%3B T-153 and A-163. In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighterH than ECFP%3B when associated with T-65%3B W-66%3B A-72%3B A-145%3B I-146%3B D-148%3B T-153 and A-163. In R10-3%3B matures to the red-emitting state with excitation and emission maxima at 555 and 585 nm%2C respectively%3B when associated with L-46%3B N-68%3B Q-162%3B A-163%3B V-167 and L-171. In GFPmut 1%3B red-shifts by about 100 nm the excitation maxima%2C permitting efficient excitation at 488 nm and increases fluorescence%3B when associated with T-65. In VisGreen%3B leads to brighter fluorescence%3B when associated with T-65%3B A-72%3B K-149 and T-167. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-46%3B G-65%3B L-68%3B A-72%3B T-153%3B A-163%3B G-175 and Y-203. F->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:11776264,ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:14990965,ECO:0000269|PubMed:15065907,ECO:0000269|PubMed:17658219,ECO:0000269|PubMed:18366185,ECO:0000269|PubMed:8707053,ECO:0000269|PubMed:9145105,ECO:0000269|PubMed:9370472;Dbxref=PMID:11299042,PMID:11776264,PMID:12370172,PMID:14990965,PMID:15065907,PMID:17658219,PMID:18366185,PMID:8707053,PMID:9145105,PMID:9370472	
P42212	UniProtKB	Mutagenesis	64	64	.	.	.	Note=In RSGFP4%3B increases fluorescence and shifts the major exitation peak to 489-490 nm%3B when associated with G-65 and L-69. F->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9634755;Dbxref=PMID:9634755	
P42212	UniProtKB	Mutagenesis	65	66	.	.	.	Note=Gives rise to variants with cerulean fluorsecence. SY->TW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17685554;Dbxref=PMID:17685554	
P42212	UniProtKB	Mutagenesis	65	65	.	.	.	Note=In GFPmut 2%3B red-shifts by about 100 nm the excitation maxima%2C permitting efficient excitation at 488 nm and increases fluorescence%3B when associated with L-68 and A-72. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8707053;Dbxref=PMID:8707053	
P42212	UniProtKB	Mutagenesis	65	65	.	.	.	Note=In EYFP%3B leads to yellow fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with L-68%3B A-72 and Y-203. In GFPmut 3%3B highly fluorescent mutant when excited at 488 nm%3B when associated with A-72. Highly fluorescent%3B when associated with Y-203%3B L-68 and A-72. In RSGFP4%3B increases fluoresence and shifts the major exitation peak to 489-490 nm%3B when associated with M-64 and L-69. In YFP 10C%3B shifts the major emission and exitation peak up to 20 nm%3B when associated with L-68%3B A-72 and Y-203. In Topaz%3B shifts the major emission and exitation peak up to 20 nm%3B when associated with A-72%3B R-79 and Y-203. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-46%3B L-64%3B L-68%3B A-72%3B T-153%3B A-163%3B G-175 and Y-203. S->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:8707053,ECO:0000269|PubMed:9634755,ECO:0000269|PubMed:9759496,ECO:0000269|PubMed:9782051;Dbxref=PMID:11299042,PMID:12370172,PMID:8707053,PMID:9634755,PMID:9759496,PMID:9782051	
P42212	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Increases fluoresence%2C photostability and shifts the major exitation peak to 488 nm. In EGFP%3B increases fluoresence at warmer temperatures such as 37 degrees Celsius%3B when associated with L-64. In EBFP%3B gives rise to variants with blue fluorescence%3B when associated with L-64 and H-66. In GFPmut 1%3B red-shifts by about 100 nm the excitation maxima%2C permitting efficient excitation at 488 nm and increases fluorescence%3B when associated with T-65. In ECFP%3B leads to cyan fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with L-64%3B W-66%3B I-146%3B T-153 and A-163. In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighter than ECFP%3B when associated with L-64%3B W-66%3B A-72%3B A-145%3B I-146%3B D-148%3B T-153 and A-163. In Esmerald%3B leads to brighter fluorescence%3B when associated with A-72%3B K-149%3B T-153 and T-167. In VisGreen%3B leads to brighter fluorescence%3B when associated with L-64%3B A-72%3B K-149 and T-167. S->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:11776264,ECO:0000269|PubMed:14990965,ECO:0000269|PubMed:15065907,ECO:0000269|PubMed:17658219,ECO:0000269|PubMed:8703075,ECO:0000269|PubMed:8707053,ECO:0000269|PubMed:9370472;Dbxref=PMID:11299042,PMID:11776264,PMID:14990965,PMID:15065907,PMID:17658219,PMID:8703075,PMID:8707053,PMID:9370472	
P42212	UniProtKB	Mutagenesis	66	66	.	.	.	Note=In BFP%3B shifts the excitation and emission spectra to shorter wavelengths. In EBFP%3B gives rise to variants with blue fluorescence%3B when associated with L-64 and T-65. In Azurite%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-80%3B F-145%3B I-150 and R-224. In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B A-72%3B T-105%3B F-145%3B V-171%3B S-198 and V-206. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B A-72%3B T-105%3B V-128%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198%3B V-206 and V-224. Y->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22891786,ECO:0000269|PubMed:8578587,ECO:0000269|PubMed:9145105,ECO:0000269|PubMed:9370472;Dbxref=PMID:22891786,PMID:8578587,PMID:9145105,PMID:9370472	
P42212	UniProtKB	Mutagenesis	66	66	.	.	.	Note=Shifts the excitation and emission spectra to shorter wavelengths. Y->T%2CF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8578587;Dbxref=PMID:8578587	
P42212	UniProtKB	Mutagenesis	66	66	.	.	.	Note=In W%3B leads to excitation and emission wavelengths intermediate between tyrosine and histidine but is only weakly fluorescent. In ECFP%3B leads to cyan fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with L-64%3B T-65%3B I-146%3B T-153 and A-163. In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighter than ECFP%3B when associated with L-64%3B T-65%3B A-72%3B A-145%3B I-146%3B D-148%3B T-153 and A-163. Y->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:14990965,ECO:0000269|PubMed:15065907,ECO:0000269|PubMed:7809066;Dbxref=PMID:11299042,PMID:14990965,PMID:15065907,PMID:7809066	
P42212	UniProtKB	Mutagenesis	68	68	.	.	.	Note=In EYFP%3B leads to yellow fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with G-65%3B A-72 and Y-203. In GFPmut 2%3B red-shifts by about 100 nm the excitation maxima%2C permitting efficient excitation at 488 nm and increases fluorescence%3B when associated with A-65 and A-72. In Citrinine%3B leads to excitation and emission peaks of 516 and 529 nm%2C respectively%3B when associated with M-69%3B A-72 and Y-203. In YFP 10C%3B shifts the major emission and exitation peak up to 20 nm%3B when associated with G-65%3B A-72 and Y-203. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-46%3B L-64%3B G-65%3B A-72%3B T-153%3B A-163%3B G-175 and Y-203. V->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:11387331,ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:8707053,ECO:0000269|PubMed:9759496,ECO:0000269|PubMed:9782051;Dbxref=PMID:11299042,PMID:11387331,PMID:12370172,PMID:8707053,PMID:9759496,PMID:9782051	
P42212	UniProtKB	Mutagenesis	68	68	.	.	.	Note=In R10-3%3B matures to the red-emitting state with excitation and emission maxima at 555 and 585 nm%2C respectively%3B when associated with L-46%3B L-64%3B Q-162%3B A-163%3B V-167 and L-171. V->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18366185;Dbxref=PMID:18366185	
P42212	UniProtKB	Mutagenesis	69	69	.	.	.	Note=In P4%3B leads to no detectable fluorescence. In mut2.2%3B shifts fluorescence lifetime from 3.03 to 1.94 ns%3B when associated with R-30 and H-145. In mut3.3%3B shifts fluorescence lifetime from 3.03 to 1.88 ns%3B when associated with R-30%3B L-46 and H-145. Q->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16201762,ECO:0000269|PubMed:7809066;Dbxref=PMID:16201762,PMID:7809066	
P42212	UniProtKB	Mutagenesis	69	69	.	.	.	Note=In RSGFP4%3B increases fluorescence and shifts the major exitation peak to 489-490 nm%3B when associated with M-64 and G-65. Q->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9634755;Dbxref=PMID:9634755	
P42212	UniProtKB	Mutagenesis	69	69	.	.	.	Note=In Citrinine%3B leads to excitation and emission peaks of 516 and 529 nm%2C respectively%3B when associated with L-68%3B A-72 and Y-203. Q->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11387331;Dbxref=PMID:11387331	
P42212	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Increases fluoresence at warmer temperatures such as 37 degrees Celsius. In GFPmut 3%3B highly fluorescent mutant when excited at 488 nm%3B when associated with G-65. In EYFP%3B leads to yellow fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with G-65%3B L-68 and Y-203. In GFPmut 2%3B red-shifts by about 100 nm the excitation maxima%2C permitting efficient excitation at 488 nm and increases fluorescence%3B when associated with A-65 and L-68. In Citrinine%3B leads to excitation and emission peaks of 516 and 529 nm%2C respectively%3B when associated with L-68%3B M-69 and Y-203. In YFP 10C%3B shifts the major emission and exitation peak up to 20 nm%3B when associated with G-65%3B L-68%3B and Y-203. In Topaz%3B shifts the major emission and exitation peak up to 20 nm%3B when associated with G-65%3B R-79 and Y-203. In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighter than ECFP%3B when associated with L-64%3B T-65%3B W-66%3B A-145%3B I-146%3B D-148%3B T-153 and A-163. In Sapphire/H9-40%3B exhibits a huge Stoke's shift%2C with an excitation peak at 399 nm and an emission peak at 511 nm%3B when associated with F-145 and I-203. In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B T-105%3B F-145%3B V-171%3B S-198 and V-206. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B T-105%3B V-128%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198%3B V-206 and V-224. In Esmerald%3B leads to brighter fluorescence%3B when associated with T-65%3B K-149%3B T-153 and T-167. In VisGreen%3B leads to brighter fluorescence%3B when associated with L-64%3B T-65%3B K-149 and T-167. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-46%3B L-64%3B G-65%3B L-68%3B T-153%3B A-163%3B G-175 and Y-203. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:11387331,ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:12769828,ECO:0000269|PubMed:14990965,ECO:0000269|PubMed:17658219,ECO:0000269|PubMed:22891786,ECO:0000269|PubMed:8707053,ECO:0000269|PubMed:9145105,ECO:0000269|PubMed:9759496,ECO:0000269|PubMed:9782051;Dbxref=PMID:11299042,PMID:11387331,PMID:12370172,PMID:12769828,PMID:14990965,PMID:17658219,PMID:22891786,PMID:8707053,PMID:9145105,PMID:9759496,PMID:9782051	
P42212	UniProtKB	Mutagenesis	79	79	.	.	.	Note=In Topaz%3B shifts the major emission and exitation peak up to 20 nm%3B when associated with G-65%3B A-72 and Y-203. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9759496;Dbxref=PMID:9759496	
P42212	UniProtKB	Mutagenesis	80	80	.	.	.	Note=In Azurite%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with H-66%3B F-145%3B I-150 and R-224. Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Mutagenesis	99	99	.	.	.	Note=In alphaGFP/cycle 3 GFP%3B improves folding at 37 degrees Celsius%2C reduces aggregation at high concentrations%2C and increases the diffusibility of the protein inside cells%3B when associated with T-153 and A-163. F->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9370472,ECO:0000269|PubMed:9630892,ECO:0000269|PubMed:9631088;Dbxref=PMID:9370472,PMID:9630892,PMID:9631088	
P42212	UniProtKB	Mutagenesis	103	103	.	.	.	Note=In mut1.27%3B shifts fluorescence lifetime from 3.03 to 2.85 ns%3B when associated with H-145. D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16201762;Dbxref=PMID:16201762	
P42212	UniProtKB	Mutagenesis	105	105	.	.	.	Note=In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B F-145%3B V-171%3B S-198 and V-206. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B V-128%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198%3B V-206 and V-224. N->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Mutagenesis	128	128	.	.	.	Note=In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198%3B V-206 and V-224. I->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Mutagenesis	145	145	.	.	.	Note=In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighter than ECFP%3B when associated with L-64%3B T-65%3B W-66%3B A-72%3B I-146%3B D-148%3B T-153 and A-163. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14990965;Dbxref=PMID:14990965	
P42212	UniProtKB	Mutagenesis	145	145	.	.	.	Note=In mut1.9%3B shifts fluorescence lifetime from 3.03 to 2.74 ns. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16201762;Dbxref=PMID:16201762	
P42212	UniProtKB	Mutagenesis	145	145	.	.	.	Note=In Sapphire/H9-40%3B exhibits a huge Stoke's shift%2C with an excitation peak at 399 nm and an emission peak at 511 nm%3B when associated with A-72 and I-203. In Azurite%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with H-66%3B R-80%3B I-150 and R-224. In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B V-171%3B S-198 and V-206. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B V-128%3B I-150%3B V-155%3B V-171%3B S-198%3B V-206 and V-224. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12769828,ECO:0000269|PubMed:22891786;Dbxref=PMID:12769828,PMID:22891786	
P42212	UniProtKB	Mutagenesis	145	145	.	.	.	Note=In mut1.3%3B shifts fluorescence lifetime from 3.03 to 2.78 ns. In mut1.5%3B shifts fluorescence lifetime from 3.03 to 2.72 ns%3B when associated with A-193. In mut1.27%3B shifts fluorescence lifetime from 3.03 to 2.85 ns%3B when associated with E-103. In mut1.28%3B shifts fluorescence lifetime from 3.03 to 2.76 ns%3B when associated with R-30. In mut2.1%3B shifts fluorescence lifetime from 3.03 to 2.50 ns%3B when associated with A-176 and I-198. In mut2.2%3B shifts fluorescence lifetime from 3.03 to 1.94 ns%3B when associated with R-30 and H-69. In mut3.3%3B shifts fluorescence lifetime from 3.03 to 1.88 ns%3B when associated with R-30%3B L-46 and H-69. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16201762;Dbxref=PMID:16201762	
P42212	UniProtKB	Mutagenesis	146	146	.	.	.	Note=In ECFP%3B leads to cyan fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with L-64%3B T-65%3B W-66%3B T-153 and A-163. In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighter than ECFP%3B when associated with L-64%3B T-65%3B W-66%3B A-72%3B A-145%3B D-148%3B T-153 and A-163. N->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:14990965,ECO:0000269|PubMed:15065907;Dbxref=PMID:11299042,PMID:14990965,PMID:15065907	
P42212	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Increases fluorescence at warmer temperatures such as 37 degrees Celsius. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9125154;Dbxref=PMID:9125154	
P42212	UniProtKB	Mutagenesis	148	148	.	.	.	Note=In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighter than ECFP%3B when associated with L-64%3B T-65%3B W-66%3B A-72%3B A-145%3B I-146%3B T-153 and A-163. H->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14990965;Dbxref=PMID:14990965	
P42212	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Increases fluorescence at warmer temperatures such as 37 degrees Celsius. In Esmerald%3B leads to brighter fluorescence%3B when associated with T-65%3B A-72%3B T-153 and T-167. In VisGreen%3B leads to brighter fluorescence%3B when associated with L-64%3B T-65%3B A-72 and T-167. N->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17658219,ECO:0000269|PubMed:9145105;Dbxref=PMID:17658219,PMID:9145105	
P42212	UniProtKB	Mutagenesis	150	150	.	.	.	Note=In Azurite%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with H-66%3B R-80%3B F-145 and R-224. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B V-128%3B F-145%3B V-155%3B V-171%3B S-198%3B V-206 and V-224. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Mutagenesis	153	153	.	.	.	Note=Increases fluorescence at warmer temperatures such as 37 degrees Celsius. In alphaGFP/cycle 3 GFP%3B improves folding at 37 degrees Celsius%2C reduces aggregation at high concentrations%2C and increases the diffusibility of the protein inside cells%3B when associated with S-99 and A-163. In ECFP%3B leads to cyan fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with L-64%3B T-65%3B W-66%3B I-146 and A-163. In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighter than ECFP%3B when associated with L-64%3B T-65%3B W-66%3B A-72%3B A-145%3B I-146%3B D-148 and A-163. In Esmerald%3B leads to brighter fluorescence%3B when associated with T-65%3B A-72%3B K-149 and T-167. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-46%3B L-64%3B G-65%3B L-68%3B A-72%3B A-163%3B G-175 and Y-203. M->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:14990965,ECO:0000269|PubMed:15065907,ECO:0000269|PubMed:17658219,ECO:0000269|PubMed:9145105,ECO:0000269|PubMed:9370472,ECO:0000269|PubMed:9630892,ECO:0000269|PubMed:9631088;Dbxref=PMID:11299042,PMID:12370172,PMID:14990965,PMID:15065907,PMID:17658219,PMID:9145105,PMID:9370472,PMID:9630892,PMID:9631088	
P42212	UniProtKB	Mutagenesis	155	155	.	.	.	Note=In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B V-128%3B F-145%3B I-150%3B V-171%3B S-198%3B V-206 and V-224. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Mutagenesis	162	162	.	.	.	Note=In R10-3%3B matures to the red-emitting state with excitation and emission maxima at 555 and 585 nm%2C respectively%3B when associated with L-46%3B L-64%3B N-68%3B A-163%3B V-167 and L-171. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18366185;Dbxref=PMID:18366185	
P42212	UniProtKB	Mutagenesis	163	163	.	.	.	Note=In GFPB%3B leads to enhanced fluorescence at 37 degrees Celsius. In GFPA%3B leads to even higher fluorescence at 37 degrees Celsius than GFPA%3B whenassociated with G-175. In alphaGFP/cycle 3 GFP%3B improves folding at 37 degrees Celsius%2C reduces aggregation at high concentrations%2C and increases the diffusibility of the protein inside cells%3B when associated with S-99 and T-153. In R10-3%3B matures to the red-emitting state with excitation and emission maxima at 555 and 585 nm%2C respectively%3B when associated with L-46%3B L-64%3B N-68%3B Q-162%3B V-167 and L-171. In ECFP%3B leads to cyan fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with L-64%3B T-65%3B W-66%3B I-146 and T-153. In Cerulean%3B leads to improved quantum yield%2C a higher extinction coefficient and is 2.5-fold brighter than ECFP%3B when associated with L-64%3B T-65%3B W-66%3B A-72%3B A-145%3B I-146%3B D-148 and T-153. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-46%3B L-64%3B G-65%3B L-68%3B A-72%3B T-153%3B G-175 and Y-203. V->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:14990965,ECO:0000269|PubMed:15065907,ECO:0000269|PubMed:18366185,ECO:0000269|PubMed:8994830,ECO:0000269|PubMed:9370472,ECO:0000269|PubMed:9630892,ECO:0000269|PubMed:9631088;Dbxref=PMID:11299042,PMID:12370172,PMID:14990965,PMID:15065907,PMID:18366185,PMID:8994830,PMID:9370472,PMID:9630892,PMID:9631088	
P42212	UniProtKB	Mutagenesis	167	167	.	.	.	Note=In P11%3B increases fluorescence at 475 nm excitation and at warmer temperatures such as 37 degrees Celsius. In Esmerald%3B leads to brighter fluorescence%3B when associated with T-65%3B A-72%3B K-149 and T-153. In VisGreen%3B leads to brighter fluorescence%3B when associated with L-64%3B T-65%3B A-72 and K-149. I->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17658219,ECO:0000269|PubMed:7809066,ECO:0000269|PubMed:9145105;Dbxref=PMID:17658219,PMID:7809066,PMID:9145105	
P42212	UniProtKB	Mutagenesis	167	167	.	.	.	Note=In P9%3B increases fluorescence at 475 nm excitation. In R10-3%3B matures to the red-emitting state with excitation and emission maxima at 555 and 585 nm%2C respectively%3B when associated with L-46%3B L-64%3B N-68%3B Q-162%3B A-163 and L-171. I->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18366185,ECO:0000269|PubMed:7809066;Dbxref=PMID:18366185,PMID:7809066	
P42212	UniProtKB	Mutagenesis	171	171	.	.	.	Note=In R10-3%3B matures to the red-emitting state with excitation and emission maxima at 555 and 585 nm%2C respectively%3B when associated with L-46%3B L-64%3B N-68%3B Q-162%3B A-163 and V-167. I->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18366185;Dbxref=PMID:18366185	
P42212	UniProtKB	Mutagenesis	171	171	.	.	.	Note=In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B F-145%3B S-198 and V-206. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B V-128%3B F-145%3B I-150%3B V-155%3B S-198%3B V-206 and V-224. I->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Mutagenesis	175	175	.	.	.	Note=In GFPA%3B leads to enhanced fluorescence at 37 degrees Celsius%3B when associated with A-163. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-46%3B L-64%3B G-65%3B L-68%3B A-72%3B T-153%3B A-163 and Y-203. S->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:8994830;Dbxref=PMID:12370172,PMID:8994830	
P42212	UniProtKB	Mutagenesis	176	176	.	.	.	Note=In mut2.1%3B shifts fluorescence lifetime from 3.03 to 2.50 ns%3B when associated with H-145 and I-198. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16201762;Dbxref=PMID:16201762	
P42212	UniProtKB	Mutagenesis	193	193	.	.	.	Note=In mut1.5%3B shifts fluorescence lifetime from 3.03 to 2.72 ns%3B when associated with H-145. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16201762;Dbxref=PMID:16201762	
P42212	UniProtKB	Mutagenesis	198	198	.	.	.	Note=In mut2.1%3B shifts fluorescence lifetime from 3.03 to 2.50 ns%3B when associated with H-145 and A-176. N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16201762;Dbxref=PMID:16201762	
P42212	UniProtKB	Mutagenesis	198	198	.	.	.	Note=In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B F-145%3B V-171 and V-206. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B V-128%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198 and V-224. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Mutagenesis	202	202	.	.	.	Note=In H9%3B increases fluorescence at 395 nm excitation%3B when associated with I-203. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7809066;Dbxref=PMID:7809066	
P42212	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Results in significantly red-shifted excitation and emission maxima. T->H%2CW%2CF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8703075;Dbxref=PMID:8703075	
P42212	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Suppresses the 475 nm excitation peak%2C leaving only the shorter wavelength peak at 399 nm. In H9%3B increases fluorescence at 395 nm excitation%3B when associated with I-203. In Sapphire/H9-40%3B exhibits a huge Stoke's shift%2C with an excitation peak at 399 nm and an emission peak at 511 nm%3B when associated with A-72 and F-145. T->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12769828,ECO:0000269|PubMed:7796912,ECO:0000269|PubMed:7809066;Dbxref=PMID:12769828,PMID:7796912,PMID:7809066	
P42212	UniProtKB	Mutagenesis	203	203	.	.	.	Note=Gives rise to yellow-emission variants. In EYFP%3B leads to yellow fluorescence%2C folds faster and more efficiently at 37 degrees Celsius and has superior solubility and brightness%3B when associated with G-65%3B L-68 and A-72. In Citrinine%3B leads to excitation and emission peaks of 516 and 529 nm%2C respectively%3B when associated with L-68%3B M-69 and A-72. In YFP 10C%3B shifts the major emission and exitation peak up to 20 nm%3B when associated with G-65%3B L-68 and A-72. In Topaz%3B shifts the major emission and exitation peak up to 20 nm%3B when associated with G-65%3B A-72 and R-79. In Venus%3B leads to yellow fluorescence%2C improved maturation and reduced environmental sensitivity%3B when associated with L-46%3B L-64%3B G-65%3B L-68%3B A-72%3B T-153%3B A-163 and G-175. T->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11299042,ECO:0000269|PubMed:11387331,ECO:0000269|PubMed:12370172,ECO:0000269|PubMed:9759496,ECO:0000269|PubMed:9782051;Dbxref=PMID:11299042,PMID:11387331,PMID:12370172,PMID:9759496,PMID:9782051	
P42212	UniProtKB	Mutagenesis	206	206	.	.	.	Note=Abolishes the tendency to dimerize and leads to monomeric fluorescent proteins. A->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16739159;Dbxref=PMID:16739159	
P42212	UniProtKB	Mutagenesis	206	206	.	.	.	Note=In EBFP1.2%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B F-145%3B V-171 and S-198. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B V-128%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198 and V-206. A->V	
P42212	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Suppresses the 399 nm excitation peak%2C leaving only the longer wavelength peak at 475 nm. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7796912;Dbxref=PMID:7796912	
P42212	UniProtKB	Mutagenesis	224	224	.	.	.	Note=In Azurite%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with H-66%3B R-80%3B F-145 and I-150. In EBFP2.0%3B shifts the excitation and emission spectra to shorter wavelengths and increases quantum yields compared to BFP%3B when associated with R-30%3B N-39%3B H-66%3B A-72%3B T-105%3B V-128%3B F-145%3B I-150%3B V-155%3B V-171%3B S-198 and V-206. V->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22891786;Dbxref=PMID:22891786	
P42212	UniProtKB	Sequence conflict	2	2	.	.	.	Note=S->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P42212	UniProtKB	Sequence conflict	25	25	.	.	.	Note=H->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P42212	UniProtKB	Sequence conflict	80	80	.	.	.	Note=Q->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P42212	UniProtKB	Sequence conflict	157	157	.	.	.	Note=Q->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P42212	UniProtKB	Sequence conflict	172	172	.	.	.	Note=E->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P42212	UniProtKB	Helix	3	6	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	8	10	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3DQA	
P42212	UniProtKB	Beta strand	12	22	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	25	36	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Helix	37	39	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	41	48	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	50	52	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5LEM	
P42212	UniProtKB	Helix	57	60	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Helix	61	64	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Turn	65	67	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1QYO	
P42212	UniProtKB	Helix	69	71	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Helix	73	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3EVV	
P42212	UniProtKB	Helix	76	81	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Helix	83	86	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Turn	87	90	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	92	100	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	101	103	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6MWQ	
P42212	UniProtKB	Beta strand	105	115	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	118	129	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	132	134	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1EMK	
P42212	UniProtKB	Turn	135	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	143	145	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3OSQ	
P42212	UniProtKB	Beta strand	146	148	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IK8	
P42212	UniProtKB	Beta strand	149	155	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Helix	156	158	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	160	171	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Turn	172	174	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4OGS	
P42212	UniProtKB	Beta strand	176	187	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	189	191	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Beta strand	198	208	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Helix	209	213	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IK8	
P42212	UniProtKB	Beta strand	215	228	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6JGJ	
P42212	UniProtKB	Helix	233	236	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4GF6	
##sequence-region P15056 1 766
P15056	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8	
P15056	UniProtKB	Chain	2	766	.	.	.	ID=PRO_0000085665;Note=Serine/threonine-protein kinase B-raf	
P15056	UniProtKB	Domain	155	227	.	.	.	Note=RBD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00262	
P15056	UniProtKB	Domain	457	717	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P15056	UniProtKB	Zinc finger	234	280	.	.	.	Note=Phorbol-ester/DAG-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00226	
P15056	UniProtKB	Nucleotide binding	463	471	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P15056	UniProtKB	Compositional bias	6	11	.	.	.	Note=Poly-Gly	
P15056	UniProtKB	Compositional bias	122	129	.	.	.	Note=Poly-Ser	
P15056	UniProtKB	Compositional bias	428	432	.	.	.	Note=Poly-Ser	
P15056	UniProtKB	Active site	576	576	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000255,ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027	
P15056	UniProtKB	Metal binding	235	235	.	.	.	Note=Zinc 1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P15056	UniProtKB	Metal binding	248	248	.	.	.	Note=Zinc 2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P15056	UniProtKB	Metal binding	251	251	.	.	.	Note=Zinc 2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P15056	UniProtKB	Metal binding	261	261	.	.	.	Note=Zinc 1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P15056	UniProtKB	Metal binding	264	264	.	.	.	Note=Zinc 1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P15056	UniProtKB	Metal binding	269	269	.	.	.	Note=Zinc 2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P15056	UniProtKB	Metal binding	272	272	.	.	.	Note=Zinc 2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P15056	UniProtKB	Metal binding	280	280	.	.	.	Note=Zinc 1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P15056	UniProtKB	Binding site	483	483	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P15056	UniProtKB	Site	380	381	.	.	.	Note=Breakpoint for translocation to form KIAA1549-BRAF fusion protein	
P15056	UniProtKB	Site	438	439	.	.	.	Note=Breakpoint for translocation to form KIAA1549-BRAF fusion protein	
P15056	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8	
P15056	UniProtKB	Modified residue	151	151	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
P15056	UniProtKB	Modified residue	333	333	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P28028	
P15056	UniProtKB	Modified residue	365	365	.	.	.	Note=Phosphoserine%3B by SGK1;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:11410590,ECO:0000269|Ref.8;Dbxref=PMID:23186163,PMID:11410590	
P15056	UniProtKB	Modified residue	373	373	.	.	.	Note=Phosphothreonine%3B by autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1508179;Dbxref=PMID:1508179	
P15056	UniProtKB	Modified residue	396	396	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8	
P15056	UniProtKB	Modified residue	399	399	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.8	
P15056	UniProtKB	Modified residue	401	401	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000269|Ref.8;Dbxref=PMID:16964243,PMID:18669648,PMID:23186163	
P15056	UniProtKB	Modified residue	446	446	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
P15056	UniProtKB	Modified residue	447	447	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
P15056	UniProtKB	Modified residue	671	671	.	.	.	Note=Omega-N-methylarginine%3B by PRMT5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21917714;Dbxref=PMID:21917714	
P15056	UniProtKB	Modified residue	729	729	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000269|Ref.8;Dbxref=PMID:18669648,PMID:21406692,PMID:23186163	
P15056	UniProtKB	Modified residue	750	750	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P28028	
P15056	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphothreonine%3B by MAPK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19710016;Dbxref=PMID:19710016	
P15056	UniProtKB	Cross-link	578	578	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23907581;Dbxref=PMID:23907581	
P15056	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_058620;Note=In a patient with Noonan syndrome. T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs387906660,PMID:19206169	
P15056	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_058621;Note=In CFC1 and LPRD3. T->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18042262,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs387906661,PMID:18042262,PMID:19206169	
P15056	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_058622;Note=In a patient with Noonan syndrome. T->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs387906660,PMID:19206169	
P15056	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_065171;Note=In CFC1. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18042262;Dbxref=dbSNP:rs397507465,PMID:18042262	
P15056	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_058623;Note=In CFC1. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs397507466,PMID:19206169	
P15056	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_026113;Note=In CFC1. A->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16474404,ECO:0000269|PubMed:18042262,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs180177034,PMID:16474404,PMID:18042262,PMID:19206169	
P15056	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_026114;Note=In CFC1. Q->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:16474404,ECO:0000269|PubMed:18042262,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs180177035,PMID:16439621,PMID:16474404,PMID:18042262,PMID:19206169	
P15056	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_065172;Note=In CFC1. Q->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18042262;Dbxref=dbSNP:rs397507470,PMID:18042262	
P15056	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_058624;Note=In CFC1. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=PMID:19206169	
P15056	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_040391;Note=P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs34776339,PMID:17344846	
P15056	UniProtKB	Natural variant	462	462	.	.	.	ID=VAR_018613;Note=In CRC. R->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12198537;Dbxref=dbSNP:rs180177032,PMID:12198537	
P15056	UniProtKB	Natural variant	463	463	.	.	.	ID=VAR_018614;Note=In CRC. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12198537;Dbxref=dbSNP:rs180177033,PMID:12198537	
P15056	UniProtKB	Natural variant	464	464	.	.	.	ID=VAR_018615;Note=In CRC. G->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:12198537;Dbxref=dbSNP:rs121913348,PMID:12068308,PMID:12198537	
P15056	UniProtKB	Natural variant	464	464	.	.	.	ID=VAR_018616;Note=In a colorectal cancer cell line%3B elevated kinase activity%3B efficiently induces cell transformation. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12068308;Dbxref=dbSNP:rs121913348,PMID:12068308	
P15056	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_018617;Note=In melanoma. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12068308;Dbxref=dbSNP:rs121913351,PMID:12068308	
P15056	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_018618;Note=In melanoma. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12068308;Dbxref=dbSNP:rs121913351,PMID:12068308	
P15056	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_018512;Note=In LNCR. G->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:12460919;Dbxref=dbSNP:rs121913351,PMID:12068308,PMID:12460919	
P15056	UniProtKB	Natural variant	467	467	.	.	.	ID=VAR_035096;Note=In CFC1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16439621;Dbxref=dbSNP:rs869025606,PMID:16439621	
P15056	UniProtKB	Natural variant	468	468	.	.	.	ID=VAR_035097;Note=In CFC1. F->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:18042262;Dbxref=dbSNP:rs397507473,PMID:16439621,PMID:18042262	
P15056	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_018620;Note=In NHL%3B also in a lung adenocarcinoma sample%3B somatic mutation%3B elevated kinase activity%3B efficiently induces cell transformation. G->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:14612909,ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs121913355,PMID:12068308,PMID:14612909,PMID:17344846	
P15056	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_018621;Note=In CFC1 and colon cancer. G->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:16474404,ECO:0000269|PubMed:18042262,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs121913355,PMID:12068308,PMID:16439621,PMID:16474404,PMID:18042262,PMID:19206169	
P15056	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_018622;Note=In NHL. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14612909;Dbxref=dbSNP:rs121913357,PMID:14612909	
P15056	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_040392;Note=In a colorectal adenocarcinoma sample%3B somatic mutation. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs121913355,PMID:17344846	
P15056	UniProtKB	Natural variant	485	485	.	.	.	ID=VAR_026115;Note=In CFC1. L->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:16474404,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs180177036,PMID:16439621,PMID:16474404,PMID:19206169	
P15056	UniProtKB	Natural variant	499	499	.	.	.	ID=VAR_026116;Note=In CFC1. K->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:16474404,ECO:0000269|PubMed:18042262;Dbxref=dbSNP:rs180177037,PMID:16439621,PMID:16474404,PMID:18042262	
P15056	UniProtKB	Natural variant	499	499	.	.	.	ID=VAR_058625;Note=In CFC1. K->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18042262,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs397507476,PMID:18042262,PMID:19206169	
P15056	UniProtKB	Natural variant	501	501	.	.	.	ID=VAR_026117;Note=In CFC1. E->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:16474404;Dbxref=dbSNP:rs180177039,PMID:16439621,PMID:16474404	
P15056	UniProtKB	Natural variant	501	501	.	.	.	ID=VAR_026118;Note=In CFC1. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:16474404,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs180177038,PMID:16439621,PMID:16474404,PMID:19206169	
P15056	UniProtKB	Natural variant	525	525	.	.	.	ID=VAR_058626;Note=In CFC1. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs869025340,PMID:19206169	
P15056	UniProtKB	Natural variant	531	531	.	.	.	ID=VAR_058627;Note=In NS7. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs606231228,PMID:19206169	
P15056	UniProtKB	Natural variant	580	580	.	.	.	ID=VAR_065173;Note=In CFC1. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18042262;Dbxref=PMID:18042262	
P15056	UniProtKB	Natural variant	581	581	.	.	.	ID=VAR_026119;Note=In CFC1. N->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:16474404,ECO:0000269|PubMed:18042262;Dbxref=dbSNP:rs180177040,PMID:16439621,PMID:16474404,PMID:18042262	
P15056	UniProtKB	Natural variant	581	581	.	.	.	ID=VAR_040393;Note=In a colorectal adenocarcinoma sample%3B somatic mutation. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs121913370,PMID:17344846	
P15056	UniProtKB	Natural variant	586	586	.	.	.	ID=VAR_018623;Note=In ovarian cancer. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12068308;Dbxref=dbSNP:rs121913340,PMID:12068308	
P15056	UniProtKB	Natural variant	594	594	.	.	.	ID=VAR_018624;Note=In NHL. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14612909;Dbxref=dbSNP:rs121913338,PMID:14612909	
P15056	UniProtKB	Natural variant	595	595	.	.	.	ID=VAR_018625;Note=In colon cancer and CFC1. F->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:16439621,ECO:0000269|PubMed:18042262,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs121913341,PMID:12068308,PMID:16439621,PMID:18042262,PMID:19206169	
P15056	UniProtKB	Natural variant	596	596	.	.	.	ID=VAR_018626;Note=In a colorectal adenocarcinoma sample%3B somatic mutation. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs121913361,PMID:12068308,PMID:17344846	
P15056	UniProtKB	Natural variant	596	596	.	.	.	ID=VAR_035098;Note=In CFC1. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16439621;Dbxref=dbSNP:rs397507483,PMID:16439621	
P15056	UniProtKB	Natural variant	597	597	.	.	.	ID=VAR_018513;Note=In LNCR%3B also found in an ovarian serous carcinoma sample%3B somatic mutation. L->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:12460919,ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs121913366,PMID:12068308,PMID:12460919,PMID:17344846	
P15056	UniProtKB	Natural variant	597	597	.	.	.	ID=VAR_018627;Note=In NS7%3B also in a lung adenocarcinoma sample%3B somatic mutation%3B elevated kinase activity%3B efficiently induces cell transformation. L->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:17344846,ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs121913369,PMID:12068308,PMID:17344846,PMID:19206169	
P15056	UniProtKB	Natural variant	599	599	.	.	.	ID=VAR_058628;Note=In CFC1. T->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs121913375,PMID:19206169	
P15056	UniProtKB	Natural variant	600	600	.	.	.	ID=VAR_018628;Note=In a melanoma cell line%3B requires 2 nucleotide substitutions. V->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12068308;Dbxref=dbSNP:rs121913377,PMID:12068308	
P15056	UniProtKB	Natural variant	600	600	.	.	.	ID=VAR_018629;Note=In CRC%3B also found in sarcoma%2C metastatic melanoma%2C ovarian serous carcinoma%2C pilocytic astrocytoma%3B somatic mutation%3B most common mutation%3B constitutive and elevated kinase activity%3B efficiently induces cell transformation%3B suppression of mutation in melanoma causes growth arrest and promotes apoptosis%3B loss of regulation by PMRT5. V->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12068308,ECO:0000269|PubMed:12198537,ECO:0000269|PubMed:14500344,ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:17344846,ECO:0000269|PubMed:21917714,ECO:0000269|PubMed:23263490,ECO:0000269|PubMed:24455489;Dbxref=dbSNP:rs113488022,PMID:12068308,PMID:12198537,PMID:14500344,PMID:16959974,PMID:17344846,PMID:21917714,PMID:23263490,PMID:24455489	
P15056	UniProtKB	Natural variant	601	601	.	.	.	ID=VAR_018630;Note=In CRC. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12198537;Dbxref=dbSNP:rs121913364,PMID:12198537	
P15056	UniProtKB	Natural variant	601	601	.	.	.	ID=VAR_058629;Note=In CFC1. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs121913364,PMID:19206169	
P15056	UniProtKB	Natural variant	638	638	.	.	.	ID=VAR_058630;Note=In CFC1. D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs180177042,PMID:19206169	
P15056	UniProtKB	Natural variant	709	709	.	.	.	ID=VAR_058631;Note=In CFC1. Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19206169;Dbxref=dbSNP:rs397507486,PMID:19206169	
P15056	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1. M->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29433126;Dbxref=PMID:29433126	
P15056	UniProtKB	Mutagenesis	88	88	.	.	.	Note=Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29433126;Dbxref=PMID:29433126	
P15056	UniProtKB	Mutagenesis	483	483	.	.	.	Note=Reduces kinase activity with MAP2K1. K->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21441910;Dbxref=PMID:21441910	
P15056	UniProtKB	Mutagenesis	509	509	.	.	.	Note=Loss of MAP2K1-mediated-BRAF-KSR1 dimerization. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29433126;Dbxref=PMID:29433126	
P15056	UniProtKB	Mutagenesis	578	578	.	.	.	Note=Blocks EGF-induced ubiquitination and ERK activation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23907581;Dbxref=PMID:23907581	
P15056	UniProtKB	Mutagenesis	666	666	.	.	.	Note=No effect on MAP2K1-mediated-BRAF-KSR1 dimerization%2C however loss of BRAF-mediated phosphorylation of MAP2K1. I->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29433126;Dbxref=PMID:29433126	
P15056	UniProtKB	Mutagenesis	671	671	.	.	.	Note=Increased kinase activity and stability in response to EGF treatment. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21917714;Dbxref=PMID:21917714	
P15056	UniProtKB	Sequence conflict	766	766	.	.	.	Note=H->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P15056	UniProtKB	Helix	43	68	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5VYK	
P15056	UniProtKB	Helix	76	103	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5VYK	
P15056	UniProtKB	Beta strand	156	161	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Turn	162	164	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Beta strand	165	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Helix	177	186	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Turn	187	189	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Helix	192	194	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Beta strand	195	199	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Beta strand	206	208	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Helix	214	217	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Beta strand	221	226	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3NY5	
P15056	UniProtKB	Helix	448	450	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5JRQ	
P15056	UniProtKB	Helix	454	456	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5JRQ	
P15056	UniProtKB	Beta strand	458	466	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	469	486	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	487	489	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6N0P	
P15056	UniProtKB	Helix	492	506	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	516	520	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	522	524	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	526	530	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	534	536	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5VAM	
P15056	UniProtKB	Helix	537	542	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	543	545	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RZW	
P15056	UniProtKB	Helix	550	569	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Helix	579	581	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	582	585	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Turn	586	588	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	589	592	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Turn	598	600	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5JSM	
P15056	UniProtKB	Turn	602	605	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RZV	
P15056	UniProtKB	Helix	611	613	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4WO5	
P15056	UniProtKB	Turn	614	616	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HID	
P15056	UniProtKB	Helix	617	619	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Helix	622	625	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	629	631	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5VAM	
P15056	UniProtKB	Helix	635	651	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Turn	655	659	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Helix	662	670	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Helix	678	680	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Beta strand	683	685	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5JRQ	
P15056	UniProtKB	Helix	687	696	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Helix	701	703	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Helix	707	717	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5ITA	
P15056	UniProtKB	Turn	718	720	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RZV	
P15056	UniProtKB	Beta strand	723	726	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6U2H	
##sequence-region P04637 1 393
P04637	UniProtKB	Chain	1	393	.	.	.	ID=PRO_0000185703;Note=Cellular tumor antigen p53	
P04637	UniProtKB	DNA binding	102	292	.	.	.	.	
P04637	UniProtKB	Region	1	320	.	.	.	Note=Interaction with CCAR2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25732823;Dbxref=PMID:25732823	
P04637	UniProtKB	Region	1	83	.	.	.	Note=Interaction with HRMT1L2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15186775;Dbxref=PMID:15186775	
P04637	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P04637	UniProtKB	Region	66	110	.	.	.	Note=Interaction with WWOX	
P04637	UniProtKB	Region	100	370	.	.	.	Note=Interaction with HIPK1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P04637	UniProtKB	Region	100	300	.	.	.	Note=Required for interaction with ZNF385A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17719541;Dbxref=PMID:17719541	
P04637	UniProtKB	Region	113	236	.	.	.	Note=Required for interaction with FBXO42;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19509332;Dbxref=PMID:19509332	
P04637	UniProtKB	Region	116	292	.	.	.	Note=Interaction with AXIN1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P04637	UniProtKB	Region	241	248	.	.	.	Note=Interaction with the 53BP2 SH3 domain	
P04637	UniProtKB	Region	256	294	.	.	.	Note=Interaction with E4F1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10644996;Dbxref=PMID:10644996	
P04637	UniProtKB	Region	273	280	.	.	.	Note=Interaction with DNA	
P04637	UniProtKB	Region	300	393	.	.	.	Note=Interaction with CARM1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15186775;Dbxref=PMID:15186775	
P04637	UniProtKB	Region	319	360	.	.	.	Note=Interaction with HIPK2	
P04637	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
P04637	UniProtKB	Region	359	363	.	.	.	Note=Interaction with USP7	
P04637	UniProtKB	Region	368	387	.	.	.	Note=Basic (repression of DNA-binding)	
P04637	UniProtKB	Motif	17	25	.	.	.	Note=TADI	
P04637	UniProtKB	Motif	48	56	.	.	.	Note=TADII	
P04637	UniProtKB	Motif	305	321	.	.	.	Note=Bipartite nuclear localization signal	
P04637	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal	
P04637	UniProtKB	Motif	370	372	.	.	.	Note=[KR]-[STA]-K motif	
P04637	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc	
P04637	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc	
P04637	UniProtKB	Metal binding	238	238	.	.	.	Note=Zinc	
P04637	UniProtKB	Metal binding	242	242	.	.	.	Note=Zinc	
P04637	UniProtKB	Site	120	120	.	.	.	Note=Interaction with DNA	
P04637	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18022393;Dbxref=PMID:18022393	
P04637	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10570149,ECO:0000269|PubMed:11554766,ECO:0000269|PubMed:15701641,ECO:0000269|PubMed:15866171,ECO:0000269|PubMed:17108107,ECO:0000269|PubMed:17591690,ECO:0000269|PubMed:17967874,ECO:0000269|PubMed:21317932,ECO:0000269|PubMed:28842590;Dbxref=PMID:10570149,PMID:11554766,PMID:15701641,PMID:15866171,PMID:17108107,PMID:17591690,PMID:17967874,PMID:21317932,PMID:28842590	
P04637	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10606744,ECO:0000269|PubMed:10951572,ECO:0000269|PubMed:16704422;Dbxref=PMID:10606744,PMID:10951572,PMID:16704422	
P04637	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10570149,ECO:0000269|PubMed:11447225,ECO:0000269|PubMed:11551930,ECO:0000269|PubMed:12810724,ECO:0000269|PubMed:20041275;Dbxref=PMID:10570149,PMID:11447225,PMID:11551930,PMID:12810724,PMID:20041275	
P04637	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17591690,ECO:0000269|PubMed:9372954;Dbxref=PMID:17591690,PMID:9372954	
P04637	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17254968;Dbxref=PMID:17254968	
P04637	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11740489,ECO:0000269|PubMed:11780126,ECO:0000269|PubMed:16377624,ECO:0000269|PubMed:17349958,ECO:0000269|PubMed:17591690;Dbxref=PMID:11740489,PMID:11780126,PMID:16377624,PMID:17349958,PMID:17591690	
P04637	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1 and GRK5;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15053879,ECO:0000269|PubMed:20124405;Dbxref=PMID:15053879,PMID:20124405	
P04637	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-acetyllysine%3B by KAT6A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23431171;Dbxref=PMID:23431171	
P04637	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine%3B by AURKB;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959462;Dbxref=PMID:20959462	
P04637	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphoserine%3B by AURKB;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959462;Dbxref=PMID:20959462	
P04637	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphothreonine%3B by AURKB;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959462;Dbxref=PMID:20959462	
P04637	UniProtKB	Modified residue	305	305	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12724314;Dbxref=PMID:12724314	
P04637	UniProtKB	Modified residue	315	315	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10884347,ECO:0000269|PubMed:14702041;Dbxref=PMID:10884347,PMID:14702041	
P04637	UniProtKB	Modified residue	321	321	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P02340	
P04637	UniProtKB	Modified residue	333	333	.	.	.	Note=Omega-N-methylarginine%3B by PRMT5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19011621;Dbxref=PMID:19011621	
P04637	UniProtKB	Modified residue	335	335	.	.	.	Note=Symmetric dimethylarginine%3B by PRMT5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19011621;Dbxref=PMID:19011621	
P04637	UniProtKB	Modified residue	337	337	.	.	.	Note=Symmetric dimethylarginine%3B by PRMT5;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19011621;Dbxref=PMID:19011621	
P04637	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17108971,ECO:0000269|PubMed:22864287;Dbxref=PMID:17108971,PMID:22864287	
P04637	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17108971,ECO:0000269|PubMed:22864287;Dbxref=PMID:17108971,PMID:22864287	
P04637	UniProtKB	Modified residue	372	372	.	.	.	Note=N6-methyllysine%3B by SETD7;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15525938,ECO:0000269|PubMed:16415881;Dbxref=PMID:15525938,PMID:16415881	
P04637	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20118233;Dbxref=PMID:20118233	
P04637	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10656795;Dbxref=PMID:10656795	
P04637	UniProtKB	Modified residue	381	381	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P04637	UniProtKB	Modified residue	382	382	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17707234,ECO:0000269|PubMed:20870725,ECO:0000269|PubMed:22864287;Dbxref=PMID:17707234,PMID:20870725,PMID:22864287	
P04637	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19608861,ECO:0000269|PubMed:10656795,ECO:0000269|PubMed:20228809,ECO:0000269|PubMed:23431171;Dbxref=PMID:19608861,PMID:10656795,PMID:20228809,PMID:23431171	
P04637	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine%3B by KMT5A%3B alternate;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17707234,ECO:0000269|PubMed:20870725,ECO:0000269|PubMed:22864287;Dbxref=PMID:17707234,PMID:20870725,PMID:22864287	
P04637	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10884347,ECO:0000269|PubMed:11239457,ECO:0000269|PubMed:17108107,ECO:0000269|PubMed:21317932,ECO:0000269|PubMed:22214662;Dbxref=PMID:10884347,PMID:11239457,PMID:17108107,PMID:21317932,PMID:22214662	
P04637	UniProtKB	Cross-link	291	291	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19536131;Dbxref=PMID:19536131	
P04637	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19536131;Dbxref=PMID:19536131	
P04637	UniProtKB	Cross-link	386	386	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11124955,ECO:0000269|PubMed:22214662,ECO:0000269|Ref.37;Dbxref=PMID:11124955,PMID:22214662	
P04637	UniProtKB	Alternative sequence	1	132	.	.	.	ID=VSP_040833;Note=In isoform 7%2C isoform 8 and isoform 9. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16131611;Dbxref=PMID:16131611	
P04637	UniProtKB	Alternative sequence	1	39	.	.	.	ID=VSP_040832;Note=In isoform 4%2C isoform 5 and isoform 6. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04637	UniProtKB	Alternative sequence	332	346	.	.	.	ID=VSP_040560;Note=In isoform 3%2C isoform 6 and isoform 9. IRGRERFEMFRELNE->MLLDLRWCYFLINSS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16131611;Dbxref=PMID:16131611	
P04637	UniProtKB	Alternative sequence	332	341	.	.	.	ID=VSP_006535;Note=In isoform 2%2C isoform 5 and isoform 8. IRGRERFEMF->DQTSFQKENC;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16131611;Dbxref=PMID:16131611	
P04637	UniProtKB	Alternative sequence	342	393	.	.	.	ID=VSP_006536;Note=In isoform 2%2C isoform 5 and isoform 8. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16131611;Dbxref=PMID:16131611	
P04637	UniProtKB	Alternative sequence	347	393	.	.	.	ID=VSP_040561;Note=In isoform 3%2C isoform 6 and isoform 9. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16131611;Dbxref=PMID:16131611	
P04637	UniProtKB	Natural variant	5	5	.	.	.	ID=VAR_044543;Note=In a sporadic cancer%3B somatic mutation%3B abolishes strongly phosphorylation. Q->H	
P04637	UniProtKB	Natural variant	6	6	.	.	.	ID=VAR_044544;Note=In a sporadic cancer%3B somatic mutation%3B reduces interaction with ZNF385A. S->L	
P04637	UniProtKB	Natural variant	7	7	.	.	.	ID=VAR_005851;Note=In a sporadic cancer%3B somatic mutation. D->H;Dbxref=dbSNP:rs587782646	
P04637	UniProtKB	Natural variant	8	8	.	.	.	ID=VAR_044545;Note=In a sporadic cancer%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_044546;Note=In a sporadic cancer%3B somatic mutation. V->I;Dbxref=dbSNP:rs535274413	
P04637	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_044547;Note=In sporadic cancers%3B somatic mutation. E->K;Dbxref=dbSNP:rs201382018	
P04637	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_044548;Note=In sporadic cancers%3B somatic mutation. E->Q;Dbxref=dbSNP:rs201382018	
P04637	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_044549;Note=In a sporadic cancer%3B somatic mutation. S->R	
P04637	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_044550;Note=In a sporadic cancer%3B somatic mutation. Q->L	
P04637	UniProtKB	Natural variant	17	17	.	.	.	ID=VAR_044551;Note=In a sporadic cancer%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	24	24	.	.	.	ID=VAR_044552;Note=In a sporadic cancer%3B somatic mutation. K->N	
P04637	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_044553;Note=In a sporadic cancer%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	29	30	.	.	.	ID=VAR_047158;Note=In a sporadic cancer%3B somatic mutation. NN->KD	
P04637	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_044554;Note=In sporadic cancers%3B somatic mutation. V->I;Dbxref=dbSNP:rs201753350	
P04637	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_044555;Note=In a sporadic cancer%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_044556;Note=In a sporadic cancer%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_005852;Note=In sporadic cancers%3B somatic mutation. L->F;Dbxref=dbSNP:rs121912661	
P04637	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_044557;Note=In a sporadic cancer%3B somatic mutation. P->L;Dbxref=dbSNP:rs587781866	
P04637	UniProtKB	Natural variant	37	37	.	.	.	ID=VAR_044558;Note=In a sporadic cancer%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	37	37	.	.	.	ID=VAR_044559;Note=In a sporadic cancer%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_044560;Note=In a sporadic cancer%3B somatic mutation. A->P	
P04637	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_044561;Note=In a sporadic cancer%3B somatic mutation. A->V;Dbxref=dbSNP:rs1353016807	
P04637	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_044562;Note=In a sporadic cancer%3B somatic mutation. D->Y	
P04637	UniProtKB	Natural variant	43	43	.	.	.	ID=VAR_005853;Note=In a sporadic cancer%3B somatic mutation. L->S	
P04637	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_044563;Note=In a sporadic cancer%3B somatic mutation. M->I;Dbxref=dbSNP:rs1060501190	
P04637	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_044564;Note=In a sporadic cancer%3B somatic mutation. M->T	
P04637	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_044565;Note=In a sporadic cancer%3B somatic mutation. M->V	
P04637	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_044566;Note=In a sporadic cancer%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_044567;Note=In sporadic cancers%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_044568;Note=In sporadic cancers%3B somatic mutation. S->P;Dbxref=dbSNP:rs876659630	
P04637	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_044569;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_014632;Note=P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.12;Dbxref=dbSNP:rs1800371	
P04637	UniProtKB	Natural variant	48	48	.	.	.	ID=VAR_044570;Note=In a sporadic cancer%3B somatic mutation. D->G	
P04637	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_044571;Note=In sporadic cancers%3B somatic mutation. D->H;Dbxref=dbSNP:rs587780728	
P04637	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_044572;Note=In a sporadic cancer%3B somatic mutation. D->N;Dbxref=dbSNP:rs587780728	
P04637	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_044573;Note=In sporadic cancers%3B somatic mutation. D->Y	
P04637	UniProtKB	Natural variant	52	52	.	.	.	ID=VAR_044574;Note=In a sporadic cancer%3B somatic mutation. Q->H	
P04637	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_005854;Note=In sporadic cancers%3B somatic mutation. W->C	
P04637	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_044575;Note=In a sporadic cancer%3B somatic mutation. W->G	
P04637	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_044576;Note=In a sporadic cancer%3B somatic mutation. F->L;Dbxref=dbSNP:rs1555526742	
P04637	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_044577;Note=In a sporadic cancer%3B somatic mutation. F->Y	
P04637	UniProtKB	Natural variant	56	56	.	.	.	ID=VAR_044578;Note=In sporadic cancers%3B somatic mutation. E->K	
P04637	UniProtKB	Natural variant	56	56	.	.	.	ID=VAR_044579;Note=In a sporadic cancer%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_044580;Note=In a sporadic cancer%3B somatic mutation. P->Q	
P04637	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_044581;Note=In a sporadic cancer%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_044582;Note=In sporadic cancers%3B somatic mutation. G->C;Dbxref=dbSNP:rs1237722021	
P04637	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_044583;Note=In sporadic cancers%3B somatic mutation. G->D	
P04637	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_045783;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. G->N	
P04637	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_044584;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_044585;Note=In a sporadic cancer%3B somatic mutation. P->Q	
P04637	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_005855;Note=In a sporadic cancer%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_044586;Note=In sporadic cancers%3B somatic mutation. D->G;Dbxref=dbSNP:rs1460793472	
P04637	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_044587;Note=In sporadic cancers%3B somatic mutation. D->N	
P04637	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_044588;Note=In a sporadic cancer%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_044589;Note=In a sporadic cancer%3B somatic mutation. A->T;Dbxref=dbSNP:rs876658902	
P04637	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_044590;Note=In a sporadic cancer%3B somatic mutation. A->V;Dbxref=dbSNP:rs372201428	
P04637	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_044591;Note=In a sporadic cancer%3B somatic mutation. R->T;Dbxref=dbSNP:rs1060501210	
P04637	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_044592;Note=In a sporadic cancer%3B somatic mutation. M->I;Dbxref=dbSNP:rs1555526711	
P04637	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_044593;Note=In a sporadic cancer%3B somatic mutation. M->R	
P04637	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_044594;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_044595;Note=In a sporadic cancer%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_044596;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_044597;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_044598;Note=In a sporadic cancer%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_044599;Note=In a sporadic cancer%3B somatic mutation. A->D	
P04637	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_044600;Note=In sporadic cancers%3B somatic mutation. A->G;Dbxref=dbSNP:rs756233241	
P04637	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_044601;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_044602;Note=In a sporadic cancer%3B somatic mutation. A->V;Dbxref=dbSNP:rs756233241	
P04637	UniProtKB	Natural variant	70	70	.	.	.	ID=VAR_044603;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_044604;Note=In a sporadic cancer%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_045784;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. P->C;Dbxref=dbSNP:rs730882014	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_045785;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. P->G	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_045786;Note=In sporadic cancers%3B somatic mutation. P->H;Dbxref=dbSNP:rs1042522	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_045787;Note=In a sporadic cancer%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_005856;Note=P->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:16131611,ECO:0000269|PubMed:1999338,ECO:0000269|Ref.17;Dbxref=dbSNP:rs1042522,PMID:14702039,PMID:16131611,PMID:1999338	
P04637	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_044605;Note=In a sporadic cancer%3B somatic mutation. V->E	
P04637	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_044606;Note=In sporadic cancers%3B somatic mutation. V->L	
P04637	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_044607;Note=In sporadic cancers%3B somatic mutation. V->M;Dbxref=dbSNP:rs587782423	
P04637	UniProtKB	Natural variant	74	74	.	.	.	ID=VAR_044608;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_044609;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_044610;Note=In sporadic cancers%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_044611;Note=In a sporadic cancer%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_044612;Note=In a sporadic cancer%3B somatic mutation. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2946935;Dbxref=PMID:2946935	
P04637	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_044613;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	77	77	.	.	.	ID=VAR_044614;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_044615;Note=In sporadic cancers%3B somatic mutation. A->V	
P04637	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_044616;Note=In a sporadic cancer%3B somatic mutation. A->G	
P04637	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_005857;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_044617;Note=In sporadic cancers%3B somatic mutation. A->V	
P04637	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_044618;Note=In a sporadic cancer%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_044619;Note=In a sporadic cancer%3B somatic mutation. P->S;Dbxref=dbSNP:rs1060501204	
P04637	UniProtKB	Natural variant	81	81	.	.	.	ID=VAR_044620;Note=In sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_044621;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs534447939	
P04637	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_044622;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_044623;Note=In a sporadic cancer%3B somatic mutation. A->E;Dbxref=dbSNP:rs201717599	
P04637	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_044624;Note=In sporadic cancers%3B somatic mutation. A->V;Dbxref=dbSNP:rs201717599	
P04637	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_044625;Note=In sporadic cancers%3B somatic mutation. A->G	
P04637	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_044626;Note=In sporadic cancers%3B somatic mutation. A->V	
P04637	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_044627;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_044628;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_044629;Note=In a sporadic cancer%3B somatic mutation. A->V	
P04637	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_005858;Note=In sporadic cancers%3B somatic mutation. P->Q	
P04637	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_044630;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_044631;Note=In sporadic cancers%3B somatic mutation. A->V;Dbxref=dbSNP:rs1555526631	
P04637	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_044632;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs730881994	
P04637	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_044633;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_044634;Note=In sporadic cancers%3B somatic mutation. S->F;Dbxref=dbSNP:rs1555526625	
P04637	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_044635;Note=In a sporadic cancer%3B somatic mutation. S->Y	
P04637	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_044636;Note=In a sporadic cancer%3B somatic mutation. W->C	
P04637	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_044637;Note=In a sporadic cancer%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_044638;Note=In a sporadic cancer%3B somatic mutation. P->L;Dbxref=dbSNP:rs1210700121	
P04637	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_044639;Note=In a sporadic cancer%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_044640;Note=In a sporadic cancer%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_044641;Note=In a sporadic cancer%3B somatic mutation. L->P	
P04637	UniProtKB	Natural variant	94	94	.	.	.	ID=VAR_044642;Note=In sporadic cancers%3B somatic mutation. S->L	
P04637	UniProtKB	Natural variant	94	94	.	.	.	ID=VAR_005859;Note=In sporadic cancers%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_044643;Note=In sporadic cancers%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_044644;Note=In a sporadic cancer%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_044645;Note=In a sporadic cancer%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_044646;Note=In sporadic cancers%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_044647;Note=In a sporadic cancer%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_044648;Note=In a sporadic cancer%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_044649;Note=In a sporadic cancer%3B somatic mutation. V->F	
P04637	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_044650;Note=In familial cancer not matching LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. V->I;Dbxref=dbSNP:rs730882023	
P04637	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_044651;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs1245723119	
P04637	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_044652;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_044653;Note=In sporadic cancers%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_044654;Note=In a sporadic cancer%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	100	100	.	.	.	ID=VAR_044655;Note=In a sporadic cancer%3B somatic mutation. Q->R	
P04637	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_044656;Note=In a sporadic cancer%3B somatic mutation. K->N;Dbxref=dbSNP:rs878854069	
P04637	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_044657;Note=In sporadic cancers%3B somatic mutation. K->R	
P04637	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_044658;Note=In sporadic cancers%3B somatic mutation. T->I;Dbxref=dbSNP:rs786202717	
P04637	UniProtKB	Natural variant	104	104	.	.	.	ID=VAR_044659;Note=In sporadic cancers%3B somatic mutation. Q->H	
P04637	UniProtKB	Natural variant	104	104	.	.	.	ID=VAR_044660;Note=In a sporadic cancer%3B somatic mutation. Q->L	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044661;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. G->C	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044662;Note=In sporadic cancers%3B somatic mutation. G->D;Dbxref=dbSNP:rs587781504	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044663;Note=In sporadic cancers%3B somatic mutation. G->R;Dbxref=dbSNP:rs1060501195	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044664;Note=In a sporadic cancer%3B somatic mutation. G->S;Dbxref=dbSNP:rs1060501195	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044665;Note=In sporadic cancers%3B somatic mutation. G->V	
P04637	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_044666;Note=In a sporadic cancer%3B somatic mutation. S->G	
P04637	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_044667;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. S->R;Dbxref=dbSNP:rs1555526581	
P04637	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_044668;Note=In a sporadic cancer%3B somatic mutation. Y->C;Dbxref=dbSNP:rs587782447	
P04637	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_044669;Note=In sporadic cancers%3B somatic mutation. Y->D	
P04637	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_044670;Note=In a sporadic cancer%3B somatic mutation. Y->H;Dbxref=dbSNP:rs368771578	
P04637	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_044671;Note=In a sporadic cancer%3B somatic mutation. G->D	
P04637	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_044672;Note=In sporadic cancers%3B somatic mutation. G->S;Dbxref=dbSNP:rs587782461	
P04637	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_044673;Note=In sporadic cancers%3B somatic mutation. F->C	
P04637	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_044674;Note=In a sporadic cancer%3B somatic mutation. F->L	
P04637	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_044675;Note=In sporadic cancers%3B somatic mutation. F->S;Dbxref=dbSNP:rs1064796722	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_005860;Note=In sporadic cancers%3B somatic mutation. R->C;Dbxref=dbSNP:rs587781371	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_044676;Note=In a sporadic cancer%3B somatic mutation. R->G	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_044677;Note=In sporadic cancers%3B somatic mutation. R->H;Dbxref=dbSNP:rs11540654	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_005861;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20385133;Dbxref=dbSNP:rs11540654,PMID:20385133	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_005862;Note=In sporadic cancers%3B somatic mutation. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs11540654,PMID:17224074	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_044678;Note=In a sporadic cancer%3B somatic mutation. R->S;Dbxref=dbSNP:rs587781371	
P04637	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_044679;Note=In a sporadic cancer%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_044680;Note=In sporadic cancers%3B somatic mutation. L->P;Dbxref=dbSNP:rs1057519997	
P04637	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_044681;Note=In sporadic cancers%3B somatic mutation. L->Q;Dbxref=dbSNP:rs1057519997	
P04637	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_044682;Note=In sporadic cancers%3B somatic mutation. L->R;Dbxref=dbSNP:rs1057519997	
P04637	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_044683;Note=In sporadic cancers%3B somatic mutation. G->D	
P04637	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_044684;Note=In sporadic cancers%3B somatic mutation. G->S;Dbxref=dbSNP:rs1423803759	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_005863;Note=In sporadic cancers%3B somatic mutation. F->C	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_045788;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. F->G	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_044685;Note=In a sporadic cancer%3B somatic mutation. F->I	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_044686;Note=In sporadic cancers%3B somatic mutation. F->L	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_044687;Note=In sporadic cancers%3B somatic mutation. F->S	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_033033;Note=In sporadic cancers%3B somatic mutation. F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs587781642,PMID:17224074	
P04637	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_044688;Note=In sporadic cancers%3B somatic mutation. H->Y	
P04637	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_044689;Note=In sporadic cancers%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_044690;Note=In a sporadic cancer%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_044691;Note=In a sporadic cancer%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_044692;Note=In sporadic cancers%3B somatic mutation. G->E;Dbxref=dbSNP:rs755238756	
P04637	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_044693;Note=In sporadic cancers%3B somatic mutation. G->R;Dbxref=dbSNP:rs1555526518	
P04637	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_044694;Note=In a sporadic cancer%3B somatic mutation. T->A	
P04637	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_044695;Note=In sporadic cancers%3B somatic mutation. T->I;Dbxref=dbSNP:rs1064794141	
P04637	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_044696;Note=In a sporadic cancer%3B somatic mutation. T->R	
P04637	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_044697;Note=In a sporadic cancer%3B somatic mutation. A->D	
P04637	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_044698;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_044699;Note=In sporadic cancers%3B somatic mutation. K->E;Dbxref=dbSNP:rs121912658	
P04637	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_044700;Note=In sporadic cancers%3B somatic mutation. K->M	
P04637	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_044701;Note=In a sporadic cancer%3B somatic mutation. K->Q;Dbxref=dbSNP:rs121912658	
P04637	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_044702;Note=In sporadic cancers%3B somatic mutation. K->R	
P04637	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_044703;Note=In sporadic cancers%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_044704;Note=In a sporadic cancer%3B somatic mutation. V->L	
P04637	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_044705;Note=In a sporadic cancer%3B somatic mutation. T->I;Dbxref=dbSNP:rs1555526486	
P04637	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_044706;Note=In a sporadic cancer%3B somatic mutation. T->N	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044707;Note=In a sporadic cancer%3B somatic mutation. C->G;Dbxref=dbSNP:rs730881997	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044708;Note=In sporadic cancers%3B somatic mutation. C->R	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044709;Note=In sporadic cancers%3B somatic mutation. C->S;Dbxref=dbSNP:rs730881997	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044710;Note=In a sporadic cancer%3B somatic mutation. C->W	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044711;Note=In a sporadic cancer%3B somatic mutation. C->Y	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_044712;Note=In a sporadic cancer%3B somatic mutation. T->A	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_044713;Note=In sporadic cancers%3B somatic mutation. T->K;Dbxref=dbSNP:rs786201057	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_005864;Note=In sporadic cancers%3B somatic mutation. T->M;Dbxref=dbSNP:rs786201057	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_044714;Note=In a sporadic cancer%3B somatic mutation. T->P;Dbxref=dbSNP:rs1057520003	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_044715;Note=In sporadic cancers%3B somatic mutation. T->R;Dbxref=dbSNP:rs786201057	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_044716;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. Y->C;Dbxref=dbSNP:rs1555526335	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_005865;Note=In sporadic cancers%3B somatic mutation. Y->D;Dbxref=dbSNP:rs886039483	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_044717;Note=In a sporadic cancer%3B somatic mutation. Y->F	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_045789;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. Y->G	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_044718;Note=In sporadic cancers%3B somatic mutation. Y->H	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_005866;Note=In sporadic cancers%3B somatic mutation. Y->N;Dbxref=dbSNP:rs886039483	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_044719;Note=In sporadic cancers%3B somatic mutation. Y->S	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_044720;Note=In a sporadic cancer%3B somatic mutation. S->C;Dbxref=dbSNP:rs730881999	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_005867;Note=In sporadic cancers%3B somatic mutation. S->F;Dbxref=dbSNP:rs730881999	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_044721;Note=In sporadic cancers%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_044722;Note=In sporadic cancers%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_044723;Note=In sporadic cancers%3B somatic mutation. S->Y	
P04637	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_044724;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_044725;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_044726;Note=In sporadic cancers%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_005868;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_005869;Note=In sporadic cancers%3B somatic mutation. A->D	
P04637	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_044727;Note=In a sporadic cancer%3B somatic mutation. A->G	
P04637	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_044728;Note=In sporadic cancers%3B somatic mutation. A->T;Dbxref=dbSNP:rs1438095083	
P04637	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_044729;Note=In sporadic cancers%3B somatic mutation. A->V;Dbxref=dbSNP:rs137852792	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044730;Note=In sporadic cancers%3B somatic mutation. L->F;Dbxref=dbSNP:rs863224683	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044731;Note=In sporadic cancers%3B somatic mutation. L->H	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044732;Note=In a sporadic cancer%3B somatic mutation. L->I	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044733;Note=In sporadic cancers%3B somatic mutation. L->P;Dbxref=dbSNP:rs1131691013	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_005870;Note=In sporadic cancers%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044734;Note=In sporadic cancers%3B somatic mutation. L->V;Dbxref=dbSNP:rs863224683	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044735;Note=In a sporadic cancer%3B somatic mutation. N->D	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044736;Note=In sporadic cancers%3B somatic mutation. N->H	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044737;Note=In sporadic cancers%3B somatic mutation. N->I;Dbxref=dbSNP:rs1131691037	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_005872;Note=In sporadic cancers%3B somatic mutation. N->K;Dbxref=dbSNP:rs769270327	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_005871;Note=In sporadic cancers%3B somatic mutation. N->S	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044738;Note=In a sporadic cancer%3B somatic mutation. N->T	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044739;Note=In sporadic cancers%3B somatic mutation. N->Y;Dbxref=dbSNP:rs587782160	
P04637	UniProtKB	Natural variant	132	133	.	.	.	ID=VAR_047159;Note=In a sporadic cancer%3B somatic mutation. KM->NL	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_044740;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. K->E;Dbxref=dbSNP:rs747342068	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_045790;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. K->L	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_005873;Note=In sporadic cancers%3B somatic mutation. K->M;Dbxref=dbSNP:rs1057519996	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_044741;Note=In sporadic cancers%3B somatic mutation. K->N;Dbxref=dbSNP:rs866775781	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_005874;Note=In sporadic cancers%3B somatic mutation. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1694291;Dbxref=dbSNP:rs747342068,PMID:1694291	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_044742;Note=In sporadic cancers%3B somatic mutation. K->R;Dbxref=dbSNP:rs1057519996	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_044743;Note=In sporadic cancers%3B somatic mutation. K->T;Dbxref=dbSNP:rs1057519996	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_045791;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. K->W	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044744;Note=In sporadic cancers%3B somatic mutation. M->I;Dbxref=dbSNP:rs1064795139	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044745;Note=In sporadic cancers%3B somatic mutation. M->K	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044746;Note=In sporadic cancers%3B somatic mutation. M->L	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044747;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. M->R	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_005875;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1933902;Dbxref=dbSNP:rs28934873,PMID:1933902	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044748;Note=In sporadic cancers%3B somatic mutation. M->V;Dbxref=dbSNP:rs1057280220	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_044749;Note=In sporadic cancers%3B somatic mutation. F->C;Dbxref=dbSNP:rs780442292	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_044750;Note=In sporadic cancers%3B somatic mutation. F->I	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_036504;Note=In sporadic cancers%3B somatic mutation. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs267605077,PMID:16959974	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_044751;Note=In sporadic cancers%3B somatic mutation. F->S	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_044752;Note=In sporadic cancers%3B somatic mutation. F->V	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_005877;Note=In sporadic cancers%3B somatic mutation. C->F;Dbxref=dbSNP:rs587781991	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_044753;Note=In sporadic cancers%3B somatic mutation. C->G;Dbxref=dbSNP:rs1057519975	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_044754;Note=In sporadic cancers%3B somatic mutation. C->R;Dbxref=dbSNP:rs1057519975	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_005876;Note=In sporadic cancers%3B somatic mutation. C->S;Dbxref=dbSNP:rs1057519975	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_045792;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. C->T	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_044755;Note=In sporadic cancers%3B somatic mutation. C->W;Dbxref=dbSNP:rs1057519976	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_044756;Note=In sporadic cancers%3B somatic mutation%3B decreased E6-mediated binding to E6-AP. C->Y;Dbxref=dbSNP:rs587781991	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_005878;Note=In sporadic cancers%3B somatic mutation. Q->E;Dbxref=dbSNP:rs1555526268	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_044757;Note=In sporadic cancers%3B somatic mutation. Q->H;Dbxref=dbSNP:rs758781593	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_005879;Note=In a sporadic cancer%3B somatic mutation. Q->K	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_044758;Note=In sporadic cancers%3B somatic mutation. Q->P	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_044759;Note=In sporadic cancers%3B somatic mutation. Q->R	
P04637	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_044760;Note=In sporadic cancers%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_044761;Note=In sporadic cancers%3B somatic mutation. L->P	
P04637	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_005880;Note=In sporadic cancers%3B somatic mutation. L->Q	
P04637	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_044762;Note=In sporadic cancers%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_044763;Note=In sporadic cancers%3B somatic mutation. A->D	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_005881;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. A->P;Dbxref=dbSNP:rs28934875	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_044764;Note=In LFS%3B germline mutation. A->S	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_044765;Note=In sporadic cancers%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_033034;Note=In sporadic cancers%3B somatic mutation. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs750600586,PMID:17224074	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_044766;Note=In sporadic cancers%3B somatic mutation. K->E;Dbxref=dbSNP:rs1212996409	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_005882;Note=In sporadic cancers%3B somatic mutation. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14660794;Dbxref=PMID:14660794	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_044767;Note=In sporadic cancers%3B somatic mutation. K->Q	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_044768;Note=In sporadic cancers%3B somatic mutation. K->R	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_044769;Note=In sporadic cancers%3B somatic mutation. K->T	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044770;Note=In sporadic cancers%3B somatic mutation. T->A	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044771;Note=In sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044772;Note=In a sporadic cancer%3B somatic mutation. T->N;Dbxref=dbSNP:rs786202561	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044773;Note=In a sporadic cancer%3B somatic mutation. T->P	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044774;Note=In sporadic cancers%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_045793;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. C->A	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_005885;Note=In sporadic cancers%3B somatic mutation. C->F;Dbxref=dbSNP:rs587781288	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_005884;Note=In sporadic cancers%3B somatic mutation. C->G;Dbxref=dbSNP:rs1057519978	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_044775;Note=In sporadic cancers%3B somatic mutation. C->R;Dbxref=dbSNP:rs1057519978	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_044776;Note=In sporadic cancers%3B somatic mutation. C->S;Dbxref=dbSNP:rs1057519978	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_044777;Note=In sporadic cancers%3B somatic mutation. C->W;Dbxref=dbSNP:rs1057519977	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_005886;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. C->Y;Dbxref=dbSNP:rs587781288	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044778;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_045794;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. P->F	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044779;Note=In sporadic cancers%3B somatic mutation. P->H	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044780;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs779196500	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044781;Note=In a sporadic cancer%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044782;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044783;Note=In sporadic cancers%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_005887;Note=In sporadic cancers%3B somatic mutation%3B strong DNA binding ability at 32.5 degrees Celsius%3B strong reduction of transcriptional activity at 37.5 degrees Celsius%3B severely represses interaction with ZNF385A. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17719541,ECO:0000269|PubMed:8013454;Dbxref=PMID:17719541,PMID:8013454	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_044784;Note=In sporadic cancers%3B somatic mutation. V->E	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_044785;Note=In sporadic cancers%3B somatic mutation. V->G;Dbxref=dbSNP:rs1555526241	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_044786;Note=In sporadic cancers%3B somatic mutation. V->L;Dbxref=dbSNP:rs587782620	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_044787;Note=In sporadic cancers%3B somatic mutation. V->M;Dbxref=dbSNP:rs587782620	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_044788;Note=In sporadic cancers%3B somatic mutation. Q->H;Dbxref=dbSNP:rs786201419	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_044789;Note=In sporadic cancers%3B somatic mutation. Q->K	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_044790;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. Q->L;Dbxref=dbSNP:rs786203071	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_005888;Note=In sporadic cancers%3B somatic mutation. Q->P;Dbxref=dbSNP:rs786203071	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_044791;Note=In sporadic cancers%3B somatic mutation. Q->R	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_044792;Note=In sporadic cancers%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_005889;Note=In sporadic cancers%3B somatic mutation. L->P;Dbxref=dbSNP:rs587782197	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_005890;Note=In sporadic cancers%3B somatic mutation. L->Q	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_044793;Note=In sporadic cancers%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_044794;Note=In sporadic cancers%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044795;Note=In a sporadic cancer%3B somatic mutation. W->C	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044796;Note=In sporadic cancers%3B somatic mutation. W->G;Dbxref=dbSNP:rs786203064	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044797;Note=In sporadic cancers%3B somatic mutation. W->L	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044798;Note=In sporadic cancers%3B somatic mutation. W->R	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044799;Note=In sporadic cancers%3B somatic mutation. W->S	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_044800;Note=In sporadic cancers%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_005891;Note=In sporadic cancers%3B somatic mutation. V->D	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_044801;Note=In sporadic cancers%3B somatic mutation. V->E	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_044802;Note=In a sporadic cancer%3B somatic mutation. V->F	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_005892;Note=In sporadic cancers%3B somatic mutation. V->G;Dbxref=dbSNP:rs1453167097	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_044803;Note=In sporadic cancers%3B somatic mutation. V->I;Dbxref=dbSNP:rs1555526226	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044804;Note=In a sporadic cancer%3B somatic mutation. D->A;Dbxref=dbSNP:rs1046611742	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044805;Note=In sporadic cancers%3B somatic mutation. D->E	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044806;Note=In a sporadic cancer%3B somatic mutation. D->G	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044807;Note=In sporadic cancers%3B somatic mutation. D->N	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044808;Note=In sporadic cancers%3B somatic mutation. D->V	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044809;Note=In sporadic cancers%3B somatic mutation. D->Y;Dbxref=dbSNP:rs1131691007	
P04637	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_044810;Note=In sporadic cancers%3B somatic mutation. S->F;Dbxref=dbSNP:rs1555526214	
P04637	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_005893;Note=In sporadic cancers%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_044811;Note=In sporadic cancers%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044812;Note=In a sporadic cancer%3B somatic mutation. T->A	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044813;Note=In sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044814;Note=In sporadic cancers%3B somatic mutation. T->K	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044815;Note=In a sporadic cancer%3B somatic mutation. T->N	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044816;Note=In a sporadic cancer%3B somatic mutation. T->P	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044817;Note=In a sporadic cancer%3B somatic mutation. T->R	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_005894;Note=In sporadic cancers%3B somatic mutation. P->A;Dbxref=dbSNP:rs28934874	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_044818;Note=In sporadic cancers%3B somatic mutation. P->H;Dbxref=dbSNP:rs1057520000	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_044819;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_044820;Note=In sporadic cancers%3B somatic mutation. P->R;Dbxref=dbSNP:rs1057520000	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_005895;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7682763;Dbxref=dbSNP:rs28934874,PMID:7682763	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_005896;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->T;Dbxref=dbSNP:rs28934874	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_044821;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_005897;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1868473;Dbxref=dbSNP:rs587782705,PMID:1868473	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_044822;Note=In sporadic cancers%3B somatic mutation. P->Q	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_044823;Note=In sporadic cancers%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_005898;Note=In sporadic cancers%3B somatic mutation. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9450901;Dbxref=dbSNP:rs767328513,PMID:9450901	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_044824;Note=In sporadic cancers%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044825;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_045795;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. P->F	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044826;Note=In a sporadic cancer%3B somatic mutation. P->H	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044827;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044828;Note=In a sporadic cancer%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044829;Note=In sporadic cancers%3B somatic mutation. P->S;Dbxref=dbSNP:rs1064795860	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_005899;Note=In sporadic cancers%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_044830;Note=In sporadic cancers%3B somatic mutation. G->A	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_044831;Note=In a sporadic cancer%3B somatic mutation. G->C	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_044832;Note=In sporadic cancers%3B somatic mutation. G->D;Dbxref=dbSNP:rs762846821	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_045796;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. G->I	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_044833;Note=In sporadic cancers%3B somatic mutation. G->S;Dbxref=dbSNP:rs137852789	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_005900;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2263646;Dbxref=dbSNP:rs762846821,PMID:2263646	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_005901;Note=In sporadic cancers%3B somatic mutation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1868473;Dbxref=dbSNP:rs772683278,PMID:1868473	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044834;Note=In sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044835;Note=In a sporadic cancer%3B somatic mutation. T->M	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044836;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. T->N;Dbxref=dbSNP:rs786202752	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044837;Note=In sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation. T->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14660794,ECO:0000269|PubMed:20385133;Dbxref=PMID:14660794,PMID:20385133	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044838;Note=In sporadic cancers%3B somatic mutation. T->S;Dbxref=dbSNP:rs786202752	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044839;Note=In sporadic cancers%3B somatic mutation. R->C;Dbxref=dbSNP:rs563378859	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044840;Note=In sporadic cancers%3B somatic mutation. R->G	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044841;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->H;Dbxref=dbSNP:rs371524413	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044842;Note=In sporadic cancers%3B somatic mutation. R->L	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_005902;Note=In sporadic cancers%3B somatic mutation. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7682763;Dbxref=PMID:7682763	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044843;Note=In sporadic cancers%3B somatic mutation. R->S	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_044844;Note=In sporadic cancers%3B somatic mutation. V->A;Dbxref=dbSNP:rs1131691023	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_005903;Note=In sporadic cancers%3B somatic mutation. V->D	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_005904;Note=In sporadic cancers%3B somatic mutation. V->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs121912654,PMID:16959974	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_044845;Note=In sporadic cancers%3B somatic mutation. V->G	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_012977;Note=In sporadic cancers%3B somatic mutation. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9419979;Dbxref=dbSNP:rs121912654,PMID:9419979	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_044846;Note=In sporadic cancers%3B somatic mutation. V->L	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_005905;Note=In sporadic cancers%3B somatic mutation. R->C;Dbxref=dbSNP:rs587780068	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_045797;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. R->F	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_005906;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->G	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_005907;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->H;Dbxref=dbSNP:rs587782144	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_044847;Note=In sporadic cancers%3B somatic mutation. R->L	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_044848;Note=In sporadic cancers%3B somatic mutation. R->P;Dbxref=dbSNP:rs587782144	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_044849;Note=In a sporadic cancer%3B somatic mutation. R->Q	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_044850;Note=In sporadic cancers%3B somatic mutation. R->S	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_045798;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. R->Y	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044851;Note=In sporadic cancers%3B somatic mutation. A->D	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_045799;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. A->F;Dbxref=dbSNP:rs730882022	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044852;Note=In sporadic cancers%3B somatic mutation. A->G	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044853;Note=In sporadic cancers%3B somatic mutation. A->P;Dbxref=dbSNP:rs730882000	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044854;Note=In sporadic cancers%3B somatic mutation. A->S	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044855;Note=In sporadic cancers%3B somatic mutation. A->T;Dbxref=dbSNP:rs730882000	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044856;Note=In sporadic cancers%3B somatic mutation. A->V;Dbxref=dbSNP:rs1555526131	
P04637	UniProtKB	Natural variant	160	161	.	.	.	ID=VAR_047160;Note=In a sporadic cancer%3B somatic mutation. MA->IP	
P04637	UniProtKB	Natural variant	160	161	.	.	.	ID=VAR_047161;Note=In sporadic cancers%3B somatic mutation. MA->IS	
P04637	UniProtKB	Natural variant	160	161	.	.	.	ID=VAR_047162;Note=In a sporadic cancer%3B somatic mutation. MA->IT	
P04637	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_005908;Note=In sporadic cancers%3B somatic mutation. M->I;Dbxref=dbSNP:rs772354334	
P04637	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_044857;Note=In sporadic cancers%3B somatic mutation. M->K	
P04637	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_044858;Note=In a sporadic cancer%3B somatic mutation. M->T	
P04637	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_044859;Note=In sporadic cancers%3B somatic mutation. M->V;Dbxref=dbSNP:rs377274728	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044860;Note=In sporadic cancers%3B somatic mutation. A->D;Dbxref=dbSNP:rs1064795691	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_045800;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. A->F	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044861;Note=In sporadic cancers%3B somatic mutation. A->G	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044862;Note=In sporadic cancers%3B somatic mutation. A->P	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_005909;Note=In sporadic cancers%3B somatic mutation. A->S	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044863;Note=In sporadic cancers%3B somatic mutation. A->T;Dbxref=dbSNP:rs193920817	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044864;Note=In sporadic cancers%3B somatic mutation. A->V	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_044865;Note=In sporadic cancers%3B somatic mutation. I->F	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_044866;Note=In sporadic cancers%3B somatic mutation. I->M	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_044867;Note=In a breast cancer with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. I->N	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_005910;Note=In sporadic cancers%3B somatic mutation. I->S;Dbxref=dbSNP:rs587780069	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_044868;Note=In sporadic cancers%3B somatic mutation. I->T	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_005911;Note=In sporadic cancers%3B somatic mutation. I->V	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_033035;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs148924904,PMID:16959974,PMID:17224074	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_044869;Note=In sporadic cancers%3B somatic mutation. Y->D;Dbxref=dbSNP:rs786203436	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_044870;Note=In a sporadic cancer%3B somatic mutation. Y->F	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_005912;Note=In sporadic cancers%3B somatic mutation. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs786203436,PMID:17224074	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_044871;Note=In sporadic cancers%3B somatic mutation. Y->N;Dbxref=dbSNP:rs786203436	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_044872;Note=In sporadic cancers%3B somatic mutation. Y->S	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_044873;Note=In sporadic cancers%3B somatic mutation. K->E;Dbxref=dbSNP:rs879254249	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_044874;Note=In sporadic cancers%3B somatic mutation. K->M	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_005913;Note=In sporadic cancers%3B somatic mutation. K->N;Dbxref=dbSNP:rs1131691034	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_005914;Note=In sporadic cancers%3B somatic mutation. K->Q	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_044875;Note=In sporadic cancers%3B somatic mutation. K->R	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_044876;Note=In sporadic cancers%3B somatic mutation. K->T	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_044877;Note=In sporadic cancers%3B somatic mutation. Q->E	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_044878;Note=In a sporadic cancer%3B somatic mutation. Q->H	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_005915;Note=In sporadic cancers%3B somatic mutation. Q->L	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_044879;Note=In sporadic cancers%3B somatic mutation. Q->P	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_005916;Note=In sporadic cancers%3B somatic mutation. Q->R	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_044880;Note=In sporadic cancers%3B somatic mutation. S->A	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_044881;Note=In a sporadic cancer%3B somatic mutation. S->G	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_005917;Note=In sporadic cancers%3B somatic mutation. S->L;Dbxref=dbSNP:rs1555526101	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_044882;Note=In sporadic cancers%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_044883;Note=In sporadic cancers%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	167	168	.	.	.	ID=VAR_047163;Note=In a sporadic cancer%3B somatic mutation. QH->HD	
P04637	UniProtKB	Natural variant	167	168	.	.	.	ID=VAR_047164;Note=In a sporadic cancer%3B somatic mutation. QH->YL	
P04637	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_044884;Note=In sporadic cancers%3B somatic mutation. Q->H	
P04637	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_044885;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. Q->K	
P04637	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_044886;Note=In sporadic cancers%3B somatic mutation. Q->L	
P04637	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_044887;Note=In sporadic cancers%3B somatic mutation. Q->R	
P04637	UniProtKB	Natural variant	168	169	.	.	.	ID=VAR_047165;Note=In a sporadic cancer%3B somatic mutation. HM->LI	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044888;Note=In sporadic cancers%3B somatic mutation. H->D	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044889;Note=In sporadic cancers%3B somatic mutation. H->L	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044890;Note=In sporadic cancers%3B somatic mutation. H->N	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044891;Note=In sporadic cancers%3B somatic mutation. H->P	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044892;Note=In sporadic cancers%3B somatic mutation. H->Q	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_005918;Note=In sporadic cancers%3B somatic mutation. H->R;Dbxref=dbSNP:rs867114783	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_045801;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. H->V	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044893;Note=In sporadic cancers%3B somatic mutation. H->Y	
P04637	UniProtKB	Natural variant	169	170	.	.	.	ID=VAR_047166;Note=In a sporadic cancer%3B somatic mutation. MT->IS	
P04637	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_005919;Note=In sporadic cancers%3B somatic mutation. M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9450901;Dbxref=PMID:9450901	
P04637	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_044894;Note=In sporadic cancers%3B somatic mutation. M->K	
P04637	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_005920;Note=In sporadic cancers%3B somatic mutation. M->T	
P04637	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_044895;Note=In sporadic cancers%3B somatic mutation. M->V	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_044896;Note=In sporadic cancers%3B somatic mutation. T->A;Dbxref=dbSNP:rs587780729	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_044897;Note=In a sporadic cancer%3B somatic mutation. T->K	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_005921;Note=In sporadic cancers%3B somatic mutation. T->M;Dbxref=dbSNP:rs779000871	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_044898;Note=In a sporadic cancer%3B somatic mutation. T->P	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_005922;Note=In sporadic cancers%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044899;Note=In a sporadic cancer%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044900;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044901;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044902;Note=In sporadic cancers%3B somatic mutation. E->K;Dbxref=dbSNP:rs587781845	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044903;Note=In a sporadic cancer%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044904;Note=In sporadic cancers%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_005923;Note=In sporadic cancers%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_044905;Note=In sporadic cancers%3B somatic mutation. V->D	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_044906;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. V->F;Dbxref=dbSNP:rs1131691043	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_044907;Note=In sporadic cancers%3B somatic mutation. V->G;Dbxref=dbSNP:rs1131691021	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_044908;Note=In sporadic cancers%3B somatic mutation. V->I	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_044909;Note=In sporadic cancers%3B somatic mutation. V->A;Dbxref=dbSNP:rs1057519747	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_005924;Note=In sporadic cancers%3B somatic mutation. V->E;Dbxref=dbSNP:rs1057519747	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_044910;Note=In sporadic cancers%3B somatic mutation. V->G;Dbxref=dbSNP:rs1057519747	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_005925;Note=In sporadic cancers%3B somatic mutation. V->L;Dbxref=dbSNP:rs876660754	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_005926;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. V->M;Dbxref=dbSNP:rs876660754	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_045802;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. V->W	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044911;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. R->G;Dbxref=dbSNP:rs864622115	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_005927;Note=In sporadic cancers%3B somatic mutation. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7682763;Dbxref=dbSNP:rs1064796681,PMID:7682763	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044912;Note=In sporadic cancers%3B somatic mutation. R->M	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044913;Note=In sporadic cancers%3B somatic mutation. R->S	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044914;Note=In a sporadic cancer%3B somatic mutation. R->T	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044915;Note=In sporadic cancers%3B somatic mutation. R->W	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005928;Note=In sporadic cancers%3B somatic mutation. R->C;Dbxref=dbSNP:rs138729528	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005929;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->G;Dbxref=dbSNP:rs138729528	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005932;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation%3B reduces interaction with ZNF385A. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:17719541,ECO:0000269|PubMed:1868473,ECO:0000269|PubMed:20385133,ECO:0000269|PubMed:7887414,ECO:0000269|PubMed:8825920;Dbxref=dbSNP:rs28934578,PMID:16959974,PMID:17719541,PMID:1868473,PMID:20385133,PMID:7887414,PMID:8825920	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005930;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->L;Dbxref=dbSNP:rs28934578	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005931;Note=In sporadic cancers%3B somatic mutation. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17719541;Dbxref=PMID:17719541	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_044916;Note=In a sporadic cancer%3B somatic mutation. R->Q	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_044917;Note=In sporadic cancers%3B somatic mutation. R->S	
P04637	UniProtKB	Natural variant	176	177	.	.	.	ID=VAR_047167;Note=In a sporadic cancer%3B somatic mutation. CP->FS	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_005933;Note=In sporadic cancers%3B somatic mutation. C->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1394225,ECO:0000269|PubMed:1868473,ECO:0000269|PubMed:8829627,ECO:0000269|PubMed:9450901;Dbxref=dbSNP:rs786202962,PMID:1394225,PMID:1868473,PMID:8829627,PMID:9450901	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_044918;Note=In sporadic cancers%3B somatic mutation. C->G	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_044919;Note=In sporadic cancers%3B somatic mutation. C->R	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_044920;Note=In sporadic cancers%3B somatic mutation. C->S;Dbxref=dbSNP:rs967461896	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_005934;Note=In sporadic cancers%3B somatic mutation. C->W;Dbxref=dbSNP:rs1057519980	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_044921;Note=In sporadic cancers%3B somatic mutation. C->Y;Dbxref=dbSNP:rs786202962	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_044922;Note=In a sporadic cancer%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_045803;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. P->F	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_044923;Note=In sporadic cancers%3B somatic mutation. P->H	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_045804;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. P->I	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_005935;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs751477326	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_036505;Note=In sporadic cancers%3B somatic mutation. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs751477326,PMID:16959974	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_044924;Note=In sporadic cancers%3B somatic mutation. P->S;Dbxref=dbSNP:rs147002414	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_044925;Note=In a sporadic cancer%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	178	179	.	.	.	ID=VAR_047168;Note=In a sporadic cancer%3B somatic mutation. HH->QS	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044926;Note=In sporadic cancers%3B somatic mutation. H->D	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_005936;Note=In a Burkitt lymphoma. H->HPHP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1303181;Dbxref=PMID:1303181	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044927;Note=In a sporadic cancer%3B somatic mutation. H->L	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044928;Note=In sporadic cancers%3B somatic mutation. H->N;Dbxref=dbSNP:rs1064795203	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044929;Note=In sporadic cancers%3B somatic mutation. H->P;Dbxref=dbSNP:rs1555526004	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044930;Note=In sporadic cancers%3B somatic mutation. H->Q	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044931;Note=In sporadic cancers%3B somatic mutation. H->R	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044932;Note=In sporadic cancers%3B somatic mutation. H->Y	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044933;Note=In sporadic cancers%3B somatic mutation. H->D;Dbxref=dbSNP:rs587780070	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044934;Note=In sporadic cancers%3B somatic mutation. H->L;Dbxref=dbSNP:rs1057519991	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044935;Note=In sporadic cancers%3B somatic mutation. H->N;Dbxref=dbSNP:rs587780070	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044936;Note=In sporadic cancers%3B somatic mutation. H->P;Dbxref=dbSNP:rs1057519991	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044937;Note=In sporadic cancers%3B somatic mutation. H->Q;Dbxref=dbSNP:rs876660821	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044938;Note=In sporadic cancers%3B somatic mutation. H->R;Dbxref=dbSNP:rs1057519991	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044939;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. H->Y;Dbxref=dbSNP:rs587780070	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044940;Note=In a sporadic cancer%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044941;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044942;Note=In a sporadic cancer%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044943;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. E->K;Dbxref=dbSNP:rs879253911	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044944;Note=In sporadic cancers%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044945;Note=In a sporadic cancer%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044946;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->C;Dbxref=dbSNP:rs587782596	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044947;Note=In sporadic cancers%3B somatic mutation. R->G	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044948;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->H;Dbxref=dbSNP:rs397514495	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_005937;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->L;Dbxref=dbSNP:rs397514495	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044949;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->P	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044950;Note=In sporadic cancers%3B somatic mutation. R->S;Dbxref=dbSNP:rs587782596	
P04637	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_044951;Note=In sporadic cancers%3B somatic mutation. C->R	
P04637	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_005938;Note=In sporadic cancers%3B somatic mutation. C->S	
P04637	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_044952;Note=In sporadic cancers%3B somatic mutation. C->Y	
P04637	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_044953;Note=In sporadic cancers%3B somatic mutation. S->L;Dbxref=dbSNP:rs1555525970	
P04637	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_044954;Note=In sporadic cancers%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_044955;Note=In sporadic cancers%3B somatic mutation. D->G;Dbxref=dbSNP:rs1060501209	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_044956;Note=In sporadic cancers%3B somatic mutation. D->H	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_047169;Note=In sporadic cancers%3B somatic mutation. D->N;Dbxref=dbSNP:rs72661117	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_044957;Note=In sporadic cancers%3B somatic mutation. D->V	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_005939;Note=In sporadic cancers%3B somatic mutation. D->Y	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044958;Note=In a sporadic cancer%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044959;Note=In sporadic cancers%3B somatic mutation. S->G	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044960;Note=In sporadic cancers%3B somatic mutation. S->I	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044961;Note=In a sporadic cancer%3B somatic mutation. S->N;Dbxref=dbSNP:rs150607408	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044962;Note=In sporadic cancers%3B somatic mutation. S->R	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044963;Note=In a sporadic cancer%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044964;Note=In a sporadic cancer%3B somatic mutation. D->E;Dbxref=dbSNP:rs375275361	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044965;Note=In sporadic cancers%3B somatic mutation. D->G	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044966;Note=In sporadic cancers%3B somatic mutation. D->H	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044967;Note=In sporadic cancers%3B somatic mutation. D->N;Dbxref=dbSNP:rs1060501206	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044968;Note=In sporadic cancers%3B somatic mutation. D->V	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_005940;Note=In a sporadic cancer%3B somatic mutation. D->Y	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_005941;Note=In sporadic cancers%3B somatic mutation. G->C	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_044969;Note=In sporadic cancers%3B somatic mutation. G->D	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_045805;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. G->N	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_044970;Note=In sporadic cancers%3B somatic mutation. G->R	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_005942;Note=In sporadic cancers%3B somatic mutation. G->S;Dbxref=dbSNP:rs776167460	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_044971;Note=In sporadic cancers%3B somatic mutation. G->V	
P04637	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_044972;Note=In a sporadic cancer%3B somatic mutation. L->P;Dbxref=dbSNP:rs1199893366	
P04637	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_044973;Note=In sporadic cancers%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044974;Note=In a sporadic cancer%3B somatic mutation. A->D	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044975;Note=In sporadic cancers%3B somatic mutation. A->G	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_005943;Note=In sporadic cancers%3B somatic mutation. A->P	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044976;Note=In a sporadic cancer%3B somatic mutation. A->S;Dbxref=dbSNP:rs1555525921	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044977;Note=In sporadic cancers%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044978;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. A->V;Dbxref=dbSNP:rs121912665	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044979;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044980;Note=In a sporadic cancer%3B somatic mutation. P->H	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_005944;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs876660825	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044981;Note=In sporadic cancers%3B somatic mutation. P->R;Dbxref=dbSNP:rs876660825	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044982;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044983;Note=In sporadic cancers%3B somatic mutation. P->T;Dbxref=dbSNP:rs876660254	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_044984;Note=In sporadic cancers%3B somatic mutation. P->H;Dbxref=dbSNP:rs587778718	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_044985;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs587778718	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_044986;Note=In sporadic cancers%3B somatic mutation. P->R;Dbxref=dbSNP:rs587778718	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_044987;Note=In sporadic cancers%3B somatic mutation. P->S;Dbxref=dbSNP:rs868590738	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_005945;Note=In sporadic cancers%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	192	193	.	.	.	ID=VAR_047170;Note=In a sporadic cancer%3B somatic mutation. QH->HN	
P04637	UniProtKB	Natural variant	192	193	.	.	.	ID=VAR_047171;Note=In a sporadic cancer%3B somatic mutation. QH->HY	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_044988;Note=In sporadic cancers%3B somatic mutation. Q->H	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_044989;Note=In a sporadic cancer%3B somatic mutation. Q->K	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_044990;Note=In sporadic cancers%3B somatic mutation. Q->L	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_044991;Note=In sporadic cancers%3B somatic mutation. Q->P	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_005946;Note=In sporadic cancers%3B somatic mutation. Q->R;Dbxref=dbSNP:rs730882002	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_005947;Note=In sporadic cancers%3B somatic mutation. H->D;Dbxref=dbSNP:rs876658468	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044992;Note=In sporadic cancers%3B somatic mutation. H->L;Dbxref=dbSNP:rs786201838	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044993;Note=In sporadic cancers%3B somatic mutation. H->N;Dbxref=dbSNP:rs876658468	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044994;Note=In sporadic cancers%3B somatic mutation. H->P;Dbxref=dbSNP:rs786201838	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044995;Note=In sporadic cancers%3B somatic mutation. H->Q	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_005948;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:7887414;Dbxref=dbSNP:rs786201838,PMID:16959974,PMID:7887414	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044996;Note=In sporadic cancers%3B somatic mutation. H->Y;Dbxref=dbSNP:rs876658468	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_044997;Note=In sporadic cancers%3B somatic mutation. L->F;Dbxref=dbSNP:rs587780071	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_044998;Note=In sporadic cancers%3B somatic mutation. L->H;Dbxref=dbSNP:rs1057519998	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_044999;Note=In sporadic cancers%3B somatic mutation. L->I	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_005949;Note=In sporadic cancers%3B somatic mutation. L->P;Dbxref=dbSNP:rs1057519998	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_005950;Note=In sporadic cancers%3B somatic mutation. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7682763;Dbxref=dbSNP:rs1057519998,PMID:7682763	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_045000;Note=In sporadic cancers%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045001;Note=In sporadic cancers%3B somatic mutation. I->F;Dbxref=dbSNP:rs942158624	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_047172;Note=In a sporadic cancer%3B somatic mutation. I->L	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045002;Note=In sporadic cancers%3B somatic mutation. I->N;Dbxref=dbSNP:rs760043106	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045003;Note=In sporadic cancers%3B somatic mutation. I->S;Dbxref=dbSNP:rs760043106	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_005951;Note=In sporadic cancers%3B somatic mutation. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17224074,ECO:0000269|PubMed:9450901;Dbxref=dbSNP:rs760043106,PMID:17224074,PMID:9450901	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045004;Note=In a sporadic cancer%3B somatic mutation. I->V	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045806;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. I->Y	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045005;Note=In sporadic cancers%3B somatic mutation. R->G;Dbxref=dbSNP:rs397516435	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045006;Note=In sporadic cancers%3B somatic mutation. R->L;Dbxref=dbSNP:rs483352697	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045007;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->P;Dbxref=dbSNP:rs483352697	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045008;Note=In sporadic cancers%3B somatic mutation. R->Q;Dbxref=dbSNP:rs483352697	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045009;Note=In a sporadic cancer%3B somatic mutation. R->S	
P04637	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_045010;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. V->E	
P04637	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_045011;Note=In sporadic cancers%3B somatic mutation. V->G	
P04637	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_045012;Note=In sporadic cancers%3B somatic mutation. V->L;Dbxref=dbSNP:rs786204041	
P04637	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_045013;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. V->M;Dbxref=dbSNP:rs786204041	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_045014;Note=In a sporadic cancer%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_045015;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_005952;Note=In sporadic cancers%3B somatic mutation. E->K	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_045016;Note=In sporadic cancers%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_045017;Note=In a sporadic cancer%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_045018;Note=In a sporadic cancer%3B somatic mutation. G->A	
P04637	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_045019;Note=In sporadic cancers%3B somatic mutation. G->E	
P04637	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_045020;Note=In sporadic cancers%3B somatic mutation. G->R	
P04637	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_045021;Note=In sporadic cancers%3B somatic mutation. G->V;Dbxref=dbSNP:rs1555525857	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045022;Note=In sporadic cancers%3B somatic mutation. N->D	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045023;Note=In sporadic cancers%3B somatic mutation. N->I	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045024;Note=In a sporadic cancer%3B somatic mutation. N->K	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045807;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. N->P	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045025;Note=In sporadic cancers%3B somatic mutation. N->S	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045026;Note=In a sporadic cancer%3B somatic mutation. N->T	
P04637	UniProtKB	Natural variant	201	202	.	.	.	ID=VAR_047173;Note=In a sporadic cancer%3B somatic mutation. LR->FC	
P04637	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_045027;Note=In sporadic cancers%3B somatic mutation. L->F;Dbxref=dbSNP:rs730882024	
P04637	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_045028;Note=In a sporadic cancer%3B somatic mutation. L->P	
P04637	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_045029;Note=In a sporadic cancer%3B somatic mutation. L->S	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045030;Note=In sporadic cancers%3B somatic mutation. R->C;Dbxref=dbSNP:rs587780072	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045031;Note=In sporadic cancers%3B somatic mutation. R->G;Dbxref=dbSNP:rs587780072	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045032;Note=In sporadic cancers%3B somatic mutation. R->H;Dbxref=dbSNP:rs587778719	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045033;Note=In sporadic cancers%3B somatic mutation. R->L;Dbxref=dbSNP:rs587778719	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045034;Note=In sporadic cancers%3B somatic mutation. R->P	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045035;Note=In sporadic cancers%3B somatic mutation. R->S	
P04637	UniProtKB	Natural variant	203	204	.	.	.	ID=VAR_047174;Note=In a sporadic cancer%3B somatic mutation. VE->LV	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045036;Note=In sporadic cancers%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045037;Note=In sporadic cancers%3B somatic mutation. V->E	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045038;Note=In sporadic cancers%3B somatic mutation. V->L	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045039;Note=In sporadic cancers%3B somatic mutation. V->M;Dbxref=dbSNP:rs730882003	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045808;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. V->W	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045040;Note=In sporadic cancers%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045041;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045042;Note=In sporadic cancers%3B somatic mutation. E->G;Dbxref=dbSNP:rs1260903787	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045043;Note=In sporadic cancers%3B somatic mutation. E->K	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045044;Note=In a sporadic cancer%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045045;Note=In a sporadic cancer%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_005953;Note=In sporadic cancers%3B somatic mutation. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1459726;Dbxref=dbSNP:rs1057520007,PMID:1459726	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_005954;Note=In sporadic cancers%3B somatic mutation. Y->D;Dbxref=dbSNP:rs1057520008	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_047175;Note=In sporadic cancers%3B somatic mutation. Y->F;Dbxref=dbSNP:rs1057520007	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_045046;Note=In sporadic cancers%3B somatic mutation. Y->H;Dbxref=dbSNP:rs1057520008	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_045047;Note=In sporadic cancers%3B somatic mutation. Y->N;Dbxref=dbSNP:rs1057520008	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_045048;Note=In sporadic cancers%3B somatic mutation. Y->S;Dbxref=dbSNP:rs1057520007	
P04637	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_045049;Note=In a sporadic cancer%3B somatic mutation. L->F	
P04637	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_045050;Note=In a sporadic cancer%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	207	208	.	.	.	ID=VAR_047176;Note=In a sporadic cancer%3B somatic mutation. DD->EY	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045051;Note=In sporadic cancers%3B somatic mutation. D->E	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045052;Note=In sporadic cancers%3B somatic mutation. D->G	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045053;Note=In sporadic cancers%3B somatic mutation. D->H	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045054;Note=In sporadic cancers%3B somatic mutation. D->N;Dbxref=dbSNP:rs923100890	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045055;Note=In a sporadic cancer%3B somatic mutation. D->V	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045056;Note=In a sporadic cancer%3B somatic mutation. D->Y	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045057;Note=In sporadic cancers%3B somatic mutation. D->E	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045058;Note=In sporadic cancers%3B somatic mutation. D->G	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045059;Note=In a sporadic cancer%3B somatic mutation. D->H	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045809;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. D->I	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045060;Note=In sporadic cancers%3B somatic mutation. D->N	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045061;Note=In sporadic cancers%3B somatic mutation. D->V;Dbxref=dbSNP:rs1464727668	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045062;Note=In a sporadic cancer%3B somatic mutation. D->Y	
P04637	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_045063;Note=In sporadic cancers%3B somatic mutation. R->I	
P04637	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_045064;Note=In sporadic cancers%3B somatic mutation. R->K	
P04637	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_045065;Note=In a sporadic cancer%3B somatic mutation. R->S	
P04637	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_045066;Note=In sporadic cancers%3B somatic mutation. R->T	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045067;Note=In sporadic cancers%3B somatic mutation. N->D	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045068;Note=In sporadic cancers%3B somatic mutation. N->H	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045069;Note=In a sporadic cancer%3B somatic mutation. N->I	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045070;Note=In a sporadic cancer%3B somatic mutation. N->K	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045071;Note=In sporadic cancers%3B somatic mutation. N->S	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045072;Note=In a sporadic cancer%3B somatic mutation. N->T	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045073;Note=In a familial cancer not matching LFS%3B germline mutation. N->Y;Dbxref=dbSNP:rs1060501200	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045074;Note=In sporadic cancers%3B somatic mutation. T->A;Dbxref=dbSNP:rs1060501198	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045075;Note=In sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045076;Note=In sporadic cancers%3B somatic mutation. T->N	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045077;Note=In a sporadic cancer%3B somatic mutation. T->P	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045078;Note=In sporadic cancers%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045079;Note=In sporadic cancers%3B somatic mutation. F->I;Dbxref=dbSNP:rs1064795766	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045080;Note=In sporadic cancers%3B somatic mutation. F->L	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045081;Note=In sporadic cancers%3B somatic mutation. F->S	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045082;Note=In a sporadic cancer%3B somatic mutation. F->V	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045083;Note=In sporadic cancers%3B somatic mutation. F->Y	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_045084;Note=In sporadic cancers%3B somatic mutation. R->G;Dbxref=dbSNP:rs397516436	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_045085;Note=In sporadic cancers%3B somatic mutation. R->L;Dbxref=dbSNP:rs587778720	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_036506;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs587778720,PMID:16959974	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_005955;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->Q;Dbxref=dbSNP:rs587778720	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_045086;Note=In sporadic cancers%3B somatic mutation. R->W	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_045087;Note=In sporadic cancers%3B somatic mutation. H->D	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_045088;Note=In a sporadic cancer%3B somatic mutation. H->P;Dbxref=dbSNP:rs1057519992	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_047177;Note=In sporadic cancers%3B somatic mutation. H->Q;Dbxref=dbSNP:rs587781386	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_045089;Note=In sporadic cancers%3B somatic mutation. H->R;Dbxref=dbSNP:rs1057519992	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_045090;Note=In sporadic cancers%3B somatic mutation. H->Y	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045091;Note=In sporadic cancers%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045092;Note=In sporadic cancers%3B somatic mutation. S->G;Dbxref=dbSNP:rs886039484	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045093;Note=In sporadic cancers%3B somatic mutation. S->I;Dbxref=dbSNP:rs587782177	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045810;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. S->K	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045094;Note=In sporadic cancers%3B somatic mutation. S->N;Dbxref=dbSNP:rs587782177	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045095;Note=In sporadic cancers%3B somatic mutation. S->R;Dbxref=dbSNP:rs1057520001	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045096;Note=In sporadic cancers%3B somatic mutation. S->T;Dbxref=dbSNP:rs587782177	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045097;Note=In sporadic cancers%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045098;Note=In sporadic cancers%3B somatic mutation. V->E;Dbxref=dbSNP:rs1057520004	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045099;Note=In sporadic cancers%3B somatic mutation. V->G;Dbxref=dbSNP:rs1057520004	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045100;Note=In sporadic cancers%3B somatic mutation. V->L;Dbxref=dbSNP:rs730882025	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_005956;Note=In sporadic cancers%3B somatic mutation. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs730882025,PMID:17224074	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045811;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. V->W	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045101;Note=In sporadic cancers%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045102;Note=In sporadic cancers%3B somatic mutation. V->E	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045103;Note=In sporadic cancers%3B somatic mutation. V->G	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045104;Note=In a sporadic cancer%3B somatic mutation. V->I	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045105;Note=In sporadic cancers%3B somatic mutation. V->L	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_047178;Note=V->M;Dbxref=dbSNP:rs35163653	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045106;Note=In sporadic cancers%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045107;Note=In sporadic cancers%3B somatic mutation. V->E	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045108;Note=In sporadic cancers%3B somatic mutation. V->G;Dbxref=dbSNP:rs1555525743	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045109;Note=In sporadic cancers%3B somatic mutation. V->L	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045110;Note=In sporadic cancers%3B somatic mutation. V->M;Dbxref=dbSNP:rs878854072	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045812;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. P->C	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045111;Note=In a sporadic cancer%3B somatic mutation. P->H	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045112;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs1420675064	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045113;Note=In a sporadic cancer%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045114;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->S;Dbxref=dbSNP:rs879253894	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045115;Note=In sporadic cancers%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_005957;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7682763,ECO:0000269|PubMed:9450901;Dbxref=dbSNP:rs121912666,PMID:7682763,PMID:9450901	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_045116;Note=In sporadic cancers%3B somatic mutation. Y->D;Dbxref=dbSNP:rs530941076	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_045117;Note=In a sporadic cancer%3B somatic mutation. Y->F	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_005958;Note=In sporadic cancers%3B somatic mutation. Y->H;Dbxref=dbSNP:rs530941076	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_045118;Note=In sporadic cancers%3B somatic mutation. Y->N;Dbxref=dbSNP:rs530941076	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_005959;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. Y->S;Dbxref=dbSNP:rs121912666	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045119;Note=In sporadic cancers%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045120;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045121;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045122;Note=In sporadic cancers%3B somatic mutation. E->K;Dbxref=dbSNP:rs786201592	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045123;Note=In sporadic cancers%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045124;Note=In a sporadic cancer%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045125;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs146340390	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045126;Note=In sporadic cancers%3B somatic mutation. P->Q	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045127;Note=In a sporadic cancer%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045128;Note=In sporadic cancers%3B somatic mutation. P->S;Dbxref=dbSNP:rs1060501203	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045129;Note=In sporadic cancers%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_047179;Note=In a sporadic cancer%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045130;Note=In sporadic cancers%3B somatic mutation. P->H;Dbxref=dbSNP:rs138983188	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045131;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs138983188	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045132;Note=In a sporadic cancer%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045133;Note=In a sporadic cancer%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045134;Note=In a sporadic cancer%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_045135;Note=In sporadic cancers%3B somatic mutation. E->D;Dbxref=dbSNP:rs267605076	
P04637	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_045136;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_045137;Note=In sporadic cancers%3B somatic mutation. E->K;Dbxref=dbSNP:rs1555525707	
P04637	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_045138;Note=In a sporadic cancer%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045139;Note=In sporadic cancers%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045140;Note=In a sporadic cancer%3B somatic mutation. V->D	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045141;Note=In sporadic cancers%3B somatic mutation. V->F	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045142;Note=In a sporadic cancer%3B somatic mutation. V->G	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045143;Note=In sporadic cancers%3B somatic mutation. V->I	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045144;Note=In a sporadic cancer%3B somatic mutation. V->L;Dbxref=dbSNP:rs746504075	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_045145;Note=In sporadic cancers%3B somatic mutation. G->A	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_047180;Note=In sporadic cancers%3B somatic mutation. G->D	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_045844;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. G->N	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_045146;Note=In sporadic cancers%3B somatic mutation. G->S	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_045147;Note=In sporadic cancers%3B somatic mutation. G->V;Dbxref=dbSNP:rs970212462	
P04637	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_045148;Note=In sporadic cancers%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_045149;Note=In sporadic cancers%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_045150;Note=In a sporadic cancer%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_045151;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045152;Note=In sporadic cancers%3B somatic mutation. D->A	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_005960;Note=In sporadic cancers%3B somatic mutation. D->E	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045153;Note=In sporadic cancers%3B somatic mutation. D->G	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045154;Note=In sporadic cancers%3B somatic mutation. D->H	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045155;Note=In sporadic cancers%3B somatic mutation. D->N	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045845;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. D->P	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045156;Note=In sporadic cancers%3B somatic mutation. D->V	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045157;Note=In sporadic cancers%3B somatic mutation. D->Y	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045158;Note=In a sporadic cancer%3B somatic mutation. C->G	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045846;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. C->N	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045159;Note=In sporadic cancers%3B somatic mutation. C->R;Dbxref=dbSNP:rs1064794312	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045160;Note=In sporadic cancers%3B somatic mutation. C->S	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045161;Note=In sporadic cancers%3B somatic mutation. C->Y;Dbxref=dbSNP:rs1064793603	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_045162;Note=In sporadic cancers%3B somatic mutation. T->A	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_005961;Note=In sporadic cancers%3B somatic mutation. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9450901;Dbxref=PMID:9450901	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_045163;Note=In sporadic cancers%3B somatic mutation. T->N	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_045164;Note=In sporadic cancers%3B somatic mutation. T->P	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_045165;Note=In sporadic cancers%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_045166;Note=In sporadic cancers%3B somatic mutation. T->A	
P04637	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_045167;Note=In sporadic cancers%3B somatic mutation. T->I;Dbxref=dbSNP:rs1555525564	
P04637	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_045168;Note=In sporadic cancers%3B somatic mutation. T->N	
P04637	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_045169;Note=In sporadic cancers%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045170;Note=In sporadic cancers%3B somatic mutation. I->F	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045171;Note=In sporadic cancers%3B somatic mutation. I->L;Dbxref=dbSNP:rs1555525562	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045172;Note=In sporadic cancers%3B somatic mutation. I->N	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045173;Note=In sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20385133;Dbxref=PMID:20385133	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_005962;Note=In sporadic cancers%3B somatic mutation. I->T;Dbxref=dbSNP:rs587781589	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045174;Note=In sporadic cancers%3B somatic mutation. I->V	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045175;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. H->D	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045176;Note=In sporadic cancers%3B somatic mutation. H->L	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045177;Note=In a sporadic cancer%3B somatic mutation. H->P	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045178;Note=In sporadic cancers%3B somatic mutation. H->Q	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_047181;Note=In sporadic cancers%3B somatic mutation. H->R;Dbxref=dbSNP:rs879254233	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045179;Note=In sporadic cancers%3B somatic mutation. H->Y	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_005963;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. Y->C;Dbxref=dbSNP:rs587780073	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045180;Note=In sporadic cancers%3B somatic mutation. Y->D;Dbxref=dbSNP:rs864622237	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045181;Note=In a sporadic cancer%3B somatic mutation. Y->F	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_005964;Note=In sporadic cancers%3B somatic mutation. Y->H;Dbxref=dbSNP:rs864622237	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045847;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. Y->K	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045182;Note=In sporadic cancers%3B somatic mutation. Y->N;Dbxref=dbSNP:rs864622237	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045848;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. Y->Q	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045183;Note=In sporadic cancers%3B somatic mutation. Y->S;Dbxref=dbSNP:rs587780073	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_047182;Note=In an adrenocortical carcinoma with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. N->D	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045184;Note=In a sporadic cancer%3B somatic mutation. N->H	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045185;Note=In sporadic cancers%3B somatic mutation. N->I;Dbxref=dbSNP:rs144340710	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045849;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. N->M	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045186;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. N->S;Dbxref=dbSNP:rs144340710	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045187;Note=In sporadic cancers%3B somatic mutation. N->T	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045188;Note=In sporadic cancers%3B somatic mutation. N->Y;Dbxref=dbSNP:rs786204145	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045189;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. Y->C;Dbxref=dbSNP:rs730882026	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045190;Note=In sporadic cancers%3B somatic mutation. Y->D;Dbxref=dbSNP:rs587782289	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045191;Note=In a sporadic cancer%3B somatic mutation. Y->F	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045192;Note=In sporadic cancers%3B somatic mutation. Y->H;Dbxref=dbSNP:rs587782289	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045193;Note=In sporadic cancers%3B somatic mutation. Y->N;Dbxref=dbSNP:rs587782289	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045194;Note=In sporadic cancers%3B somatic mutation. Y->S;Dbxref=dbSNP:rs730882026	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_005965;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. M->I;Dbxref=dbSNP:rs587782664	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045195;Note=In sporadic cancers%3B somatic mutation. M->K;Dbxref=dbSNP:rs765848205	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045196;Note=In sporadic cancers%3B somatic mutation. M->L	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045197;Note=In sporadic cancers%3B somatic mutation. M->R;Dbxref=dbSNP:rs765848205	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045198;Note=In sporadic cancers%3B somatic mutation. M->T	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045199;Note=In sporadic cancers%3B somatic mutation. M->V;Dbxref=dbSNP:rs730882004	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_005966;Note=In sporadic cancers%3B somatic mutation. C->F;Dbxref=dbSNP:rs730882005	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045200;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. C->G;Dbxref=dbSNP:rs1057519981	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045850;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. C->H	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045201;Note=In sporadic cancers%3B somatic mutation. C->R;Dbxref=dbSNP:rs1057519981	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045202;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. C->S;Dbxref=dbSNP:rs730882005	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045203;Note=In sporadic cancers%3B somatic mutation. C->W;Dbxref=dbSNP:rs193920789	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_005967;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. C->Y;Dbxref=dbSNP:rs730882005	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045204;Note=In sporadic cancers%3B somatic mutation. N->D;Dbxref=dbSNP:rs876660807	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045205;Note=In a sporadic cancer%3B somatic mutation. N->H	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045206;Note=In a sporadic cancer%3B somatic mutation. N->I	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045207;Note=In sporadic cancers%3B somatic mutation. N->K;Dbxref=dbSNP:rs1057522275	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045208;Note=In sporadic cancers%3B somatic mutation. N->S;Dbxref=dbSNP:rs1057519999	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045209;Note=In sporadic cancers%3B somatic mutation. N->T;Dbxref=dbSNP:rs1057519999	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045210;Note=In sporadic cancers%3B somatic mutation. N->Y	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045211;Note=In sporadic cancers%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045212;Note=In sporadic cancers%3B somatic mutation. S->G	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_005968;Note=In sporadic cancers%3B somatic mutation. S->I	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045213;Note=In sporadic cancers%3B somatic mutation. S->N	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045214;Note=In a sporadic cancer%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045215;Note=In sporadic cancers%3B somatic mutation. S->R	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045216;Note=In sporadic cancers%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_033036;Note=In sporadic cancers%3B somatic mutation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs1057520002,PMID:17224074	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_045217;Note=In sporadic cancers%3B somatic mutation. S->C;Dbxref=dbSNP:rs28934573	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_005969;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. S->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:1699228;Dbxref=dbSNP:rs28934573,PMID:16959974,PMID:1699228	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_045218;Note=In sporadic cancers%3B somatic mutation. S->P;Dbxref=dbSNP:rs1057520002	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_047183;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_045219;Note=In sporadic cancers%3B somatic mutation. S->Y;Dbxref=dbSNP:rs28934573	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_005970;Note=In sporadic cancers%3B somatic mutation. C->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1394225,ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs121912655,PMID:1394225,PMID:16959974	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045220;Note=In sporadic cancers%3B somatic mutation. C->G;Dbxref=dbSNP:rs1057519982	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045221;Note=In sporadic cancers%3B somatic mutation. C->R	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045222;Note=In sporadic cancers%3B somatic mutation. C->S;Dbxref=dbSNP:rs121912655	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045223;Note=In sporadic cancers%3B somatic mutation. C->W;Dbxref=dbSNP:rs375874539	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045224;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. C->Y;Dbxref=dbSNP:rs121912655	
P04637	UniProtKB	Natural variant	243	244	.	.	.	ID=VAR_047184;Note=In a sporadic cancer%3B somatic mutation. MG->IC	
P04637	UniProtKB	Natural variant	243	244	.	.	.	ID=VAR_047185;Note=In a sporadic cancer%3B somatic mutation. MG->IS	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045225;Note=In sporadic cancers%3B somatic mutation. M->I	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045226;Note=In sporadic cancers%3B somatic mutation. M->K	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045227;Note=In sporadic cancers%3B somatic mutation. M->L;Dbxref=dbSNP:rs786203117	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045228;Note=In sporadic cancers%3B somatic mutation. M->R	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045229;Note=In sporadic cancers%3B somatic mutation. M->T;Dbxref=dbSNP:rs730882006	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045230;Note=In sporadic cancers%3B somatic mutation. M->V;Dbxref=dbSNP:rs786203117	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_047186;Note=In sporadic cancers%3B somatic mutation. G->A;Dbxref=dbSNP:rs985033810	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045231;Note=In sporadic cancers%3B somatic mutation. G->C;Dbxref=dbSNP:rs1057519989	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045232;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. G->D;Dbxref=dbSNP:rs1057517983	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045233;Note=In a sporadic cancer%3B somatic mutation. G->E	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045234;Note=In sporadic cancers%3B somatic mutation. G->R;Dbxref=dbSNP:rs1057519989	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045235;Note=In sporadic cancers%3B somatic mutation. G->S;Dbxref=dbSNP:rs1057519989	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045236;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. G->V;Dbxref=dbSNP:rs985033810	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005971;Note=In sporadic cancers%3B somatic mutation. G->A;Dbxref=dbSNP:rs121912656	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005972;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. G->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1394225,ECO:0000269|PubMed:1978757;Dbxref=dbSNP:rs28934575,PMID:1394225,PMID:1978757	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005973;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2259385;Dbxref=dbSNP:rs121912656,PMID:2259385	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045237;Note=In a sporadic cancer%3B somatic mutation. G->E	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045851;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. G->F	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045852;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. G->H	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045853;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. G->L	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045854;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. G->N	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045238;Note=In sporadic cancers%3B somatic mutation. G->R;Dbxref=dbSNP:rs28934575	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005974;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8829627;Dbxref=dbSNP:rs28934575,PMID:8829627	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005975;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2263646;Dbxref=dbSNP:rs121912656,PMID:2263646	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_045239;Note=In sporadic cancers%3B somatic mutation. M->I;Dbxref=dbSNP:rs1019340046	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_045240;Note=In sporadic cancers%3B somatic mutation. M->K	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_044020;Note=In sporadic cancers%3B somatic mutation. M->L;Dbxref=dbSNP:rs483352695	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_005976;Note=In sporadic cancers%3B somatic mutation. M->R;Dbxref=dbSNP:rs587780074	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_005977;Note=In sporadic cancers%3B somatic mutation. M->T;Dbxref=dbSNP:rs587780074	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_005978;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. M->V;Dbxref=dbSNP:rs483352695	
P04637	UniProtKB	Natural variant	247	248	.	.	.	ID=VAR_047187;Note=In a sporadic cancer%3B somatic mutation. NR->IP	
P04637	UniProtKB	Natural variant	247	248	.	.	.	ID=VAR_047188;Note=In sporadic cancers%3B somatic mutation. NR->KW	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045241;Note=In sporadic cancers%3B somatic mutation. N->D;Dbxref=dbSNP:rs1452189221	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045855;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. N->F	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_005980;Note=In sporadic cancers%3B somatic mutation. N->I;Dbxref=dbSNP:rs786201762	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045242;Note=In sporadic cancers%3B somatic mutation. N->K	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045243;Note=In sporadic cancers%3B somatic mutation. N->S;Dbxref=dbSNP:rs786201762	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_047189;Note=In sporadic cancers%3B somatic mutation. N->T	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045244;Note=In sporadic cancers%3B somatic mutation. N->Y	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_045245;Note=In a sporadic cancer%3B somatic mutation. R->C	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_005981;Note=In sporadic cancers%3B somatic mutation. R->G;Dbxref=dbSNP:rs121912651	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_005982;Note=In sporadic cancers%3B somatic mutation. R->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1394225,ECO:0000269|PubMed:7682763;Dbxref=dbSNP:rs11540652,PMID:1394225,PMID:7682763	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_045246;Note=In sporadic cancers%3B somatic mutation. R->P;Dbxref=dbSNP:rs11540652	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_005983;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:2263646,ECO:0000269|PubMed:7682763,ECO:0000269|PubMed:7887414;Dbxref=dbSNP:rs11540652,PMID:16959974,PMID:2263646,PMID:7682763,PMID:7887414	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_005984;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:1978757,ECO:0000269|PubMed:8829627;Dbxref=dbSNP:rs121912651,PMID:16959974,PMID:1978757,PMID:8829627	
P04637	UniProtKB	Natural variant	249	250	.	.	.	ID=VAR_047190;Note=In a sporadic cancer%3B somatic mutation. RP->SA	
P04637	UniProtKB	Natural variant	249	250	.	.	.	ID=VAR_047191;Note=In sporadic cancers%3B somatic mutation. RP->SS	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_005985;Note=In sporadic cancers%3B somatic mutation. R->G;Dbxref=dbSNP:rs587782082	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045247;Note=In a sporadic cancer%3B somatic mutation. R->I	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045248;Note=In sporadic cancers%3B somatic mutation. R->K;Dbxref=dbSNP:rs587782329	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_033037;Note=In sporadic cancers%3B somatic mutation. R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs587782329,PMID:17224074	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045856;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. R->N	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_005986;Note=In sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation. R->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1694291,ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:20385133;Dbxref=dbSNP:rs28934571,PMID:1694291,PMID:16959974,PMID:20385133	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045249;Note=In sporadic cancers%3B somatic mutation. R->T;Dbxref=dbSNP:rs587782329	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045250;Note=In sporadic cancers%3B somatic mutation. R->W;Dbxref=dbSNP:rs587782082	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045251;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045857;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. P->F	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045252;Note=In sporadic cancers%3B somatic mutation. P->H	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_047192;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs1064794311	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045858;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. P->N	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045253;Note=In sporadic cancers%3B somatic mutation. P->Q	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045254;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045255;Note=In sporadic cancers%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045256;Note=In sporadic cancers%3B somatic mutation. I->F	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045257;Note=In sporadic cancers%3B somatic mutation. I->L;Dbxref=dbSNP:rs730882007	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045258;Note=In LFS%3B germline mutation. I->M;Dbxref=dbSNP:rs878854074	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_005987;Note=In sporadic cancers%3B somatic mutation. I->N	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_033038;Note=In sporadic cancers%3B somatic mutation. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=dbSNP:rs730882027,PMID:17224074	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045259;Note=In sporadic cancers%3B somatic mutation. I->T	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045260;Note=In sporadic cancers%3B somatic mutation. I->V	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_045261;Note=In sporadic cancers%3B somatic mutation. L->F	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_045262;Note=In a sporadic cancer%3B somatic mutation. L->H	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_045263;Note=In sporadic cancers%3B somatic mutation. L->I	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_005988;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1978757;Dbxref=dbSNP:rs121912653,PMID:1978757	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_045264;Note=In a sporadic cancer%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_045265;Note=In sporadic cancers%3B somatic mutation. T->A	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_045266;Note=In sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_045267;Note=In sporadic cancers%3B somatic mutation. T->N;Dbxref=dbSNP:rs1555525465	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_047193;Note=In sporadic cancers%3B somatic mutation. T->P	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_045268;Note=In sporadic cancers%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045859;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. I->D	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045269;Note=In a sporadic cancer%3B somatic mutation. I->F	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045270;Note=In a sporadic cancer%3B somatic mutation. I->L	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045271;Note=In a sporadic cancer%3B somatic mutation. I->M	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_017908;Note=In sporadic cancers%3B somatic mutation. I->N	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045272;Note=In sporadic cancers%3B somatic mutation. I->S;Dbxref=dbSNP:rs1330865474	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_017909;Note=In sporadic cancers%3B somatic mutation. I->T	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045273;Note=In sporadic cancers%3B somatic mutation. I->V;Dbxref=dbSNP:rs746601313	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045274;Note=In sporadic cancers%3B somatic mutation. I->F;Dbxref=dbSNP:rs1057519995	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045275;Note=In sporadic cancers%3B somatic mutation. I->M	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045276;Note=In sporadic cancers%3B somatic mutation. I->N;Dbxref=dbSNP:rs876659675	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045277;Note=In sporadic cancers%3B somatic mutation. I->S;Dbxref=dbSNP:rs876659675	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045278;Note=In sporadic cancers%3B somatic mutation. I->T;Dbxref=dbSNP:rs876659675	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045279;Note=In sporadic cancers%3B somatic mutation. I->V	
P04637	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_045280;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_045281;Note=In sporadic cancers%3B somatic mutation. T->K	
P04637	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_045282;Note=In sporadic cancers%3B somatic mutation. T->P	
P04637	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_045283;Note=In sporadic cancers%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_005989;Note=In sporadic cancers%3B somatic mutation. L->P	
P04637	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_045284;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. L->Q;Dbxref=dbSNP:rs28934577	
P04637	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_045285;Note=In sporadic cancers%3B somatic mutation. L->R;Dbxref=dbSNP:rs28934577	
P04637	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_045286;Note=In sporadic cancers%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045287;Note=In sporadic cancers%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_005990;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045288;Note=In sporadic cancers%3B somatic mutation. E->G;Dbxref=dbSNP:rs1060501201	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_005991;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1978757;Dbxref=dbSNP:rs121912652,PMID:1978757	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045860;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. E->L	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045289;Note=In sporadic cancers%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045290;Note=In sporadic cancers%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_047194;Note=In a sporadic cancer%3B somatic mutation. D->A	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045291;Note=In sporadic cancers%3B somatic mutation. D->E	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045292;Note=In sporadic cancers%3B somatic mutation. D->G;Dbxref=dbSNP:rs745425759	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045293;Note=In sporadic cancers%3B somatic mutation. D->H	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045294;Note=In sporadic cancers%3B somatic mutation. D->N	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045861;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. D->P	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045862;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. D->S	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045295;Note=In sporadic cancers%3B somatic mutation. D->V	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_033039;Note=In sporadic cancers%3B somatic mutation. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17224074;Dbxref=PMID:17224074	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045296;Note=In sporadic cancers%3B somatic mutation. S->A	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045297;Note=In sporadic cancers%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045298;Note=In sporadic cancers%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045299;Note=In sporadic cancers%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045300;Note=In a sporadic cancer%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045301;Note=In sporadic cancers%3B somatic mutation. S->Y;Dbxref=dbSNP:rs876658916	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045302;Note=In a sporadic cancer%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045303;Note=In sporadic cancers%3B somatic mutation. S->G	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045304;Note=In sporadic cancers%3B somatic mutation. S->I	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045305;Note=In a sporadic cancer%3B somatic mutation. S->N	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045306;Note=In sporadic cancers%3B somatic mutation. S->R	
P04637	UniProtKB	Natural variant	262	263	.	.	.	ID=VAR_047195;Note=In a sporadic cancer%3B somatic mutation. GN->PD	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_045307;Note=In a sporadic cancer%3B somatic mutation. G->C;Dbxref=dbSNP:rs200579969	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_047196;Note=In sporadic cancers%3B somatic mutation. G->D	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_045863;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. G->H	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_045308;Note=In sporadic cancers%3B somatic mutation. G->S;Dbxref=dbSNP:rs200579969	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_045309;Note=In sporadic cancers%3B somatic mutation. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.23;Dbxref=dbSNP:rs1131691025	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045310;Note=In sporadic cancers%3B somatic mutation. N->D;Dbxref=dbSNP:rs72661119	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045311;Note=In sporadic cancers%3B somatic mutation. N->H	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045312;Note=In sporadic cancers%3B somatic mutation. N->I	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045313;Note=In a sporadic cancer%3B somatic mutation. N->K	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045314;Note=In a sporadic cancer%3B somatic mutation. N->S	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045315;Note=In sporadic cancers%3B somatic mutation. L->I	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045316;Note=In a sporadic cancer%3B somatic mutation. L->P;Dbxref=dbSNP:rs1555525353	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045317;Note=In a sporadic cancer%3B somatic mutation. L->Q	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045318;Note=In sporadic cancers%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045319;Note=In a sporadic cancer%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_045320;Note=In sporadic cancers%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_045321;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. L->P;Dbxref=dbSNP:rs879253942	
P04637	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_045322;Note=In sporadic cancers%3B somatic mutation. L->Q	
P04637	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_047197;Note=In sporadic cancers%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_045323;Note=In sporadic cancers%3B somatic mutation. G->A	
P04637	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_045324;Note=In sporadic cancers%3B somatic mutation. G->E;Dbxref=dbSNP:rs193920774	
P04637	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_045325;Note=In sporadic cancers%3B somatic mutation. G->R;Dbxref=dbSNP:rs1057519990	
P04637	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_045326;Note=In sporadic cancers%3B somatic mutation. G->V;Dbxref=dbSNP:rs193920774	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_045327;Note=In sporadic cancers%3B somatic mutation. R->G	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_045328;Note=In a sporadic cancer%3B somatic mutation. R->H	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_045329;Note=In sporadic cancers%3B somatic mutation. R->P;Dbxref=dbSNP:rs587780075	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_045330;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->Q;Dbxref=dbSNP:rs587780075	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_036507;Note=In sporadic cancers%3B somatic mutation. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs55832599,PMID:16959974	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045864;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. N->F	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045331;Note=In sporadic cancers%3B somatic mutation. N->H	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045332;Note=In sporadic cancers%3B somatic mutation. N->I	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045333;Note=In a sporadic cancer%3B somatic mutation. N->K	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045334;Note=In sporadic cancers%3B somatic mutation. N->S	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045335;Note=In a sporadic cancer%3B somatic mutation. N->Y	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045336;Note=In sporadic cancers%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045337;Note=In sporadic cancers%3B somatic mutation. S->G	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_047198;Note=In a sporadic cancer%3B somatic mutation. S->I	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045338;Note=In sporadic cancers%3B somatic mutation. S->N	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045339;Note=In sporadic cancers%3B somatic mutation. S->R	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045340;Note=In a sporadic cancer%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045341;Note=In sporadic cancers%3B somatic mutation. F->C;Dbxref=dbSNP:rs1057519986	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045342;Note=In sporadic cancers%3B somatic mutation. F->I;Dbxref=dbSNP:rs1057519988	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045343;Note=In sporadic cancers%3B somatic mutation. F->L;Dbxref=dbSNP:rs1057519987	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045344;Note=In sporadic cancers%3B somatic mutation. F->S;Dbxref=dbSNP:rs1057519986	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045345;Note=In sporadic cancers%3B somatic mutation. F->V;Dbxref=dbSNP:rs1057519988	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045346;Note=In sporadic cancers%3B somatic mutation. F->Y	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045347;Note=In sporadic cancers%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045348;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045349;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_036508;Note=In sporadic cancers%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs1060501191,PMID:16959974	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045865;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. E->P	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045350;Note=In sporadic cancers%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045866;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. E->R	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_047199;Note=In an osteosarcoma with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_045351;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. V->A	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_045352;Note=In sporadic cancers%3B somatic mutation. V->E;Dbxref=dbSNP:rs876660333	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_045353;Note=In sporadic cancers%3B somatic mutation. V->G;Dbxref=dbSNP:rs876660333	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_005992;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1737852;Dbxref=dbSNP:rs121912657,PMID:1737852	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_045354;Note=In sporadic cancers%3B somatic mutation. V->M;Dbxref=dbSNP:rs121912657	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_005993;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:17224074,ECO:0000269|PubMed:7887414,ECO:0000269|PubMed:9450901;Dbxref=dbSNP:rs121913343,PMID:16959974,PMID:17224074,PMID:7887414,PMID:9450901	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_005994;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->G	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_005995;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B abolishes sequence-specific DNA binding%3B does not induce SNAI1 degradation. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10570149,ECO:0000269|PubMed:1394225,ECO:0000269|PubMed:1565144,ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:1699228,ECO:0000269|PubMed:1868473,ECO:0000269|PubMed:20385133,ECO:0000269|PubMed:7682763,ECO:0000269|Ref.14;Dbxref=dbSNP:rs28934576,PMID:10570149,PMID:1394225,PMID:1565144,PMID:16959974,PMID:1699228,PMID:1868473,PMID:20385133,PMID:7682763	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_036509;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs28934576,PMID:16959974	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045867;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. R->N	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045355;Note=In sporadic cancers%3B somatic mutation. R->P;Dbxref=dbSNP:rs28934576	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045356;Note=In sporadic cancers%3B somatic mutation. R->Q	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045357;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->S;Dbxref=dbSNP:rs121913343	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045868;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. R->Y	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_045358;Note=In sporadic cancers%3B somatic mutation. V->A;Dbxref=dbSNP:rs1057520006	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_045359;Note=In sporadic cancers%3B somatic mutation. V->D;Dbxref=dbSNP:rs1057520006	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_005997;Note=In sporadic cancers%3B somatic mutation. V->F;Dbxref=dbSNP:rs1057520005	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_047200;Note=In sporadic cancers%3B somatic mutation. V->G;Dbxref=dbSNP:rs1057520006	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_045360;Note=In sporadic cancers%3B somatic mutation. V->I	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_045361;Note=In sporadic cancers%3B somatic mutation. V->L;Dbxref=dbSNP:rs1057520005	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_045362;Note=In sporadic cancers%3B somatic mutation. C->F;Dbxref=dbSNP:rs863224451	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_045363;Note=In sporadic cancers%3B somatic mutation. C->G	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_045364;Note=In sporadic cancers%3B somatic mutation. C->R;Dbxref=dbSNP:rs1057519983	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_045365;Note=In sporadic cancers%3B somatic mutation. C->S;Dbxref=dbSNP:rs863224451	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_005999;Note=In sporadic cancers%3B somatic mutation. C->W;Dbxref=dbSNP:rs1555525279	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_005998;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7887414;Dbxref=dbSNP:rs863224451,PMID:7887414	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045366;Note=In sporadic cancers%3B somatic mutation. A->D;Dbxref=dbSNP:rs786202082	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045367;Note=In sporadic cancers%3B somatic mutation. A->G;Dbxref=dbSNP:rs786202082	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045368;Note=In sporadic cancers%3B somatic mutation. A->P;Dbxref=dbSNP:rs1131691029	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045369;Note=In sporadic cancers%3B somatic mutation. A->S	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045370;Note=In sporadic cancers%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045371;Note=In sporadic cancers%3B somatic mutation. A->V	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_045372;Note=In sporadic cancers%3B somatic mutation. C->F;Dbxref=dbSNP:rs763098116	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_006000;Note=In sporadic cancers%3B somatic mutation. C->G;Dbxref=dbSNP:rs1064795369	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_045373;Note=In sporadic cancers%3B somatic mutation. C->R;Dbxref=dbSNP:rs1064795369	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_045374;Note=In sporadic cancers%3B somatic mutation. C->S	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_047201;Note=In sporadic cancers%3B somatic mutation. C->W	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_045375;Note=In an osteosarcoma with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. C->Y;Dbxref=dbSNP:rs763098116	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006001;Note=In sporadic cancers%3B somatic mutation. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs17849781,PMID:15489334	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_045869;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. P->F	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006002;Note=In sporadic cancers%3B somatic mutation. P->H;Dbxref=dbSNP:rs876659802	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006003;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2263646;Dbxref=dbSNP:rs876659802,PMID:2263646	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_045376;Note=In sporadic cancers%3B somatic mutation. P->R;Dbxref=dbSNP:rs876659802	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006004;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16959974,ECO:0000269|PubMed:2263646,ECO:0000269|PubMed:9450901;Dbxref=dbSNP:rs17849781,PMID:16959974,PMID:2263646,PMID:9450901	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006005;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->T;Dbxref=dbSNP:rs17849781	
P04637	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_006006;Note=In sporadic cancers%3B somatic mutation. G->E;Dbxref=dbSNP:rs1064793881	
P04637	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_045377;Note=In sporadic cancers%3B somatic mutation. G->R;Dbxref=dbSNP:rs1555525248	
P04637	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_045378;Note=In sporadic cancers%3B somatic mutation. G->V	
P04637	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_045379;Note=In sporadic cancers%3B somatic mutation. G->W	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_045380;Note=In sporadic cancers%3B somatic mutation. R->G;Dbxref=dbSNP:rs753660142	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_006008;Note=In sporadic cancers%3B somatic mutation. R->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs121912660,PMID:16959974	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_006007;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B no effect on interaction with CCAR2. R->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1694291,ECO:0000269|PubMed:25732823;Dbxref=dbSNP:rs121912660,PMID:1694291,PMID:25732823	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_045381;Note=In a sporadic cancer%3B somatic mutation. R->P	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_045382;Note=In sporadic cancers%3B somatic mutation. R->S	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_006009;Note=In sporadic cancers%3B somatic mutation. R->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1631151;Dbxref=dbSNP:rs121912660,PMID:1631151	
P04637	UniProtKB	Natural variant	281	282	.	.	.	ID=VAR_047203;Note=In sporadic cancers%3B somatic mutation. DR->EW	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006010;Note=In sporadic cancers%3B somatic mutation. D->A;Dbxref=dbSNP:rs587781525	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006011;Note=In sporadic cancers%3B somatic mutation. D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1459726;Dbxref=dbSNP:rs1057519984,PMID:1459726	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006012;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. D->G;Dbxref=dbSNP:rs587781525	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006013;Note=In sporadic cancers%3B somatic mutation. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs764146326,PMID:16959974	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_047202;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. D->N;Dbxref=dbSNP:rs764146326	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_045870;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. D->R	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006014;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. D->V;Dbxref=dbSNP:rs587781525	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_045383;Note=In sporadic cancers%3B somatic mutation. D->Y;Dbxref=dbSNP:rs764146326	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_045384;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->G;Dbxref=dbSNP:rs28934574	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_045385;Note=In a sporadic cancer%3B somatic mutation. R->H	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_006015;Note=In sporadic cancers%3B somatic mutation. R->L;Dbxref=dbSNP:rs730882008	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_045386;Note=In sporadic cancers%3B somatic mutation. R->P;Dbxref=dbSNP:rs730882008	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_045387;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18453682,ECO:0000269|Ref.22;Dbxref=dbSNP:rs730882008,PMID:18453682	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_006016;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation. R->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20385133,ECO:0000269|PubMed:8829627;Dbxref=dbSNP:rs28934574,PMID:20385133,PMID:8829627	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_006017;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->C;Dbxref=dbSNP:rs149633775	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_006018;Note=In sporadic cancers%3B somatic mutation. R->G	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_006019;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. R->H;Dbxref=dbSNP:rs371409680	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_045388;Note=In sporadic cancers%3B somatic mutation. R->L	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_006020;Note=In sporadic cancers%3B somatic mutation. R->P	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_045389;Note=In a sporadic cancer%3B somatic mutation. R->S;Dbxref=dbSNP:rs149633775	
P04637	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_006021;Note=In sporadic cancers%3B somatic mutation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959462;Dbxref=PMID:20959462	
P04637	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_045390;Note=In sporadic cancers%3B somatic mutation. T->I;Dbxref=dbSNP:rs863224685	
P04637	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_045391;Note=In sporadic cancers%3B somatic mutation. T->K	
P04637	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_006022;Note=In sporadic cancers%3B somatic mutation. T->P;Dbxref=dbSNP:rs1204379654	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_045392;Note=In a sporadic cancer%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_045393;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_045394;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_006023;Note=In sporadic cancers%3B somatic mutation. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1459726,ECO:0000269|PubMed:1694291;Dbxref=dbSNP:rs112431538,PMID:1459726,PMID:1694291	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_006024;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_006025;Note=In sporadic cancers%3B somatic mutation. E->V;Dbxref=dbSNP:rs121912667	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006026;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. E->A;Dbxref=dbSNP:rs1057519985	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006027;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006028;Note=In sporadic cancers%3B somatic mutation. E->G;Dbxref=dbSNP:rs1057519985	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006029;Note=In sporadic cancers%3B somatic mutation. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11023613,ECO:0000269|PubMed:8316628;Dbxref=dbSNP:rs786201059,PMID:11023613,PMID:8316628	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_045871;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. E->L	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006030;Note=In sporadic cancers%3B somatic mutation. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8829627;Dbxref=dbSNP:rs786201059,PMID:8829627	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_045395;Note=In sporadic cancers%3B somatic mutation. E->V;Dbxref=dbSNP:rs1057519985	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_047204;Note=In a sporadic cancer%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045396;Note=In sporadic cancers%3B somatic mutation. E->D;Dbxref=dbSNP:rs748891343	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045397;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045398;Note=In sporadic cancers%3B somatic mutation. E->K;Dbxref=dbSNP:rs587782006	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045399;Note=In sporadic cancers%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045400;Note=In a sporadic cancer%3B somatic mutation. N->D	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045401;Note=In sporadic cancers%3B somatic mutation. N->K	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045402;Note=In sporadic cancers%3B somatic mutation. N->S	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045403;Note=In sporadic cancers%3B somatic mutation. N->T	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045404;Note=In sporadic cancers%3B somatic mutation. N->Y	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045405;Note=In sporadic cancers%3B somatic mutation. L->F	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045406;Note=In sporadic cancers%3B somatic mutation. L->H	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045407;Note=In sporadic cancers%3B somatic mutation. L->P	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045408;Note=In a sporadic cancer%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045409;Note=In sporadic cancers%3B somatic mutation. L->V;Dbxref=dbSNP:rs1555525154	
P04637	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_045410;Note=In sporadic cancers%3B somatic mutation. R->C;Dbxref=dbSNP:rs770374782	
P04637	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_045411;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->H;Dbxref=dbSNP:rs55819519	
P04637	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_045412;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->L	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045413;Note=In sporadic cancers%3B somatic mutation. K->E;Dbxref=dbSNP:rs1555525126	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045414;Note=In sporadic cancers%3B somatic mutation. K->M	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045415;Note=In sporadic cancers%3B somatic mutation. K->N;Dbxref=dbSNP:rs372613518	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_047205;Note=In sporadic cancers%3B somatic mutation. K->Q	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045416;Note=In sporadic cancers%3B somatic mutation. K->R;Dbxref=dbSNP:rs781490101	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045417;Note=In sporadic cancers%3B somatic mutation. K->T	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045418;Note=In sporadic cancers%3B somatic mutation. K->E	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045872;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. K->G	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_015819;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10484981;Dbxref=dbSNP:rs121912663,PMID:10484981	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045419;Note=In sporadic cancers%3B somatic mutation. K->N	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045420;Note=In a sporadic cancer%3B somatic mutation. K->Q	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045421;Note=In sporadic cancers%3B somatic mutation. K->R;Dbxref=dbSNP:rs121912663	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045422;Note=In sporadic cancers%3B somatic mutation. K->T	
P04637	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_045423;Note=In a sporadic cancer%3B somatic mutation. G->A	
P04637	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_045424;Note=In sporadic cancers%3B somatic mutation. G->R;Dbxref=dbSNP:rs587780076	
P04637	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_045425;Note=In sporadic cancers%3B somatic mutation. G->V	
P04637	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_045426;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation. G->W;Dbxref=dbSNP:rs587780076	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045427;Note=In a sporadic cancer%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045428;Note=In sporadic cancers%3B somatic mutation. E->D;Dbxref=dbSNP:rs1305324490	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045429;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_047206;Note=In sporadic cancers%3B somatic mutation. E->K	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045430;Note=In sporadic cancers%3B somatic mutation. E->Q	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045431;Note=In sporadic cancers%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_045432;Note=In a sporadic cancer%3B somatic mutation. P->H	
P04637	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_045433;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs751713111	
P04637	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_045434;Note=In a sporadic cancer%3B somatic mutation. P->R;Dbxref=dbSNP:rs751713111	
P04637	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_045435;Note=In sporadic cancers%3B somatic mutation. P->S;Dbxref=dbSNP:rs1131691006	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045873;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions. H->C	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045436;Note=In sporadic cancers%3B somatic mutation. H->D	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_047207;Note=In sporadic cancers%3B somatic mutation. H->L	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045437;Note=In sporadic cancers%3B somatic mutation. H->N	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_006031;Note=In a sporadic cancer%3B somatic mutation. H->P	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045438;Note=In sporadic cancers%3B somatic mutation. H->Q	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045439;Note=In a sporadic cancer%3B somatic mutation. H->R;Dbxref=dbSNP:rs483352696	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045440;Note=In sporadic cancers%3B somatic mutation. H->Y;Dbxref=dbSNP:rs672601296	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045441;Note=In a sporadic cancer%3B somatic mutation. H->D	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045442;Note=In a sporadic cancer%3B somatic mutation. H->N	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045443;Note=In sporadic cancers%3B somatic mutation. H->P	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045444;Note=In sporadic cancers%3B somatic mutation. H->R;Dbxref=dbSNP:rs876659477	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045445;Note=In sporadic cancers%3B somatic mutation. H->Y	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045446;Note=In a sporadic cancer%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045447;Note=In sporadic cancers%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045448;Note=In sporadic cancers%3B somatic mutation. E->K;Dbxref=dbSNP:rs201744589	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045449;Note=In sporadic cancers%3B somatic mutation. E->Q;Dbxref=dbSNP:rs201744589	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045450;Note=In sporadic cancers%3B somatic mutation. E->V	
P04637	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_045451;Note=In sporadic cancers%3B somatic mutation. L->P	
P04637	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_045452;Note=In sporadic cancers%3B somatic mutation. L->Q	
P04637	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_045453;Note=In a sporadic cancer%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_045454;Note=In a sporadic cancer%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_045455;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_045456;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs909643864	
P04637	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_006032;Note=In a sporadic cancer%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_045457;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_045458;Note=In sporadic cancers%3B somatic mutation. P->A	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_006033;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs1555525067	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_045459;Note=In sporadic cancers%3B somatic mutation. P->Q	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_045460;Note=In sporadic cancers%3B somatic mutation. P->S	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_047208;Note=In a sporadic cancer%3B somatic mutation. P->T	
P04637	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_045461;Note=In a sporadic cancer%3B somatic mutation. G->A	
P04637	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_006034;Note=In sporadic cancers%3B somatic mutation. G->E;Dbxref=dbSNP:rs1060501202	
P04637	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_045462;Note=In a sporadic cancer%3B somatic mutation. G->R;Dbxref=dbSNP:rs863224686	
P04637	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_006035;Note=In a sporadic cancer%3B somatic mutation. G->V	
P04637	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_045463;Note=In sporadic cancers%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_045464;Note=In sporadic cancers%3B somatic mutation. S->I	
P04637	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_045465;Note=In sporadic cancers%3B somatic mutation. S->N;Dbxref=dbSNP:rs876658714	
P04637	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_045466;Note=In sporadic cancers%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_045467;Note=In sporadic cancers%3B somatic mutation. T->A;Dbxref=dbSNP:rs587782654	
P04637	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_045468;Note=In sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_045469;Note=In a sporadic cancer%3B somatic mutation. T->N	
P04637	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_047209;Note=In a sporadic cancer%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045470;Note=In a sporadic cancer%3B somatic mutation. K->E	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045471;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. K->M	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045472;Note=In sporadic cancers%3B somatic mutation%3B loss of nuclear localization. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10551826;Dbxref=PMID:10551826	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045473;Note=In sporadic cancers%3B somatic mutation. K->R	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045474;Note=In a sporadic cancer%3B somatic mutation. K->T	
P04637	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_045475;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. R->P	
P04637	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_006036;Note=In sporadic cancers%3B somatic mutation. R->Q;Dbxref=dbSNP:rs1048095040	
P04637	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_045476;Note=In a sporadic cancer%3B somatic mutation. A->P	
P04637	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_045477;Note=In sporadic cancers%3B somatic mutation. A->S	
P04637	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_006037;Note=In sporadic cancers%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_045478;Note=In sporadic cancers%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_045479;Note=In a sporadic cancer%3B somatic mutation. L->V	
P04637	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_045480;Note=In a sporadic cancer%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_006038;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.14;Dbxref=dbSNP:rs1555525012	
P04637	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_045481;Note=In a sporadic cancer%3B somatic mutation. N->I	
P04637	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_045482;Note=In sporadic cancers%3B somatic mutation. N->T	
P04637	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_045483;Note=In sporadic cancers%3B somatic mutation. N->H;Dbxref=dbSNP:rs1555525007	
P04637	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_045484;Note=In a sporadic cancer%3B somatic mutation. N->K	
P04637	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_045485;Note=In a sporadic cancer%3B somatic mutation. N->S;Dbxref=dbSNP:rs56184981	
P04637	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_045486;Note=In sporadic cancers%3B somatic mutation. N->T;Dbxref=dbSNP:rs56184981	
P04637	UniProtKB	Natural variant	312	312	.	.	.	ID=VAR_045487;Note=In sporadic cancers%3B somatic mutation. T->I	
P04637	UniProtKB	Natural variant	312	312	.	.	.	ID=VAR_045488;Note=In sporadic cancers%3B somatic mutation. T->S;Dbxref=dbSNP:rs145151284	
P04637	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_045489;Note=In a sporadic cancer%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_045490;Note=In a sporadic cancer%3B somatic mutation. S->I	
P04637	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_045491;Note=In a sporadic cancer%3B somatic mutation. S->N	
P04637	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_045492;Note=In a sporadic cancer%3B somatic mutation. S->R;Dbxref=dbSNP:rs1367492395	
P04637	UniProtKB	Natural variant	314	314	.	.	.	ID=VAR_045493;Note=In a sporadic cancer%3B somatic mutation. S->F;Dbxref=dbSNP:rs751440465	
P04637	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_045494;Note=In a sporadic cancer%3B somatic mutation. S->C	
P04637	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_045495;Note=In a sporadic cancer%3B somatic mutation. S->F	
P04637	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_045496;Note=In a sporadic cancer%3B somatic mutation. S->P	
P04637	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_045497;Note=In a sporadic cancer%3B somatic mutation. P->L;Dbxref=dbSNP:rs1555524979	
P04637	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_045498;Note=In a sporadic cancer%3B somatic mutation. P->T;Dbxref=dbSNP:rs772773208	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_045499;Note=In a kidney cancer with no family history%3B germline mutation and in a sporadic cancer%3B somatic mutation. Q->H;Dbxref=dbSNP:rs1060501199	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_045500;Note=In sporadic cancers%3B somatic mutation. Q->K;Dbxref=dbSNP:rs764735889	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_047210;Note=In a sporadic cancer%3B somatic mutation. Q->L	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_045501;Note=In a sporadic cancer%3B somatic mutation. Q->P	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_045502;Note=In sporadic cancers%3B somatic mutation. Q->R;Dbxref=dbSNP:rs1159579789	
P04637	UniProtKB	Natural variant	318	318	.	.	.	ID=VAR_045503;Note=In sporadic cancers%3B somatic mutation. P->L;Dbxref=dbSNP:rs1555524975	
P04637	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_045504;Note=In sporadic cancers%3B somatic mutation. K->E	
P04637	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_045505;Note=In a sporadic cancer%3B somatic mutation. K->N	
P04637	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_045506;Note=In a sporadic cancer%3B somatic mutation. K->R	
P04637	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_045507;Note=In sporadic cancers%3B somatic mutation. K->N	
P04637	UniProtKB	Natural variant	321	321	.	.	.	ID=VAR_045508;Note=In kidney cancer%3B germline mutation. K->E	
P04637	UniProtKB	Natural variant	321	321	.	.	.	ID=VAR_045509;Note=In a sporadic cancer%3B somatic mutation. K->R	
P04637	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_045510;Note=In sporadic cancers%3B somatic mutation. P->L	
P04637	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_045511;Note=In sporadic cancers%3B somatic mutation. P->R	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_045874;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. L->G	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_045512;Note=In a sporadic cancer%3B somatic mutation. L->M	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_045513;Note=In a sporadic cancer%3B somatic mutation. L->P	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_045514;Note=In a sporadic cancer%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_047211;Note=In a sporadic cancer%3B somatic mutation. L->V;Dbxref=dbSNP:rs1432281680	
P04637	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_045515;Note=In sporadic cancers%3B somatic mutation. D->E	
P04637	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_045875;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions. D->S	
P04637	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_045516;Note=In a sporadic cancer%3B somatic mutation. D->Y	
P04637	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_045517;Note=In a sporadic cancer%3B somatic mutation. G->A	
P04637	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_045518;Note=In sporadic cancers%3B somatic mutation. G->E	
P04637	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_006039;Note=In LFS%3B germline mutation. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1565144;Dbxref=dbSNP:rs121912659,PMID:1565144	
P04637	UniProtKB	Natural variant	326	326	.	.	.	ID=VAR_045519;Note=In a sporadic cancer%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	327	327	.	.	.	ID=VAR_045520;Note=In a sporadic cancer%3B somatic mutation. Y->H	
P04637	UniProtKB	Natural variant	327	327	.	.	.	ID=VAR_045521;Note=In a sporadic cancer%3B somatic mutation. Y->S	
P04637	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_045522;Note=In a sporadic cancer%3B somatic mutation. F->L	
P04637	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_045523;Note=In sporadic cancers%3B somatic mutation. F->S	
P04637	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_045524;Note=In a sporadic cancer%3B somatic mutation. F->V	
P04637	UniProtKB	Natural variant	329	329	.	.	.	ID=VAR_045525;Note=In a sporadic cancer%3B somatic mutation. T->I;Dbxref=dbSNP:rs969930693	
P04637	UniProtKB	Natural variant	329	329	.	.	.	ID=VAR_045526;Note=In a sporadic cancer%3B somatic mutation. T->S	
P04637	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_045527;Note=In sporadic cancers%3B somatic mutation. L->H	
P04637	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_047212;Note=In a sporadic cancer%3B somatic mutation. L->P	
P04637	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_045528;Note=In sporadic cancers%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_045529;Note=In sporadic cancers%3B somatic mutation. Q->H;Dbxref=dbSNP:rs11575996	
P04637	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_045530;Note=In sporadic cancers%3B somatic mutation. Q->P	
P04637	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_045531;Note=In sporadic cancers%3B somatic mutation. Q->R;Dbxref=dbSNP:rs1064795056	
P04637	UniProtKB	Natural variant	332	332	.	.	.	ID=VAR_045532;Note=In a sporadic cancer%3B somatic mutation. I->V	
P04637	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_006040;Note=In sporadic cancers%3B somatic mutation. G->V	
P04637	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_045533;Note=In a sporadic cancer%3B somatic mutation. G->W;Dbxref=dbSNP:rs730882028	
P04637	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_045534;Note=In a sporadic cancer%3B somatic mutation. R->G	
P04637	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_045535;Note=In a sporadic cancer%3B somatic mutation. R->H;Dbxref=dbSNP:rs771939956	
P04637	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_045536;Note=In a sporadic cancer%3B somatic mutation. R->L	
P04637	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_006041;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9452042;Dbxref=dbSNP:rs587782529,PMID:9452042	
P04637	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_035016;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11481490;Dbxref=dbSNP:rs121912664,PMID:11481490	
P04637	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_045537;Note=In sporadic cancers%3B somatic mutation. R->L;Dbxref=dbSNP:rs121912664	
P04637	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_045538;Note=In sporadic cancers%3B somatic mutation. R->P;Dbxref=dbSNP:rs121912664	
P04637	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_045539;Note=In a sporadic cancer%3B somatic mutation. F->I	
P04637	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_045540;Note=In a sporadic cancer%3B somatic mutation. F->L;Dbxref=dbSNP:rs150293825	
P04637	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_022316;Note=In a sporadic cancer%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.12;Dbxref=dbSNP:rs17882252	
P04637	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_045541;Note=In a sporadic cancer%3B somatic mutation. E->Q;Dbxref=dbSNP:rs17882252	
P04637	UniProtKB	Natural variant	341	341	.	.	.	ID=VAR_045542;Note=In sporadic cancers%3B somatic mutation. F->C	
P04637	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_045543;Note=In a sporadic cancer%3B somatic mutation. R->L	
P04637	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_045544;Note=In sporadic cancers%3B somatic mutation. R->P;Dbxref=dbSNP:rs375338359	
P04637	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_047213;Note=In sporadic cancers%3B somatic mutation. R->Q;Dbxref=dbSNP:rs375338359	
P04637	UniProtKB	Natural variant	343	343	.	.	.	ID=VAR_045545;Note=In sporadic cancers%3B somatic mutation. E->G	
P04637	UniProtKB	Natural variant	344	344	.	.	.	ID=VAR_045546;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. L->P;Dbxref=dbSNP:rs121912662	
P04637	UniProtKB	Natural variant	344	344	.	.	.	ID=VAR_045547;Note=In a sporadic cancer%3B somatic mutation. L->R	
P04637	UniProtKB	Natural variant	346	346	.	.	.	ID=VAR_045548;Note=In a sporadic cancer%3B somatic mutation. E->A	
P04637	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_045549;Note=In a sporadic cancer%3B somatic mutation. A->G	
P04637	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_045550;Note=In sporadic cancers%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_045551;Note=In a sporadic cancer%3B somatic mutation. L->F	
P04637	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_045552;Note=In a sporadic cancer%3B somatic mutation. L->S	
P04637	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_045553;Note=In a sporadic cancer%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_045554;Note=In a sporadic cancer%3B somatic mutation. D->H	
P04637	UniProtKB	Natural variant	353	353	.	.	.	ID=VAR_045555;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_045556;Note=In a sporadic cancer%3B somatic mutation. Q->E	
P04637	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_045557;Note=In a sporadic cancer%3B somatic mutation. Q->K;Dbxref=dbSNP:rs755394212	
P04637	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_047214;Note=In sporadic cancers%3B somatic mutation. Q->R;Dbxref=dbSNP:rs752142489	
P04637	UniProtKB	Natural variant	356	356	.	.	.	ID=VAR_045558;Note=In a sporadic cancer%3B somatic mutation. G->A	
P04637	UniProtKB	Natural variant	356	356	.	.	.	ID=VAR_045559;Note=In a sporadic cancer%3B somatic mutation. G->W	
P04637	UniProtKB	Natural variant	358	358	.	.	.	ID=VAR_045560;Note=In a sporadic cancer%3B somatic mutation. E->D	
P04637	UniProtKB	Natural variant	358	358	.	.	.	ID=VAR_045561;Note=In a sporadic cancer%3B somatic mutation. E->K;Dbxref=dbSNP:rs587782237	
P04637	UniProtKB	Natural variant	360	360	.	.	.	ID=VAR_045562;Note=G->A;Dbxref=dbSNP:rs35993958	
P04637	UniProtKB	Natural variant	360	360	.	.	.	ID=VAR_045563;Note=In a sporadic cancer%3B somatic mutation. G->V;Dbxref=dbSNP:rs35993958	
P04637	UniProtKB	Natural variant	363	363	.	.	.	ID=VAR_045564;Note=In a sporadic cancer%3B somatic mutation. R->K;Dbxref=dbSNP:rs876660285	
P04637	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_045565;Note=In a sporadic cancer%3B somatic mutation. A->P	
P04637	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_045566;Note=In a sporadic cancer%3B somatic mutation. A->T	
P04637	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_045567;Note=In a sporadic cancer%3B somatic mutation. A->V	
P04637	UniProtKB	Natural variant	365	365	.	.	.	ID=VAR_047215;Note=In a sporadic cancer%3B somatic mutation. H->R	
P04637	UniProtKB	Natural variant	365	365	.	.	.	ID=VAR_045568;Note=In a familial cancer not matching LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation. H->Y;Dbxref=dbSNP:rs267605075	
P04637	UniProtKB	Natural variant	366	366	.	.	.	ID=VAR_022317;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.12;Dbxref=dbSNP:rs17881470	
P04637	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_045569;Note=In a sporadic cancer%3B somatic mutation. K->Q	
P04637	UniProtKB	Natural variant	376	376	.	.	.	ID=VAR_045570;Note=In a sporadic cancer%3B somatic mutation. S->A	
P04637	UniProtKB	Natural variant	376	376	.	.	.	ID=VAR_045571;Note=In a sporadic cancer%3B somatic mutation. S->T	
P04637	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_045572;Note=In sporadic cancers%3B somatic mutation. R->H;Dbxref=dbSNP:rs863224682	
P04637	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_045573;Note=In a sporadic cancer%3B somatic mutation. F->L;Dbxref=dbSNP:rs1555524094	
P04637	UniProtKB	Natural variant	389	389	.	.	.	ID=VAR_045574;Note=In a sporadic cancer%3B somatic mutation. G->W;Dbxref=dbSNP:rs587783064	
P04637	UniProtKB	Natural variant	392	392	.	.	.	ID=VAR_045575;Note=In a sporadic cancer%3B somatic mutation. S->L	
P04637	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Loss of interaction with PPP2R5C%2C PPP2CA AND PPP2R1A. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17967874;Dbxref=PMID:17967874	
P04637	UniProtKB	Mutagenesis	18	18	.	.	.	Note=No effect on interaction with MDM2 and increase in protein levels after DNA damage. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10570149;Dbxref=PMID:10570149	
P04637	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Abolishes phosphorylation site. Abolishes increase in protein levels after DNA damage. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10570149;Dbxref=PMID:10570149	
P04637	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Constitutively increased TP53 protein levels. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10570149;Dbxref=PMID:10570149	
P04637	UniProtKB	Mutagenesis	22	23	.	.	.	Note=Loss of interaction with MDM2%2C leading to constitutively increased TP53 protein levels. LW->QS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10570149;Dbxref=PMID:10570149	
P04637	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Abolihes phosphorylation by MAPKAPK5. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17254968;Dbxref=PMID:17254968	
P04637	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Abolishes phosphorylation by DYRK2 and HIPK2 and acetylation of K-382 by CREBBP. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11740489,ECO:0000269|PubMed:16219768,ECO:0000269|PubMed:17349958;Dbxref=PMID:11740489,PMID:16219768,PMID:17349958	
P04637	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Alters interaction with WWOX. Missing;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11740489,ECO:0000269|PubMed:16219768,ECO:0000269|PubMed:17349958;Dbxref=PMID:11740489,PMID:16219768,PMID:17349958	
P04637	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Blocks phosphorylation by TAF1. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15053879;Dbxref=PMID:15053879	
P04637	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Abolishes strongly phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959462;Dbxref=PMID:20959462	
P04637	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Inhibits slightly its transcriptional activity. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959462;Dbxref=PMID:20959462	
P04637	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Does not induce SNAI1 degradation. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20385133;Dbxref=PMID:20385133	
P04637	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Abolishes phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959462;Dbxref=PMID:20959462	
P04637	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Inhibits strongly its transcriptional activity. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20959462;Dbxref=PMID:20959462	
P04637	UniProtKB	Mutagenesis	284	284	.	.	.	Note=Inhibits strongly its transcriptional activity. T->E	
P04637	UniProtKB	Mutagenesis	291	292	.	.	.	Note=Abolishes polyubiquitination by MKRN1. KK->RR;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19536131;Dbxref=PMID:19536131	
P04637	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Loss of nuclear localization%3B when associated with A-320 and A-321. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2156209;Dbxref=PMID:2156209	
P04637	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Loss of nuclear localization%3B when associated with A-319 and A-321. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2156209;Dbxref=PMID:2156209	
P04637	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Loss of nuclear localization%3B when associated with A-319 and A-320. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2156209;Dbxref=PMID:2156209	
P04637	UniProtKB	Mutagenesis	333	337	.	.	.	Note=Reduced methylation by PRMT5. Reduced nuclear localization. Decreased binding to promoters of target genes. Reduced transcriptional activity. Decrease in cell cycle arrest. RGRER->KGKEK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19011621;Dbxref=PMID:19011621	
P04637	UniProtKB	Mutagenesis	359	359	.	.	.	Note=Abolishes binding to USP7. P->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16402859;Dbxref=PMID:16402859	
P04637	UniProtKB	Mutagenesis	361	361	.	.	.	Note=Abolishes binding to USP7. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16402859;Dbxref=PMID:16402859	
P04637	UniProtKB	Mutagenesis	362	362	.	.	.	Note=Abolishes binding to USP7. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16402859;Dbxref=PMID:16402859	
P04637	UniProtKB	Mutagenesis	370	370	.	.	.	Note=Induces a decrease in methylation by SMYD2. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17108971;Dbxref=PMID:17108971	
P04637	UniProtKB	Mutagenesis	372	372	.	.	.	Note=Induces a decrease in protein stabilization. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15525938;Dbxref=PMID:15525938	
P04637	UniProtKB	Mutagenesis	373	373	.	.	.	Note=Abolishes dimethylation by EHMT1 and EHMT2. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20118233;Dbxref=PMID:20118233	
P04637	UniProtKB	Mutagenesis	382	382	.	.	.	Note=Abolishes acetylation by CREBBP. K->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10884347,ECO:0000269|PubMed:11740489,ECO:0000269|PubMed:17707234,ECO:0000269|PubMed:20870725;Dbxref=PMID:10884347,PMID:11740489,PMID:17707234,PMID:20870725	
P04637	UniProtKB	Mutagenesis	382	382	.	.	.	Note=Abolishes monomethylation by KMT5A. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10884347,ECO:0000269|PubMed:11740489,ECO:0000269|PubMed:17707234,ECO:0000269|PubMed:20870725;Dbxref=PMID:10884347,PMID:11740489,PMID:17707234,PMID:20870725	
P04637	UniProtKB	Mutagenesis	383	383	.	.	.	Note=Abolishes S-315 phosphorylation by CDK2/cyclin A. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10884347;Dbxref=PMID:10884347	
P04637	UniProtKB	Mutagenesis	385	385	.	.	.	Note=Reduced SUMO1 conjugation. F->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10884347,ECO:0000269|PubMed:11124955;Dbxref=PMID:10884347,PMID:11124955	
P04637	UniProtKB	Mutagenesis	386	386	.	.	.	Note=Abolishes SUMO1 conjugation%2C in vitro and in vivo. K->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11124955,ECO:0000269|Ref.37;Dbxref=PMID:11124955	
P04637	UniProtKB	Mutagenesis	387	387	.	.	.	Note=No effect SUMO1 conjugation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11124955;Dbxref=PMID:11124955	
P04637	UniProtKB	Mutagenesis	388	388	.	.	.	Note=Abolishes SUMO1 conjugation. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11124955;Dbxref=PMID:11124955	
P04637	UniProtKB	Helix	3	6	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HOU	
P04637	UniProtKB	Turn	8	10	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HOU	
P04637	UniProtKB	Helix	19	23	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3DAC	
P04637	UniProtKB	Beta strand	27	29	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2K8F	
P04637	UniProtKB	Helix	30	32	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HPD	
P04637	UniProtKB	Beta strand	33	35	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L14	
P04637	UniProtKB	Helix	36	38	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2B3G	
P04637	UniProtKB	Helix	41	44	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2B3G	
P04637	UniProtKB	Helix	47	55	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2B3G	
P04637	UniProtKB	Turn	105	108	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	110	112	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	118	120	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q05	
P04637	UniProtKB	Turn	121	123	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q05	
P04637	UniProtKB	Beta strand	124	127	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Turn	128	131	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	132	135	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	141	146	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	148	150	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UN8	
P04637	UniProtKB	Beta strand	156	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Helix	166	168	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Helix	177	180	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	181	183	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4KVP	
P04637	UniProtKB	Beta strand	187	189	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GGC	
P04637	UniProtKB	Beta strand	194	199	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	204	207	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Turn	209	211	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	214	219	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Turn	225	227	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2FEJ	
P04637	UniProtKB	Beta strand	228	236	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Helix	240	242	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D07	
P04637	UniProtKB	Turn	243	248	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	251	258	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Beta strand	260	262	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ADY	
P04637	UniProtKB	Beta strand	264	274	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Helix	278	287	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3D06	
P04637	UniProtKB	Helix	288	290	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4HJE	
P04637	UniProtKB	Helix	322	324	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q01	
P04637	UniProtKB	Beta strand	327	334	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3Q01	
P04637	UniProtKB	Helix	335	354	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1AIE	
P04637	UniProtKB	Helix	375	380	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1YC5	
##sequence-region P04147 1 577
P04147	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9298649;Dbxref=PMID:9298649	
P04147	UniProtKB	Chain	2	577	.	.	.	ID=PRO_0000081720;Note=Polyadenylate-binding protein%2C cytoplasmic and nuclear	
P04147	UniProtKB	Domain	38	116	.	.	.	Note=RRM 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00176	
P04147	UniProtKB	Domain	126	203	.	.	.	Note=RRM 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00176	
P04147	UniProtKB	Domain	219	296	.	.	.	Note=RRM 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00176	
P04147	UniProtKB	Domain	322	399	.	.	.	Note=RRM 4;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00176	
P04147	UniProtKB	Domain	489	568	.	.	.	Note=PABC;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00641	
P04147	UniProtKB	Region	9	61	.	.	.	Note=Required and sufficient for nuclear export;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P04147	UniProtKB	Region	281	317	.	.	.	Note=Required and sufficient for nuclear import;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P04147	UniProtKB	Region	473	577	.	.	.	Note=Interaction with SUP35	
P04147	UniProtKB	Motif	12	17	.	.	.	Note=Nuclear export signal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P04147	UniProtKB	Compositional bias	422	431	.	.	.	Note=Poly-Ala	
P04147	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9298649;Dbxref=PMID:9298649	
P04147	UniProtKB	Modified residue	107	107	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23865587;Dbxref=PMID:23865587	
P04147	UniProtKB	Modified residue	249	249	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18407956;Dbxref=PMID:18407956	
P04147	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19779198;Dbxref=PMID:19779198	
P04147	UniProtKB	Modified residue	405	405	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19779198;Dbxref=PMID:19779198	
P04147	UniProtKB	Cross-link	7	7	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22106047;Dbxref=PMID:22106047	
P04147	UniProtKB	Cross-link	337	337	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22106047;Dbxref=PMID:22106047	
P04147	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Impairs nuclear export%3B when associated with A-15. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630021;Dbxref=PMID:15630021	
P04147	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Impairs nuclear export%3B when associated with A-12. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15630021;Dbxref=PMID:15630021	
P04147	UniProtKB	Mutagenesis	79	79	.	.	.	Note=In PAB1-14%3B fails to bind poly(U)%2C but not poly(A) RNA%3B when associated with Q-166%3B Q-259 and Q-362. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9193001;Dbxref=PMID:9193001	
P04147	UniProtKB	Mutagenesis	83	83	.	.	.	Note=In PAB1-16%3B reduces affinity for oligo(A) about 100-fold%2C impairs poly(A)-dependent translation%2C but still interacts with eIF4G%3B when associated with V-170. In PAB1-15%3B fails to bind RNA%3B when associated with V-170%3B V-263 and V-366. Y->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9193001,ECO:0000269|PubMed:9418852;Dbxref=PMID:9193001,PMID:9418852	
P04147	UniProtKB	Mutagenesis	134	136	.	.	.	Note=In PAB1-134. HPD->DKS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	148	148	.	.	.	Note=In PAB1-148%3B greatly reduces poly(A)-dependent translation and moderately reduces stimulation of cap-dependent translation in vitro%3B when associated with N-151. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	151	151	.	.	.	Note=In PAB1-148%3B greatly reduces poly(A)-dependent translation and moderately reduces stimulation of cap-dependent translation in vitro%3B when associated with A-148. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	157	159	.	.	.	Note=In PAB1-157%3B greatly reduces poly(A)-dependent translation and stimulation of cap-dependent translation in vitro. IAT->VVC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	166	166	.	.	.	Note=In PAB1-14%3B fails to bind poly(U)%2C but not poly(A) RNA%3B when associated with A-79%3B Q-259 and Q-362. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9193001;Dbxref=PMID:9193001	
P04147	UniProtKB	Mutagenesis	170	170	.	.	.	Note=In PAB1-6%3B selectively reduces poly(A) RNA binding. In PAB1-16%3B reduces affinity for oligo(A) about 100-fold%2C impairs poly(A)-dependent translation%2C but still interacts with eIF4G%3B when associated with V-83. In PAB1-15%3B fails to bind RNA%3B when associated with V-83%3B V-263 and V-366. F->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9193001,ECO:0000269|PubMed:9418852;Dbxref=PMID:9193001,PMID:9418852	
P04147	UniProtKB	Mutagenesis	175	177	.	.	.	Note=In PAB1-175%3B greatly reduces poly(A)-dependent translation and stimulation of cap-dependent translation in vitro. EEG->TQE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	180	181	.	.	.	Note=In PAB1-180%3B abolishes poly(A)-dependent translation and greatly reduces stimulation of cap-dependent translation in vitro. Impairs interaction with eIF4G. KE->ER;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	184	186	.	.	.	Note=In PAB1-184%3B abolishes poly(A)-dependent translation and moderately reduces stimulation of cap-dependent translation in vitro. Impairs interaction with eIF4G. DAL->EKM;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	193	197	.	.	.	Note=In PAB1-193%3B moderately reduces stimulation of cap-dependent translation in vitro. GQEIY->DRKVF;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	199	202	.	.	.	Note=In PAB1-199%3B moderately reduces poly(A)-dependent translation and stimulation of cap-dependent translation in vitro. APHL->GRFK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10357826;Dbxref=PMID:10357826	
P04147	UniProtKB	Mutagenesis	259	259	.	.	.	Note=In PAB1-14%3B fails to bind poly(U)%2C but not poly(A) RNA%3B when associated with A-79%3B Q-166 and Q-362. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9193001;Dbxref=PMID:9193001	
P04147	UniProtKB	Mutagenesis	263	263	.	.	.	Note=In PAB1-7. In PAB1-15%3B fails to bind RNA%3B when associated with V-83%3B V-170 and V-366. F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9193001;Dbxref=PMID:9193001	
P04147	UniProtKB	Mutagenesis	362	362	.	.	.	Note=In PAB1-14%3B fails to bind poly(U)%2C but not poly(A) RNA%3B when associated with A-79%3B Q-166 and Q-259. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9193001;Dbxref=PMID:9193001	
P04147	UniProtKB	Mutagenesis	366	366	.	.	.	Note=In PAB1-8%3B selectively reduces poly(U) RNA binding. In PAB1-15%3B fails to bind RNA%3B when associated with V-83%3B V-170 and V-263. F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9193001;Dbxref=PMID:9193001	
P04147	UniProtKB	Sequence conflict	426	426	.	.	.	Note=A->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04147	UniProtKB	Helix	503	517	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFW	
P04147	UniProtKB	Helix	518	520	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFW	
P04147	UniProtKB	Helix	524	534	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFW	
P04147	UniProtKB	Helix	539	546	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFW	
P04147	UniProtKB	Helix	549	568	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1IFW	
##sequence-region P51681 1 352
P51681	UniProtKB	Chain	1	352	.	.	.	ID=PRO_0000069257;Note=C-C chemokine receptor type 5	
P51681	UniProtKB	Topological domain	1	30	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	31	58	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	59	68	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	69	89	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	90	102	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	103	124	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	125	141	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	142	166	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	167	198	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	199	218	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	219	235	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	236	260	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	261	277	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Transmembrane	278	301	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Topological domain	302	352	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Modified residue	3	3	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10089882;Dbxref=PMID:10089882	
P51681	UniProtKB	Modified residue	10	10	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21763489;Dbxref=PMID:21763489	
P51681	UniProtKB	Modified residue	14	14	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21763489;Dbxref=PMID:21763489	
P51681	UniProtKB	Modified residue	15	15	.	.	.	Note=Sulfotyrosine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphoserine%3B by BARK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10085131;Dbxref=PMID:10085131	
P51681	UniProtKB	Modified residue	337	337	.	.	.	Note=Phosphoserine%3B by BARK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10085131;Dbxref=PMID:10085131	
P51681	UniProtKB	Modified residue	342	342	.	.	.	Note=Phosphoserine%3B by BARK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10085131;Dbxref=PMID:10085131	
P51681	UniProtKB	Modified residue	349	349	.	.	.	Note=Phosphoserine%3B by BARK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10085131;Dbxref=PMID:10085131	
P51681	UniProtKB	Lipidation	321	321	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Lipidation	323	323	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Lipidation	324	324	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Glycosylation	6	6	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Glycosylation	7	7	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:10089882;Dbxref=PMID:10089882	
P51681	UniProtKB	Glycosylation	16	16	.	.	.	Note=O-linked (GalNAc...) threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Glycosylation	17	17	.	.	.	Note=O-linked (GalNAc...) serine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P51681	UniProtKB	Disulfide bond	20	269	.	.	.	Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PDB:4MBS,ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Disulfide bond	101	178	.	.	.	Ontology_term=ECO:0000244,ECO:0000244,ECO:0000255;evidence=ECO:0000244|PDB:4MBS,ECO:0000244|PDB:5UIW,ECO:0000255|PROSITE-ProRule:PRU00521	
P51681	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_003481;Note=In INCCR5-71A%3B results in absent sulfation and greatly decreased binding CCL4 and CCL5 when associated with D-3%2C D-10 and D-15%3B restored most CCL4 binding when associated with D-3 and D-15. Y->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_024066;Note=I->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=PMID:9399903	
P51681	UniProtKB	Natural variant	20	20	.	.	.	ID=VAR_024067;Note=C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs145061115,PMID:9399903	
P51681	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_011839;Note=A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800939,PMID:9399903	
P51681	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_003482;Note=In INCCR5-72A. R->H;Dbxref=dbSNP:rs56340326	
P51681	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_003483;Note=In TZCCR5-179. P->L	
P51681	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_024068;Note=I->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1475319259,PMID:9399903	
P51681	UniProtKB	Natural variant	55	55	.	.	.	ID=VAR_011840;Note=L->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9207783,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1799863,PMID:9207783,PMID:9399903	
P51681	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_011841;Note=Associated with susceptibility to HIV-1%3B reduced surface expression and function of CCR5 protein. R->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11369664,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800940,PMID:11369664,PMID:9399903	
P51681	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_003484;Note=In UGCCR5-145B. K->R	
P51681	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_003485;Note=In ZWCCR5-7. Y->H;Dbxref=dbSNP:rs758090461	
P51681	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_024069;Note=A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs56198941,PMID:9399903	
P51681	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_003486;Note=In MWCCR5-107. D->N;Dbxref=dbSNP:rs149975182	
P51681	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_003487;Note=In INCCR5-467. G->E	
P51681	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_080410;Note=Rare polymorphism%3B protects against HIV-1 infection%3B CD4+ T-cells from R-106 carriers are less susceptible to infection by HIV-1 R5%3B results in reduced CCR5 surface expression. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17092330;Dbxref=dbSNP:rs183662584,PMID:17092330	
P51681	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_003488;Note=In ZWCCR5-7. L->P	
P51681	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_003489;Note=In UGCCR5-145A. F->S	
P51681	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_003490;Note=In KECCR5-116. Y->C	
P51681	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_003491;Note=In INCCR5-45C. T->A	
P51681	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_012481;Note=Rare polymorphism%3B protects against HIV-1 infection%3B CD4+ T-cells from R-178 carriers are less susceptible to infection by HIV-1 R5%3B results in reduced CCR5 surface expression. C->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10917742,ECO:0000269|PubMed:17092330;Dbxref=dbSNP:rs199824195,PMID:10917742,PMID:17092330	
P51681	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_003492;Note=In UGCCR5-145A. S->N	
P51681	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_003493;Note=In ZWCCR5-7. M->V	
P51681	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_003494;Note=In KECCR5-3B. Y->C	
P51681	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_024070;Note=S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9207783;Dbxref=dbSNP:rs1017863136,PMID:9207783	
P51681	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_011842;Note=R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9207783,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800452,PMID:9207783,PMID:9399903	
P51681	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_024071;Note=Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=PMID:9399903	
P51681	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_003495;Note=In INCCR5-71A. T->S	
P51681	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_003496;Note=In UGCCR5-145A. L->P;Dbxref=dbSNP:rs143181119	
P51681	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_003497;Note=In INCCR5-72A. T->M;Dbxref=dbSNP:rs534088482	
P51681	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_011843;Note=G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800943,PMID:9399903	
P51681	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_003498;Note=In TZCCR5-179. E->G	
P51681	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_003499;Note=In THCCR5-5. K->E	
P51681	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_003500;Note=In MWCCR5-1567. N->S	
P51681	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_003501;Note=In THCCR5-5. K->R	
P51681	UniProtKB	Natural variant	333	333	.	.	.	ID=VAR_003502;Note=In THCCR5-2. E->G	
P51681	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_003503;Note=In MWCCR5-1567%2C MWCCR5-1568%2C ZWCCR5-14 and ZWCCR5-112. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9207783,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800944,PMID:9207783,PMID:9399903	
P51681	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_003504;Note=In TZCCR5-181A and MWCCR5-107. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9207783,ECO:0000269|PubMed:9399903;Dbxref=dbSNP:rs1800945,PMID:9207783,PMID:9399903	
P51681	UniProtKB	Natural variant	345	345	.	.	.	ID=VAR_003505;Note=In UGCCR5-145C. E->G	
P51681	UniProtKB	Mutagenesis	3	3	.	.	.	Note=No sulfation and greatly decreased binding of CCL4 and CCL5%3B when associated with D-10%3B D-14 and D-15. Restored most CCL4 binding%3B when associated with D-10 and D-15. Y->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	3	3	.	.	.	Note=No sulfation and greatly decreases binding of CCL4 and CCL5%3B when associated with F-10%3B F-14 and F-15. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	6	6	.	.	.	Note=No change in glycosylation status and greatly decreased CCL4 binding. Loss of molecular mass of about 2 kDa as compared to wild type. Dramatically reduced binding of CCL4%3B when associated with A-7%3B A-16%3B A-17. Similar molecular mass loss. Dramatically reduced binding of CCL4%3B when associated with A-7 only. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Mutagenesis	7	7	.	.	.	Note=No change in glycosylation status and binds CCL4 as efficiently as wild type. Loss of molecular mass of about 2 kDa as compared to wild type. Dramatically reduced binding of CCL4%3B when associated with A-6%3B A-16%3B A-17. Similar molecular mass loss. Dramatically reduced binding of CCL4%3B when associated with A-6 only. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Mutagenesis	10	10	.	.	.	Note=No sulfation and greatly decreases binding of CCL4 and CCL5%3B when associated with F-3%3B F-14 and F-15. Small loss of sulfation%3B when associated with F-14 and F-15. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No sulfation and greatly decreased binding of CCL4 and CCL5%3B when associated with D-3%3B D-10 and D-14. No restoration of CCL4 binding%3B when associated with D-10 and D-15. Y->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No sulfation and greatly decreases binding of CCL4 and CCL5%3B when associated with F-3%3B F-10%3B and F-15. Small loss of sulfation%3B when associated with F-10 and F-15. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	15	15	.	.	.	Note=No sulfation and greatly decreased binding of CCL4 and CCL5%3B when associated with D-3%3B D-10 and D-14. Restored most CCL4 binding%3B when associated with D-3 and D-10. Y->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	15	15	.	.	.	Note=No sulfation and greatly decreases binding of CCL4 and CCL5%3B when associated with F-3%3B F-10 and F-14. Small loss of sulfation%3B when associated with F-10 and F-14. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10089882,ECO:0000269|PubMed:11733580;Dbxref=PMID:10089882,PMID:11733580	
P51681	UniProtKB	Mutagenesis	16	16	.	.	.	Note=Similar decrease in molecular mass when treated with O-glycosidase as for wild type%3B when associated with A-17. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Similar decrease in molecular mass when treated with O-glycosidase as for wild type%3B when associated with A-16. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11733580;Dbxref=PMID:11733580	
P51681	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Decreases to 40%25 surface expression. No effect on conformational integrity. Disrupts binding of CCL4. Decreases cell HIV infection. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383387;Dbxref=PMID:10383387	
P51681	UniProtKB	Mutagenesis	101	101	.	.	.	Note=Decreases to 40%25 surface expression. Disrupts conformational integrity. Disrupts binding of CCL4. Decreases HIV cell infection. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383387;Dbxref=PMID:10383387	
P51681	UniProtKB	Mutagenesis	178	178	.	.	.	Note=Decreases to 40%25 surface expression. Disrupts conformational integrity. Disrupts binding of CCL4. Decreases HIV cell infection. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383387;Dbxref=PMID:10383387	
P51681	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Decreases to 40%25 surface expression. No effect on conformational integrity. Disrupts binding of CCL4. Decreases cell HIV infection. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10383387;Dbxref=PMID:10383387	
P51681	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Small reduction in palmitoylation. Cell surface expression reduced by 50%25. Greatly reduced palmitoylation. Cell surface expression greatly reduced%3B when associated with A-323 or A-324. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%25%3B when associated with A-323 and A-324. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Mutagenesis	323	323	.	.	.	Note=Small reduction in palmitoylation. Cell surface expression reduced by 50%25. Greatly reduced palmitoylation. Cell surface expression greatly reduced%3B when associated with A-321 or A-324. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%25%3B when associated with A-321 and A-324. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Mutagenesis	324	324	.	.	.	Note=Small reduction in palmitoylation. Cell surface expression reduced by 50%25. Greatly reduced palmitoylation. Cell surface expression greatly reduced%3B when associated with A-321 or A-323. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%25%3B when associated with A-321 and A-323. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11323418;Dbxref=PMID:11323418	
P51681	UniProtKB	Mutagenesis	336	336	.	.	.	Note=APO-RANTES-stimulated phosphorylation reduced by 15%25%3B APO-RANTES-stimulated phosphorylation reduced by 30-50%25%3B when associated with A-337 or A-342 or A-349%3B APO-RANTES-stimulated phosphorylation reduced by 80%25%3B when associated with A-337 and A-342 or A-349%3B No APO-RANTES-stimulated phosphorylation%3B when associated with A-337%3B A-342 and A349%3B abolishes interaction with ARRB2%3B when associated with S-337%3B S-342 and S-349. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10085131,ECO:0000269|PubMed:11448957;Dbxref=PMID:10085131,PMID:11448957	
P51681	UniProtKB	Mutagenesis	337	337	.	.	.	Note=APO-RANTES-stimulated phosphorylation reduced by 18%25%3B APO-RANTES-stimulated phosphorylation reduced by 30-50%25 on APO-RANTES stimulation%3B when associated with A-336 or A-342 or A-349%3B APO-RANTES-stimulated phosphorylation reduced by 80%25%3B when associated with A-336 and A-342 or A-349%3B No APO-RANTES-stimulated phosphorylation%3B when associated with A-336%3B A-342 and A349%3B abolishes interaction with ARRB2%3B when associated with S-336%3B S-342 and S-349. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10085131,ECO:0000269|PubMed:11448957;Dbxref=PMID:10085131,PMID:11448957	
P51681	UniProtKB	Mutagenesis	342	342	.	.	.	Note=APO-RANTES-stimulated phosphorylation reduced by 42%25. Phosphorylation reduced by 50%25 on APO-RANTES stimulation%3B when associated with A-336 or A-337 or A-349%3B APO-RANTES-stimulated phosphorylation reduced by 80%25 when associated with A-336 and A-337 or A-349%3B No APO-RANTES-stimulated phosphorylation%3B when associated with A-336%3B A-337 and A349%3B abolishes interaction with ARRB2%3B when associated with S-336%3B S-337 and S-349. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10085131,ECO:0000269|PubMed:11448957;Dbxref=PMID:10085131,PMID:11448957	
P51681	UniProtKB	Mutagenesis	349	349	.	.	.	Note=APO-RANTES-stimulated phosphorylation reduced by 43%25%3B APO-RANTES-stimulated phosphorylation reduced by 30-50%25%3B when associated with A-336 or A-337 or A-342%3B APO-RANTES-stimulated phosphorylation reduced by 80%25%3B when associated with A-336 and A-337 or A-342%3B No APO-RANTES-stimulated phosphorylation stimulation%3B when associated with A-336%3B A-337 and A347%3B abolishes interaction with ARRB2%3B when associated with S-336%3B S-337 and S-342. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10085131,ECO:0000269|PubMed:11448957;Dbxref=PMID:10085131,PMID:11448957	
P51681	UniProtKB	Helix	10	13	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L87	
P51681	UniProtKB	Helix	14	17	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L87	
P51681	UniProtKB	Turn	20	22	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L87	
P51681	UniProtKB	Helix	23	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	64	91	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	97	131	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Turn	133	135	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	136	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	142	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Beta strand	167	172	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Beta strand	175	180	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	184	186	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	187	202	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	204	221	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	227	259	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Turn	260	265	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	269	288	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	289	291	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	292	299	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
P51681	UniProtKB	Helix	302	313	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5UIW	
##sequence-region P28482 1 360
P28482	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22223895,ECO:0000244|PubMed:22814378,ECO:0000269|PubMed:12665801;Dbxref=PMID:19413330,PMID:22223895,PMID:22814378,PMID:12665801	
P28482	UniProtKB	Chain	2	360	.	.	.	ID=PRO_0000186247;Note=Mitogen-activated protein kinase 1	
P28482	UniProtKB	Domain	25	313	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P28482	UniProtKB	Nucleotide binding	31	39	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P28482	UniProtKB	DNA binding	259	277	.	.	.	.	
P28482	UniProtKB	Region	105	108	.	.	.	Note=Inhibitor-binding	
P28482	UniProtKB	Region	153	154	.	.	.	Note=Inhibitor-binding	
P28482	UniProtKB	Motif	185	187	.	.	.	Note=TXY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18760948;Dbxref=PMID:18760948	
P28482	UniProtKB	Motif	318	322	.	.	.	Note=Cytoplasmic retention motif;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18760948;Dbxref=PMID:18760948	
P28482	UniProtKB	Motif	327	333	.	.	.	Note=Nuclear translocation motif;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18760948;Dbxref=PMID:18760948	
P28482	UniProtKB	Compositional bias	2	9	.	.	.	Note=Poly-Ala	
P28482	UniProtKB	Active site	149	149	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000255,ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027	
P28482	UniProtKB	Binding site	54	54	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P28482	UniProtKB	Binding site	54	54	.	.	.	Note=Inhibitor;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16139248,ECO:0000269|PubMed:16242327,ECO:0000269|PubMed:17194451,ECO:0000269|PubMed:17300186,ECO:0000269|PubMed:19827834,ECO:0000269|PubMed:9827991;Dbxref=PMID:16139248,PMID:16242327,PMID:17194451,PMID:17300186,PMID:19827834,PMID:9827991	
P28482	UniProtKB	Binding site	108	108	.	.	.	Note=Inhibitor%3B via amide nitrogen and carbonyl oxygen;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16139248,ECO:0000269|PubMed:16242327,ECO:0000269|PubMed:17194451,ECO:0000269|PubMed:17300186,ECO:0000269|PubMed:19827834,ECO:0000269|PubMed:9827991;Dbxref=PMID:16139248,PMID:16242327,PMID:17194451,PMID:17300186,PMID:19827834,PMID:9827991	
P28482	UniProtKB	Binding site	114	114	.	.	.	Note=Inhibitor;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16139248,ECO:0000269|PubMed:16242327,ECO:0000269|PubMed:17194451,ECO:0000269|PubMed:17300186,ECO:0000269|PubMed:19827834,ECO:0000269|PubMed:9827991;Dbxref=PMID:16139248,PMID:16242327,PMID:17194451,PMID:17300186,PMID:19827834,PMID:9827991	
P28482	UniProtKB	Binding site	154	154	.	.	.	Note=Inhibitor;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16139248,ECO:0000269|PubMed:16242327,ECO:0000269|PubMed:17194451,ECO:0000269|PubMed:17300186,ECO:0000269|PubMed:19827834,ECO:0000269|PubMed:9827991;Dbxref=PMID:16139248,PMID:16242327,PMID:17194451,PMID:17300186,PMID:19827834,PMID:9827991	
P28482	UniProtKB	Binding site	166	166	.	.	.	Note=Inhibitor;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16139248,ECO:0000269|PubMed:16242327,ECO:0000269|PubMed:17194451,ECO:0000269|PubMed:17300186,ECO:0000269|PubMed:19827834,ECO:0000269|PubMed:9827991;Dbxref=PMID:16139248,PMID:16242327,PMID:17194451,PMID:17300186,PMID:19827834,PMID:9827991	
P28482	UniProtKB	Binding site	167	167	.	.	.	Note=Inhibitor;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16139248,ECO:0000269|PubMed:16242327,ECO:0000269|PubMed:17194451,ECO:0000269|PubMed:17300186,ECO:0000269|PubMed:19827834,ECO:0000269|PubMed:9827991;Dbxref=PMID:16139248,PMID:16242327,PMID:17194451,PMID:17300186,PMID:19827834,PMID:9827991	
P28482	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22223895,ECO:0000244|PubMed:22814378,ECO:0000269|PubMed:12665801;Dbxref=PMID:19413330,PMID:22223895,PMID:22814378,PMID:12665801	
P28482	UniProtKB	Modified residue	29	29	.	.	.	Note=Phosphoserine%3B by SGK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19447520;Dbxref=PMID:19447520	
P28482	UniProtKB	Modified residue	185	185	.	.	.	Note=Phosphothreonine%3B by MAP2K1 and MAP2K2;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:21406692,PMID:23186163	
P28482	UniProtKB	Modified residue	187	187	.	.	.	Note=Phosphotyrosine%3B by MAP2K1 and MAP2K2;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:19053285,ECO:0000269|PubMed:19494114;Dbxref=PMID:18669648,PMID:19690332,PMID:21406692,PMID:23186163,PMID:19053285,PMID:19494114	
P28482	UniProtKB	Modified residue	190	190	.	.	.	Note=Phosphothreonine%3B by autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19060905;Dbxref=PMID:19060905	
P28482	UniProtKB	Modified residue	246	246	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18760948;Dbxref=PMID:18760948	
P28482	UniProtKB	Modified residue	248	248	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18760948;Dbxref=PMID:18760948	
P28482	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19369195;Dbxref=PMID:19369195	
P28482	UniProtKB	Alternative sequence	242	285	.	.	.	ID=VSP_047815;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.3	
P28482	UniProtKB	Mutagenesis	54	54	.	.	.	Note=Does not inhibit interaction with MAP2K1. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794356;Dbxref=PMID:18794356	
P28482	UniProtKB	Mutagenesis	176	179	.	.	.	Note=Inhibits homodimerization and interaction with TPR. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794356;Dbxref=PMID:18794356	
P28482	UniProtKB	Mutagenesis	185	185	.	.	.	Note=Inhibits interaction with TPR%3B when associated with A-187. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794356;Dbxref=PMID:18794356	
P28482	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Inhibits interaction with TPR%3B when associated with A-185. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794356;Dbxref=PMID:18794356	
P28482	UniProtKB	Mutagenesis	234	234	.	.	.	Note=Inhibits interaction with TPR. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794356;Dbxref=PMID:18794356	
P28482	UniProtKB	Mutagenesis	318	318	.	.	.	Note=Loss of dephosphorylation by PTPRJ. D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18794356,ECO:0000269|PubMed:19494114;Dbxref=PMID:18794356,PMID:19494114	
P28482	UniProtKB	Mutagenesis	318	318	.	.	.	Note=Inhibits interaction with MAP2K1 but not with TPR%3B when associated with N-321. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18794356,ECO:0000269|PubMed:19494114;Dbxref=PMID:18794356,PMID:19494114	
P28482	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Inhibits interaction with MAP2K1 but not with TPR%3B when associated with N-318. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794356;Dbxref=PMID:18794356	
P28482	UniProtKB	Sequence conflict	91	91	.	.	.	Note=R->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P28482	UniProtKB	Beta strand	12	14	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4QTA	
P28482	UniProtKB	Beta strand	17	19	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4QTA	
P28482	UniProtKB	Turn	22	24	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	25	34	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	37	44	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Turn	45	48	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	49	56	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	59	61	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6G92	
P28482	UniProtKB	Helix	62	77	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	81	83	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5AX3	
P28482	UniProtKB	Beta strand	88	90	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Turn	95	97	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	101	106	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	109	111	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	112	118	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	123	142	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	152	154	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	155	157	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Turn	159	161	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4IZ5	
P28482	UniProtKB	Beta strand	163	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	168	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3I5Z	
P28482	UniProtKB	Helix	176	178	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Turn	181	185	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2Y9Q	
P28482	UniProtKB	Helix	191	193	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	196	200	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	201	203	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5K4I	
P28482	UniProtKB	Helix	208	223	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	235	244	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	249	253	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	258	265	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	275	278	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Beta strand	280	282	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5NHO	
P28482	UniProtKB	Helix	284	293	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Turn	298	300	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	304	308	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	311	313	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Turn	314	316	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	319	321	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	331	334	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5V62	
P28482	UniProtKB	Helix	335	337	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5K4I	
P28482	UniProtKB	Helix	340	351	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Helix	352	354	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZZN	
P28482	UniProtKB	Turn	356	358	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1PME	
##sequence-region P04386 1 881
P04386	UniProtKB	Chain	1	881	.	.	.	ID=PRO_0000114951;Note=Regulatory protein GAL4	
P04386	UniProtKB	DNA binding	11	38	.	.	.	Note=Zn(2)-C6 fungal-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00227	
P04386	UniProtKB	Motif	862	870	.	.	.	Note=9aaTAD	
P04386	UniProtKB	Metal binding	11	11	.	.	.	Note=Zinc 1	
P04386	UniProtKB	Metal binding	11	11	.	.	.	Note=Zinc 2	
P04386	UniProtKB	Metal binding	14	14	.	.	.	Note=Zinc 1	
P04386	UniProtKB	Metal binding	21	21	.	.	.	Note=Zinc 1	
P04386	UniProtKB	Metal binding	28	28	.	.	.	Note=Zinc 1	
P04386	UniProtKB	Metal binding	28	28	.	.	.	Note=Zinc 2	
P04386	UniProtKB	Metal binding	31	31	.	.	.	Note=Zinc 2	
P04386	UniProtKB	Metal binding	38	38	.	.	.	Note=Zinc 2	
P04386	UniProtKB	Modified residue	694	694	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19779198;Dbxref=PMID:19779198	
P04386	UniProtKB	Modified residue	696	696	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19779198;Dbxref=PMID:19779198	
P04386	UniProtKB	Modified residue	699	699	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19779198;Dbxref=PMID:19779198	
P04386	UniProtKB	Modified residue	703	703	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19779198;Dbxref=PMID:19779198	
P04386	UniProtKB	Modified residue	712	712	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18407956;Dbxref=PMID:18407956	
P04386	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Loss of DNA-binding. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:3299106;Dbxref=PMID:3299106	
P04386	UniProtKB	Helix	12	17	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3COQ	
P04386	UniProtKB	Beta strand	25	27	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3COQ	
P04386	UniProtKB	Helix	29	33	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3COQ	
P04386	UniProtKB	Helix	51	71	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3COQ	
P04386	UniProtKB	Beta strand	73	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3COQ	
P04386	UniProtKB	Helix	77	82	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3COQ	
P04386	UniProtKB	Helix	86	93	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3COQ	
##sequence-region P51580 1 245
P51580	UniProtKB	Chain	1	245	.	.	.	ID=PRO_0000220102;Note=Thiopurine S-methyltransferase	
P51580	UniProtKB	Region	29	40	.	.	.	Note=S-adenosyl-L-methionine binding	
P51580	UniProtKB	Region	134	135	.	.	.	Note=S-adenosyl-L-methionine binding	
P51580	UniProtKB	Binding site	40	40	.	.	.	Note=Substrate;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P51580	UniProtKB	Binding site	69	69	.	.	.	Note=S-adenosyl-L-methionine%3B via carbonyl oxygen	
P51580	UniProtKB	Binding site	90	90	.	.	.	Note=S-adenosyl-L-methionine	
P51580	UniProtKB	Binding site	152	152	.	.	.	Note=S-adenosyl-L-methionine	
P51580	UniProtKB	Modified residue	14	14	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:24275569	
P51580	UniProtKB	Modified residue	58	58	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
P51580	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_005636;Note=Polymorphism%3B allele TPMT*5%3B has very low activity when expressed in a heterologous system. L->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16220112,ECO:0000269|PubMed:9246020;Dbxref=dbSNP:rs72552740,PMID:16220112,PMID:9246020	
P51580	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_005637;Note=Polymorphism%3B allele TPMT*2%3B TPMT*2 allele frequency is 0.5%25%3B seems to be restricted to the Caucasian population%3B 100-fold reduction in activity%3B protein shows enhanced degradation. A->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10208641,ECO:0000269|PubMed:10751626,ECO:0000269|PubMed:16220112,ECO:0000269|PubMed:16476125,ECO:0000269|PubMed:16789994,ECO:0000269|PubMed:7862671,ECO:0000269|PubMed:9177237,ECO:0000269|PubMed:9931345;Dbxref=dbSNP:rs1800462,PMID:10208641,PMID:10751626,PMID:16220112,PMID:16476125,PMID:16789994,PMID:7862671,PMID:9177237,PMID:9931345	
P51580	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_005638;Note=Polymorphism%3B allele TPMT*3A and allele TPMT*3B%3B very low activity%3B protein shows enhanced degradation leading to strongly reduced protein levels. A->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10208641,ECO:0000269|PubMed:10751626,ECO:0000269|PubMed:15819814,ECO:0000269|PubMed:16220112,ECO:0000269|PubMed:16476125,ECO:0000269|PubMed:16789994,ECO:0000269|PubMed:17243178,ECO:0000269|PubMed:8561894,ECO:0000269|PubMed:8644731,ECO:0000269|PubMed:9177237,ECO:0000269|PubMed:9246020,ECO:0000269|PubMed:9336428,ECO:0000269|PubMed:9931345;Dbxref=dbSNP:rs1800460,PMID:10208641,PMID:10751626,PMID:15819814,PMID:16220112,PMID:16476125,PMID:16789994,PMID:17243178,PMID:8561894,PMID:8644731,PMID:9177237,PMID:9246020,PMID:9336428,PMID:9931345	
P51580	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_052368;Note=Q->H;Dbxref=dbSNP:rs6921269	
P51580	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_005639;Note=Polymorphism%3B allele TPMT*6%3B reduced activity. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16220112,ECO:0000269|PubMed:9246020;Dbxref=dbSNP:rs75543815,PMID:16220112,PMID:9246020	
P51580	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_008715;Note=Polymorphism%3B allele TPMT*8%3B intermediate activity. R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16220112,ECO:0000269|PubMed:9931346;Dbxref=dbSNP:rs56161402,PMID:16220112,PMID:9931346	
P51580	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_005640;Note=Polymorphism%3B allele TPMT*7%3B reduced activity. H->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16220112,ECO:0000269|PubMed:9711875;Dbxref=dbSNP:rs72552736,PMID:16220112,PMID:9711875	
P51580	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_005641;Note=Polymorphism%3B allele TPMT*3B and allele TPMT*3C%3B reduced activity%3B protein shows enhanced degradation. Y->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10208641,ECO:0000269|PubMed:10751626,ECO:0000269|PubMed:15819814,ECO:0000269|PubMed:16220112,ECO:0000269|PubMed:16476125,ECO:0000269|PubMed:16789994,ECO:0000269|PubMed:17243178,ECO:0000269|PubMed:8561894,ECO:0000269|PubMed:8644731,ECO:0000269|PubMed:9246020,ECO:0000269|PubMed:9336428,ECO:0000269|PubMed:9931345;Dbxref=dbSNP:rs1142345,PMID:10208641,PMID:10751626,PMID:15819814,PMID:16220112,PMID:16476125,PMID:16789994,PMID:17243178,PMID:8561894,PMID:8644731,PMID:9246020,PMID:9336428,PMID:9931345	
P51580	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Decreases affinity for 6-mercaptopurine. Slightly decreases catalytic activity. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18484748;Dbxref=PMID:18484748	
P51580	UniProtKB	Turn	18	21	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	26	35	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	47	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	64	67	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	75	81	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	85	89	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	93	102	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	107	111	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	119	123	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	126	133	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	135	140	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	146	154	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Turn	155	157	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	160	162	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	163	172	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	174	186	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Turn	189	191	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	201	208	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Turn	209	211	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	212	221	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Helix	225	230	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
P51580	UniProtKB	Beta strand	236	244	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BZG	
##sequence-region Q9H3S4 1 243
Q9H3S4	UniProtKB	Chain	1	243	.	.	.	ID=PRO_0000072647;Note=Thiamin pyrophosphokinase 1	
Q9H3S4	UniProtKB	Alternative sequence	1	118	.	.	.	ID=VSP_056302;Note=In isoform 2. MEHAFTPLEPLLSTGNLKYCLVILNQPLDNYFRHLWNKALLRACADGGANRLYDITEGERESFLPEFINGDFDSIRPEVREYYATKGCELISTPDQDHTDFTKCLKMLQKKIEEKDLK->M;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9H3S4	UniProtKB	Alternative sequence	205	243	.	.	.	ID=VSP_056303;Note=In isoform 2. TNDVLAFGTLVSTSNTYDGSGVVTVETDHPLLWTMAIKS->RTCDYTRTTWIAKDNPVPRLIRLIRLNHICKVPLAIK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9H3S4	UniProtKB	Natural variant	40	40	.	.	.	ID=VAR_067391;Note=In THMD5. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22152682;Dbxref=dbSNP:rs387906936,PMID:22152682	
Q9H3S4	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_067392;Note=In THMD5. N->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22152682;Dbxref=dbSNP:rs387906935,PMID:22152682	
Q9H3S4	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_067393;Note=In THMD5. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22152682;Dbxref=dbSNP:rs371271054,PMID:22152682	
Q9H3S4	UniProtKB	Sequence conflict	193	193	.	.	.	Note=M->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9H3S4	UniProtKB	Sequence conflict	218	218	.	.	.	Note=S->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9H3S4	UniProtKB	Beta strand	19	23	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Helix	32	38	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	42	45	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Helix	48	55	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Turn	56	58	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Helix	60	62	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	66	70	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	73	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Helix	77	85	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	89	92	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Helix	100	114	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	120	125	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	128	131	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Helix	132	144	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Helix	145	147	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	153	157	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	160	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	167	173	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	179	186	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	192	202	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	205	210	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Turn	211	213	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	216	219	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	225	233	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
Q9H3S4	UniProtKB	Beta strand	235	241	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3S4Y	
##sequence-region P60484 1 403
P60484	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
P60484	UniProtKB	Chain	2	403	.	.	.	ID=PRO_0000215904;Note=Phosphatidylinositol 3%2C4%2C5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	
P60484	UniProtKB	Domain	14	185	.	.	.	Note=Phosphatase tensin-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00590	
P60484	UniProtKB	Domain	190	350	.	.	.	Note=C2 tensin-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00589	
P60484	UniProtKB	Region	338	348	.	.	.	Note=Required for interaction with NOP53;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15355975;Dbxref=PMID:15355975	
P60484	UniProtKB	Region	401	403	.	.	.	Note=PDZ domain-binding	
P60484	UniProtKB	Active site	124	124	.	.	.	Note=Phosphocysteine intermediate;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00590	
P60484	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylthreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
P60484	UniProtKB	Modified residue	294	294	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O08586	
P60484	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphotyrosine%3B by FRK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19345329;Dbxref=PMID:19345329	
P60484	UniProtKB	Modified residue	366	366	.	.	.	Note=Phosphothreonine%3B by GSK3-beta and PLK3;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:12297295,ECO:0000269|PubMed:20940307;Dbxref=PMID:24275569,PMID:12297295,PMID:20940307	
P60484	UniProtKB	Modified residue	370	370	.	.	.	Note=Phosphoserine%3B by CK2 and PLK3;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11035045,ECO:0000269|PubMed:12297295,ECO:0000269|PubMed:20940307;Dbxref=PMID:11035045,PMID:12297295,PMID:20940307	
P60484	UniProtKB	Modified residue	380	380	.	.	.	Note=Phosphoserine%3B by ROCK1 and CK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11035045;Dbxref=PMID:11035045	
P60484	UniProtKB	Modified residue	382	382	.	.	.	Note=Phosphothreonine%3B by ROCK1 and CK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11035045;Dbxref=PMID:11035045	
P60484	UniProtKB	Modified residue	383	383	.	.	.	Note=Phosphothreonine%3B by ROCK1 and CK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11035045;Dbxref=PMID:11035045	
P60484	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by CK2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11035045,ECO:0000269|PubMed:12297295;Dbxref=PMID:11035045,PMID:12297295	
P60484	UniProtKB	Modified residue	401	401	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10646847;Dbxref=PMID:10646847	
P60484	UniProtKB	Cross-link	13	13	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18716620;Dbxref=PMID:18716620	
P60484	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18716620;Dbxref=PMID:18716620	
P60484	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_055420;Note=In isoform alpha. M->MERGGEAAAAAAAAAAAPGRGSESPVTISRAGNAGELVSPLLLPPTRRRRRRHIQGPGPVLNLPSAAAAPPVARAPEAAGGGSRSEDYSSSPHSAAAAARPLAAEEKQAQSLQPSSSRRSSHYPAAVQSQAAAERGASATAKSRAISILQKKPRHQQLLPSLSSFFFSHRLPDM;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P60484	UniProtKB	Alternative sequence	55	70	.	.	.	ID=VSP_055421;Note=In isoform 3. RFLDSKHKNHYKIYNL->S;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.7	
P60484	UniProtKB	Alternative sequence	165	190	.	.	.	ID=VSP_055422;Note=In isoform 3. GVTIPSQRRYVYYYSYLLKNHLDYRP->ADPTGGIPDKGIIVIGDGSSMDVIAP;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.7	
P60484	UniProtKB	Alternative sequence	191	403	.	.	.	ID=VSP_055423;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.7	
P60484	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_026248;Note=Retains phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3%3B retains the ability to bind phospholipid membranes. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_007457;Note=In glioma. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9090379;Dbxref=dbSNP:rs1064794096,PMID:9090379	
P60484	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_026249;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains the ability to bind phospholipid membranes. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_018100;Note=In malignant melanoma%3B somatic mutation. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10978354;Dbxref=dbSNP:rs121909233,PMID:10978354	
P60484	UniProtKB	Natural variant	20	20	.	.	.	ID=VAR_026250;Note=Reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains phosphatase activity towards PtdIns(3%2C4%2C5)P3. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs1064795967,PMID:10866302	
P60484	UniProtKB	Natural variant	27	27	.	.	.	ID=VAR_026251;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs886041877,PMID:10866302	
P60484	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_008733;Note=In CWS1. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10234502;Dbxref=PMID:10234502	
P60484	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_008734;Note=In CWS1. A->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10400993,ECO:0000269|PubMed:11494117;Dbxref=PMID:10400993,PMID:11494117	
P60484	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_008036;Note=In CWS1. M->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9425889;Dbxref=dbSNP:rs121909225,PMID:9425889	
P60484	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_007458;Note=In glioma. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9090379;Dbxref=dbSNP:rs1554893792,PMID:9090379	
P60484	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_026252;Note=In endometrial hyperplasia. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9635567;Dbxref=dbSNP:rs786204854,PMID:9635567	
P60484	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_007459;Note=In glioma%3B retains phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3%3B retains the ability to bind phospholipid membranes. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9090379;Dbxref=PMID:9090379	
P60484	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_011587;Note=In CWS1. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11494117;Dbxref=dbSNP:rs786204855,PMID:11494117	
P60484	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_007460;Note=In glioma%3B loss of protein phosphatase activity. L->W;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:9090379,ECO:0000269|PubMed:9256433;Dbxref=dbSNP:rs786202398,PMID:9090379,PMID:9256433	
P60484	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_018101;Note=Foun in a patient with macrocephaly%2C ventriculomegaly%2C vertebral anomalies%2C anal atresia%2C congenital cardiac disease%2C tracheoesophageal fistula%2C renal anomalies%2C radial dysplasia and other limb defects%3B unknown pathological significance. H->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11748304;Dbxref=dbSNP:rs121909236,PMID:11748304	
P60484	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_026253;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs398123316,PMID:10866302	
P60484	UniProtKB	Natural variant	65	403	.	.	.	ID=VAR_078705;Note=In MCEPHAS. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26637798;Dbxref=PMID:26637798	
P60484	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_007461;Note=In CWS1. I->R	
P60484	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_007462;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3%3B retains the ability to bind phospholipid membranes. Y->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10400993,ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:11494117,ECO:0000269|PubMed:9600246;Dbxref=dbSNP:rs398123317,PMID:10400993,PMID:10866302,PMID:11494117,PMID:9600246	
P60484	UniProtKB	Natural variant	70	70	.	.	.	ID=VAR_018102;Note=In CWS1. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9832031;Dbxref=dbSNP:rs121909226,PMID:9832031	
P60484	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_026254;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_032634;Note=In MCEPHAS. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15805158;Dbxref=dbSNP:rs121909238,PMID:15805158	
P60484	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_026255;Note=In CWS1. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_026256;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. C->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_008735;Note=In CWS1. C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10400993,ECO:0000269|PubMed:11494117;Dbxref=dbSNP:rs587782343,PMID:10400993,PMID:11494117	
P60484	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_026257;Note=In CWS1 and glioblastoma%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. D->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9331071;Dbxref=PMID:10866302,PMID:9331071	
P60484	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_007807;Note=In CWS1 and LDD%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. L->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10051160,ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9600246;Dbxref=dbSNP:rs121909230,PMID:10051160,PMID:10866302,PMID:9600246	
P60484	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_026258;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. L->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_011588;Note=In multiple cancers. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10807691;Dbxref=dbSNP:rs139767111,PMID:10807691	
P60484	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_018103;Note=In HNSCC. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11801303;Dbxref=dbSNP:rs121909237,PMID:11801303	
P60484	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_026259;Note=In glioblastoma%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. A->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9331071;Dbxref=PMID:10866302,PMID:9331071	
P60484	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_007463;Note=In CWS1. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10234502,ECO:0000269|PubMed:9259288;Dbxref=dbSNP:rs121909222,PMID:10234502,PMID:9259288	
P60484	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_026260;Note=In endometrial cancer%3B loss of protein phosphatase activity. H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9256433;Dbxref=dbSNP:rs786204931,PMID:9256433	
P60484	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_007464;Note=In CWS1. C->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10234502,ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9259288;Dbxref=dbSNP:rs121909223,PMID:10234502,PMID:10866302,PMID:9259288	
P60484	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_018104;Note=In CWS1%3B phosphatase-dead protein with neither lipid nor protein phosphatase activity. C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11230179,ECO:0000269|PubMed:9811831;Dbxref=PMID:11230179,PMID:9811831	
P60484	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_076551;Note=In a patient with prostate cancer%3B reduced phosphatase activity towards PtdIns(3%2C4%2C5)%3B shifts its activity from phosphatidylinositol phosphate 3-phosphatase to phosphatidylinositol phosphate 5-phosphatase%3B disrupts PI3K/ATK signaling%3B reduced cell migration. A->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26504226;Dbxref=PMID:26504226	
P60484	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_007465;Note=In CWS1%3B no lipid phosphatase activity but retains protein phosphatase activity%3B retains ability to inhibit focal adhesion formation. G->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:11230179,ECO:0000269|PubMed:9140396,ECO:0000269|PubMed:9616126,ECO:0000269|PubMed:9811831;Dbxref=dbSNP:rs121909218,PMID:10866302,PMID:11230179,PMID:9140396,PMID:9616126,PMID:9811831	
P60484	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_007466;Note=In glioblastoma%3B severely reduced protein phosphatase activity%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9072974,ECO:0000269|PubMed:9256433,ECO:0000269|PubMed:9331071;Dbxref=dbSNP:rs786204929,PMID:10866302,PMID:9072974,PMID:9256433,PMID:9331071	
P60484	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_026261;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs121909224,PMID:10866302	
P60484	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_007467;Note=In CWS1 and endometrial hyperplasia%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes. R->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9635567;Dbxref=dbSNP:rs121909229,PMID:10866302,PMID:9635567	
P60484	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_007468;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9915974;Dbxref=dbSNP:rs121909229,PMID:10866302,PMID:9915974	
P60484	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_076762;Note=In MCEPHAS. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23160955;Dbxref=dbSNP:rs397514560,PMID:23160955	
P60484	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_032635;Note=In one patient with clinical findings suggesting hamartoma tumor syndrome. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16752378;Dbxref=dbSNP:rs121909241,PMID:16752378	
P60484	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_026262;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P3. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_007469;Note=In prostate cancer%3B no effect on protein phosphatase activity%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P3 but retains PtdIns(3%2C4%2C5)P3 phosphatase activity. M->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9072974,ECO:0000269|PubMed:9256433;Dbxref=PMID:10866302,PMID:9072974,PMID:9256433	
P60484	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_008736;Note=In CWS1. I->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10400993,ECO:0000269|PubMed:11494117;Dbxref=dbSNP:rs587782360,PMID:10400993,PMID:11494117	
P60484	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_007808;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P3. C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9735393;Dbxref=dbSNP:rs786204859,PMID:10866302,PMID:9735393	
P60484	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_008737;Note=In CWS1. A->AN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9345101;Dbxref=PMID:9345101	
P60484	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_026263;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs1060500126,PMID:10866302	
P60484	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_011589;Note=In multiple cancers. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10807691;Dbxref=PMID:10807691	
P60484	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_008739;Note=In CWS1. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10234502;Dbxref=PMID:10234502	
P60484	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_026264;Note=In glioblastoma%3B severely reduced protein phosphatase activity%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9256433,ECO:0000269|PubMed:9331071;Dbxref=dbSNP:rs587782603,PMID:10866302,PMID:9256433,PMID:9331071	
P60484	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_008738;Note=In CWS1. G->V;Dbxref=dbSNP:rs786204863	
P60484	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_076763;Note=In MCEPHAS. T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23160955;Dbxref=dbSNP:rs397514559,PMID:23160955	
P60484	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_026265;Note=In breast cancer%3B severely reduced protein phosphatase activity. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9256433;Dbxref=PMID:9256433	
P60484	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_026266;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_007470;Note=In CWS1%3B severely reduced protein phosphatase activity%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. S->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10400993,ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:11494117,ECO:0000269|PubMed:9241266,ECO:0000269|PubMed:9256433;Dbxref=dbSNP:rs121909221,PMID:10400993,PMID:10866302,PMID:11494117,PMID:9241266,PMID:9256433	
P60484	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_026267;Note=In endometrial hyperplasia%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3%3B retains ability to bind phospholipid membranes. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9635567;Dbxref=dbSNP:rs121913293,PMID:10866302,PMID:9635567	
P60484	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_026268;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs121913294,PMID:10866302	
P60484	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_026269;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs121913294,PMID:10866302	
P60484	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_026270;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. Y->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs587782316,PMID:10866302	
P60484	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_026271;Note=In endometrial hyperplasia. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9635567;Dbxref=PMID:9635567	
P60484	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_018105;Note=In malignant melanoma%3B somatic mutation. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10978354;Dbxref=dbSNP:rs121909234,PMID:10978354	
P60484	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_026272;Note=Reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 but retains PtdIns(3%2C4%2C5)P3 phosphatase activity. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs905615413,PMID:10866302	
P60484	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_018106;Note=In GLM2%3B the patient also suffered from benign meningioma%3B not capable of inducing apoptosis%3B induced increased cell proliferation%3B led to high constitutive AKT1 activation which could not be increased further by stimulation with insulin. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12085208;Dbxref=dbSNP:rs121909235,PMID:12085208	
P60484	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_032636;Note=In MCEPHAS. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15805158;Dbxref=dbSNP:rs121909240,PMID:15805158	
P60484	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_008740;Note=In CWS1. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10400993;Dbxref=dbSNP:rs587782350,PMID:10400993	
P60484	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_026273;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes. G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_032637;Note=In MCEPHAS. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15805158;Dbxref=dbSNP:rs121909239,PMID:15805158	
P60484	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_008741;Note=In CWS1%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes%3B predominantly nuclear. K->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:18716620,ECO:0000269|PubMed:9797362;Dbxref=dbSNP:rs562015640,PMID:10866302,PMID:18716620,PMID:9797362	
P60484	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_025167;Note=V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.10;Dbxref=dbSNP:rs35600253	
P60484	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_026274;Note=In glioma%3B reduced tumor suppressor activity%3B fails to inactivate AKT/PKB. Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10468583,ECO:0000269|PubMed:9090379;Dbxref=PMID:10468583,PMID:9090379	
P60484	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_026275;Note=In CWS1%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	341	341	.	.	.	ID=VAR_026276;Note=In CWS1%3B loss of interaction with NOP53%3B decreased phosphorylation at S-380%3B decreased stability%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. F->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:15355975;Dbxref=dbSNP:rs1554825652,PMID:10866302,PMID:15355975	
P60484	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_026277;Note=In CWS1%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 but PtdIns(3%2C4%2C5)P3 phosphatase activity is similar to wild-type. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=dbSNP:rs398123314,PMID:10866302	
P60484	UniProtKB	Natural variant	343	343	.	.	.	ID=VAR_008742;Note=In CWS1%3B loss of interaction with NOP53%3B decreased phosphorylation at S-380%3B decreased stability%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. V->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:15355975,ECO:0000269|PubMed:9399897;Dbxref=PMID:10866302,PMID:15355975,PMID:9399897	
P60484	UniProtKB	Natural variant	345	345	.	.	.	ID=VAR_026278;Note=In glioblastoma%3B reduced tumor suppressor activity%3B loss of interaction with NOP53%3B decreased phosphorylation at S-380%3B decreased stability%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B reduced ability to inactivate AKT/PKB%3B retains ability to bind phospholipid membranes. L->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10468583,ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:15355975,ECO:0000269|PubMed:9331071;Dbxref=PMID:10468583,PMID:10866302,PMID:15355975,PMID:9331071	
P60484	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_008743;Note=In CWS1%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4. F->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10866302,ECO:0000269|PubMed:9399897;Dbxref=PMID:10866302,PMID:9399897	
P60484	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_026279;Note=In endometrial hyperplasia%3B reduced phosphatase activity towards PtdIns(3%2C4%2C5)P3%3B mildly reduced tumor suppressor activity%3B reduced ability to inactivate AKT/PKB. T->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10468583,ECO:0000269|PubMed:9635567;Dbxref=PMID:10468583,PMID:9635567	
P60484	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_026280;Note=Retains Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3 phosphatase activity%3B retains ability to bind phospholipid membranes. V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Natural variant	401	401	.	.	.	ID=VAR_026281;Note=Retains Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3 phosphatase activity%3B retains ability to bind phospholipid membranes. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10866302;Dbxref=PMID:10866302	
P60484	UniProtKB	Mutagenesis	1	1	.	.	.	Note=Expression is restricted to isoform alpha. M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24768297;Dbxref=PMID:24768297	
P60484	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Nuclear. Cytoplasmic%3B when associated with E-289. Shows less tumor suppressive ability%3B when associated with E-289. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18716620;Dbxref=PMID:18716620	
P60484	UniProtKB	Mutagenesis	92	92	.	.	.	Note=700-fold reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3. Loss of protein phosphatase activity. Unable to inhibit focal adhesion formation. D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10555148,ECO:0000269|PubMed:9616126;Dbxref=PMID:10555148,PMID:9616126	
P60484	UniProtKB	Mutagenesis	93	93	.	.	.	Note=75%25 reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3. Modest reduction in phosphatase activity towards PtdIns(3%2C4)P2. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10555148;Dbxref=PMID:10555148	
P60484	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Loss of protein phosphatase activity. Unable to inhibit focal adhesion formation. C->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9616126;Dbxref=PMID:9616126	
P60484	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Reduced phosphatase activity towards PtdIns(3%2C4%2C5)P3%2C PtdIns(3%2C4)P2 and PtdIns(3)P. K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10555148;Dbxref=PMID:10555148	
P60484	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Does not reduce phosphatase activity towards PtdIns(3%2C4%2C5)P3 and PtdIns(3%2C4)P2. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26504226;Dbxref=PMID:26504226	
P60484	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Does not reduce phosphatase activity towards PtdIns(3%2C4%2C5)P3 and PtdIns(3%2C4)P2. A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26504226;Dbxref=PMID:26504226	
P60484	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Does not reduce phosphatase activity towards PtdIns(3%2C4%2C5)P3 and PtdIns(3%2C4)P2. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26504226;Dbxref=PMID:26504226	
P60484	UniProtKB	Mutagenesis	128	128	.	.	.	Note=85%25 reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3. K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10555148;Dbxref=PMID:10555148	
P60484	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Does not reduce phosphatase activity towards PtdIns(3%2C4%2C5)P3. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10555148;Dbxref=PMID:10555148	
P60484	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Does not affect the ability to inhibit AKT/PKB activation. R->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9811831;Dbxref=PMID:9811831	
P60484	UniProtKB	Mutagenesis	167	167	.	.	.	Note=60%25 reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3. T->A%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10555148;Dbxref=PMID:10555148	
P60484	UniProtKB	Mutagenesis	171	171	.	.	.	Note=75%25 reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3. Q->A%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10555148;Dbxref=PMID:10555148	
P60484	UniProtKB	Mutagenesis	263	269	.	.	.	Note=Reduces the growth suppression activity and cells show anchorage-independent growth. Reduces binding to phospholipid membranes in vitro. Phosphatase activity towards PtdIns(3%2C4%2C5)P3 is not affected. KMLKKDK->AAGAADA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10555148;Dbxref=PMID:10555148	
P60484	UniProtKB	Mutagenesis	289	289	.	.	.	Note=Cytoplasmic%3B when associated with E-13. Shows less tumor suppressive ability%3B when associated with E-13. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18716620;Dbxref=PMID:18716620	
P60484	UniProtKB	Mutagenesis	327	335	.	.	.	Note=Reduces growth suppression activity and promotes anchorage-independent growth. Reduces binding to phospholipid membranes in vitro%3B phosphatase activity towards PtdIns(3%2C4%2C5)P3 is not affected. KANKDKANR->AAGADAANA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10555148;Dbxref=PMID:10555148	
P60484	UniProtKB	Mutagenesis	336	336	.	.	.	Note=Significantly lower phosphatase activity%2C reduced protein stability and decreased growth-inhibitory effect. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19345329;Dbxref=PMID:19345329	
P60484	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Decreased stability. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20940307;Dbxref=PMID:20940307	
P60484	UniProtKB	Mutagenesis	370	370	.	.	.	Note=Decreased stability. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20940307;Dbxref=PMID:20940307	
P60484	UniProtKB	Mutagenesis	401	401	.	.	.	Note=Loss of DLG1-binding. No effect on MAGI2- and MAST2-binding. T->A	
P60484	UniProtKB	Mutagenesis	402	402	.	.	.	Note=No effect on MAGI2-%2C MAST2- and DLG1-binding. K->A	
P60484	UniProtKB	Mutagenesis	402	402	.	.	.	Note=Loss of DLG1-%2C MAGI2-%2C MAGI3- and MAST2-binding. Decrease of protein stability. K->W	
P60484	UniProtKB	Mutagenesis	403	403	.	.	.	Note=Loss of DLG1-%2C MAGI2-%2C MAGI3-%2C MAST1-%2C MAST2- and MAST3-binding. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15951562;Dbxref=PMID:15951562	
P60484	UniProtKB	Turn	19	22	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	23	29	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	32	35	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	39	41	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	44	47	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5BZZ	
P60484	UniProtKB	Helix	50	60	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	61	63	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	65	73	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	78	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5BZZ	
P60484	UniProtKB	Beta strand	81	83	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5BZZ	
P60484	UniProtKB	Beta strand	85	90	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	98	100	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	101	112	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Turn	113	115	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	118	123	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	125	128	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	129	141	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	148	159	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	161	163	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	169	184	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	192	202	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	206	209	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5BZZ	
P60484	UniProtKB	Beta strand	213	219	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	222	226	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	232	235	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	238	259	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	262	264	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5BZZ	
P60484	UniProtKB	Beta strand	268	276	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	277	279	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	280	284	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5BZZ	
P60484	UniProtKB	Beta strand	310	312	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5BZX	
P60484	UniProtKB	Beta strand	315	321	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	322	324	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Helix	328	330	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	335	337	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	342	349	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1D5R	
P60484	UniProtKB	Beta strand	395	403	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KYL	
##sequence-region Q13148 1 414
Q13148	UniProtKB	Chain	1	414	.	.	.	ID=PRO_0000081972;Note=TAR DNA-binding protein 43	
Q13148	UniProtKB	Domain	104	200	.	.	.	Note=RRM 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00176	
Q13148	UniProtKB	Domain	191	262	.	.	.	Note=RRM 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00176	
Q13148	UniProtKB	Region	216	414	.	.	.	Note=Interaction with UBQLN2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23541532;Dbxref=PMID:23541532	
Q13148	UniProtKB	Motif	82	98	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18957508;Dbxref=PMID:18957508	
Q13148	UniProtKB	Motif	239	250	.	.	.	Note=Nuclear export signal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18957508;Dbxref=PMID:18957508	
Q13148	UniProtKB	Compositional bias	274	413	.	.	.	Note=Gly-rich	
Q13148	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q13148	UniProtKB	Modified residue	292	292	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:19690332,PMID:23186163,PMID:24275569	
Q13148	UniProtKB	Modified residue	293	293	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q13148	UniProtKB	Cross-link	79	79	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13148	UniProtKB	Cross-link	84	84	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13148	UniProtKB	Cross-link	95	95	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13148	UniProtKB	Cross-link	102	102	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25772364;Dbxref=PMID:25772364	
Q13148	UniProtKB	Cross-link	181	181	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25772364,PMID:28112733	
Q13148	UniProtKB	Cross-link	263	263	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q13148	UniProtKB	Alternative sequence	1	18	.	.	.	ID=VSP_056406;Note=In isoform 2. MSEYIRVTEDENDEPIEI->MPQMLAGEIWCMLSTIQK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q13148	UniProtKB	Alternative sequence	19	134	.	.	.	ID=VSP_056407;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q13148	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_045656;Note=A->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18309045,ECO:0000269|PubMed:18372902,ECO:0000269|PubMed:22456481;Dbxref=dbSNP:rs80356715,PMID:18309045,PMID:18372902,PMID:22456481	
Q13148	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_045657;Note=In ALS10. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18372902;Dbxref=dbSNP:rs80356717,PMID:18372902	
Q13148	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_058611;Note=In ALS10%3B also in a patient with frontotemporal dementia. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356718,PMID:19224587	
Q13148	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045658;Note=In ALS10. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18372902,ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356719,PMID:18372902,PMID:19224587	
Q13148	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_045659;Note=In ALS10. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18396105;Dbxref=dbSNP:rs121908395,PMID:18396105	
Q13148	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045660;Note=In ALS10. G->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18309045,ECO:0000269|PubMed:19695877;Dbxref=dbSNP:rs80356721,PMID:18309045,PMID:19695877	
Q13148	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_058612;Note=In ALS10%3B a patient with bulbar signs and dementia. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356721,PMID:19224587	
Q13148	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_058613;Note=In ALS10. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356723,PMID:19224587	
Q13148	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_058614;Note=In ALS10%3B also in patients with frontotemporal lobar degeneration with motor neuron disease. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356723,PMID:19224587	
Q13148	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045661;Note=In ALS10. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18396105;Dbxref=dbSNP:rs4884357,PMID:18396105	
Q13148	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_045662;Note=In ALS10. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18288693,ECO:0000269|PubMed:18372902;Dbxref=dbSNP:rs80356726,PMID:18288693,PMID:18372902	
Q13148	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_045663;Note=In ALS10%3B impedes the development of normal limb and tail buds and increases the number of apoptotic nuclei when expressed in chick embryos%3B does not affect the interaction with ATNX2. Q->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18309045,ECO:0000269|PubMed:20740007;Dbxref=dbSNP:rs80356727,PMID:18309045,PMID:20740007	
Q13148	UniProtKB	Natural variant	332	332	.	.	.	ID=VAR_058615;Note=In ALS10. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356728,PMID:19224587	
Q13148	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_058616;Note=In ALS10. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356729,PMID:19224587	
Q13148	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_045664;Note=In ALS10%3B impedes the development of normal limb and tail buds and increases the number of apoptotic nuclei when expressed in chick embryos. M->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18309045,ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356730,PMID:18309045,PMID:19224587	
Q13148	UniProtKB	Natural variant	343	343	.	.	.	ID=VAR_062767;Note=In ALS10. Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18438952;Dbxref=dbSNP:rs80356731,PMID:18438952	
Q13148	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_045665;Note=In ALS10. G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18372902;Dbxref=dbSNP:rs80356733,PMID:18372902	
Q13148	UniProtKB	Natural variant	357	357	.	.	.	ID=VAR_067499;Note=In ALS10. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22456481;Dbxref=PMID:22456481	
Q13148	UniProtKB	Natural variant	361	361	.	.	.	ID=VAR_045666;Note=In ALS10. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18372902;Dbxref=dbSNP:rs80356735,PMID:18372902	
Q13148	UniProtKB	Natural variant	361	361	.	.	.	ID=VAR_067500;Note=In ALS10. R->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22456481;Dbxref=PMID:22456481	
Q13148	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_058617;Note=In ALS10. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356739,PMID:19224587	
Q13148	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_058618;Note=In ALS10. S->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19224587,ECO:0000269|PubMed:22456481;Dbxref=dbSNP:rs80356738,PMID:19224587,PMID:22456481	
Q13148	UniProtKB	Natural variant	382	382	.	.	.	ID=VAR_045667;Note=In ALS10. A->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18372902,ECO:0000269|PubMed:19224587,ECO:0000269|PubMed:21220647,ECO:0000269|PubMed:21418058;Dbxref=dbSNP:rs367543041,PMID:18372902,PMID:19224587,PMID:21220647,PMID:21418058	
Q13148	UniProtKB	Natural variant	390	390	.	.	.	ID=VAR_045668;Note=In ALS10. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18372902;Dbxref=dbSNP:rs80356741,PMID:18372902	
Q13148	UniProtKB	Natural variant	390	390	.	.	.	ID=VAR_045669;Note=In ALS10. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18372902;Dbxref=dbSNP:rs80356742,PMID:18372902	
Q13148	UniProtKB	Natural variant	393	393	.	.	.	ID=VAR_058619;Note=In ALS10. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19224587;Dbxref=dbSNP:rs80356743,PMID:19224587	
Q13148	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Complete loss of self-oligomerization. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29438978;Dbxref=PMID:29438978	
Q13148	UniProtKB	Mutagenesis	106	175	.	.	.	Note=Completely abolishes RNA binding. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11470789;Dbxref=PMID:11470789	
Q13148	UniProtKB	Mutagenesis	106	111	.	.	.	Note=Completely abolishes RNA binding. LIVLGL->DIDLGD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11470789;Dbxref=PMID:11470789	
Q13148	UniProtKB	Mutagenesis	106	111	.	.	.	Note=Completely abolishes RNA binding. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11470789;Dbxref=PMID:11470789	
Q13148	UniProtKB	Mutagenesis	147	149	.	.	.	Note=Highly reduces binding to RNA and DNA. FGF->LGL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11470789;Dbxref=PMID:11470789	
Q13148	UniProtKB	Mutagenesis	193	257	.	.	.	Note=Alters but does not abolish RNA binding. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11470789;Dbxref=PMID:11470789	
Q13148	UniProtKB	Sequence conflict	200	200	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q13148	UniProtKB	Sequence conflict	278	278	.	.	.	Note=G->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q13148	UniProtKB	Beta strand	4	10	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Beta strand	16	19	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Beta strand	22	24	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2N4P	
Q13148	UniProtKB	Beta strand	25	27	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5X4F	
Q13148	UniProtKB	Helix	28	32	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Beta strand	33	37	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5X4F	
Q13148	UniProtKB	Beta strand	40	44	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Turn	46	48	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Beta strand	50	53	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Beta strand	55	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Beta strand	60	62	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Beta strand	65	67	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5X4F	
Q13148	UniProtKB	Turn	69	71	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6B1G	
Q13148	UniProtKB	Beta strand	72	76	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5MDI	
Q13148	UniProtKB	Beta strand	106	110	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Helix	117	124	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Turn	125	127	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Beta strand	130	137	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Turn	139	141	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Beta strand	144	154	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Helix	155	162	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Beta strand	166	168	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Beta strand	171	176	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4Y0F	
Q13148	UniProtKB	Beta strand	193	197	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Beta strand	200	202	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Helix	204	210	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Turn	212	214	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Beta strand	219	221	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Beta strand	231	233	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Helix	237	242	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Turn	243	245	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Beta strand	247	250	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Beta strand	253	258	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1WF0	
Q13148	UniProtKB	Beta strand	263	265	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4BS2	
Q13148	UniProtKB	Beta strand	296	304	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6N3C	
Q13148	UniProtKB	Beta strand	306	318	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6N3C	
Q13148	UniProtKB	Beta strand	321	323	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6N3A	
Q13148	UniProtKB	Beta strand	334	342	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6CFH	
Q13148	UniProtKB	Turn	343	346	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2N3X	
Q13148	UniProtKB	Beta strand	348	350	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2N3X	
Q13148	UniProtKB	Beta strand	352	359	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6N3A	
##sequence-region P63165 1 101
P63165	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000269|PubMed:20388717;Dbxref=PMID:19413330,PMID:20068231,PMID:21406692,PMID:20388717	
P63165	UniProtKB	Chain	2	97	.	.	.	ID=PRO_0000035939;Note=Small ubiquitin-related modifier 1	
P63165	UniProtKB	Propeptide	98	101	.	.	.	ID=PRO_0000035940;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15487983;Dbxref=PMID:15487983	
P63165	UniProtKB	Domain	20	97	.	.	.	Note=Ubiquitin-like;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00214	
P63165	UniProtKB	Site	36	36	.	.	.	Note=Interaction with PIAS2	
P63165	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000269|PubMed:20388717;Dbxref=PMID:19413330,PMID:20068231,PMID:21406692,PMID:20388717	
P63165	UniProtKB	Modified residue	2	2	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:18707152;Dbxref=PMID:17081983,PMID:18691976,PMID:20068231,PMID:21406692,PMID:23186163,PMID:18707152	
P63165	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P63165	UniProtKB	Modified residue	32	32	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P63165	UniProtKB	Cross-link	7	7	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate	
P63165	UniProtKB	Cross-link	7	7	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25755297,PMID:25772364,PMID:28112733	
P63165	UniProtKB	Cross-link	16	16	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:28112733	
P63165	UniProtKB	Cross-link	17	17	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25218447,ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25218447,PMID:25772364,PMID:28112733	
P63165	UniProtKB	Cross-link	23	23	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P63165	UniProtKB	Cross-link	25	25	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)	
P63165	UniProtKB	Cross-link	37	37	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25755297,ECO:0000244|PubMed:28112733;Dbxref=PMID:25755297,PMID:28112733	
P63165	UniProtKB	Cross-link	39	39	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P63165	UniProtKB	Cross-link	45	45	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P63165	UniProtKB	Cross-link	46	46	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P63165	UniProtKB	Cross-link	97	97	.	.	.	Note=Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)	
P63165	UniProtKB	Alternative sequence	4	28	.	.	.	ID=VSP_046756;Note=In isoform 2. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P63165	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Abolishes binding to PIAS2. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16204249;Dbxref=PMID:16204249	
P63165	UniProtKB	Sequence conflict	75	75	.	.	.	Note=H->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P63165	UniProtKB	Beta strand	2	6	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1A5R	
P63165	UniProtKB	Turn	9	11	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1A5R	
P63165	UniProtKB	Turn	16	18	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KQS	
P63165	UniProtKB	Beta strand	22	27	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4WJQ	
P63165	UniProtKB	Beta strand	29	31	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1Z5S	
P63165	UniProtKB	Beta strand	33	38	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4WJQ	
P63165	UniProtKB	Beta strand	40	42	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2PE6	
P63165	UniProtKB	Helix	45	55	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4WJQ	
P63165	UniProtKB	Helix	59	61	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4WJQ	
P63165	UniProtKB	Beta strand	62	66	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4WJQ	
P63165	UniProtKB	Beta strand	69	71	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5B7A	
P63165	UniProtKB	Helix	77	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4WJQ	
P63165	UniProtKB	Beta strand	87	92	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4WJQ	
P63165	UniProtKB	Beta strand	96	99	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2N1A	
##sequence-region P12931 1 536
P12931	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
P12931	UniProtKB	Chain	2	536	.	.	.	ID=PRO_0000088141;Note=Proto-oncogene tyrosine-protein kinase Src	
P12931	UniProtKB	Domain	84	145	.	.	.	Note=SH3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00192	
P12931	UniProtKB	Domain	151	248	.	.	.	Note=SH2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00191	
P12931	UniProtKB	Domain	270	523	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
P12931	UniProtKB	Nucleotide binding	276	284	.	.	.	Note=ATP	
P12931	UniProtKB	Active site	389	389	.	.	.	Note=Proton acceptor	
P12931	UniProtKB	Binding site	298	298	.	.	.	Note=ATP	
P12931	UniProtKB	Modified residue	17	17	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18088087,ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18088087,PMID:19369195,PMID:23186163,PMID:24275569	
P12931	UniProtKB	Modified residue	75	75	.	.	.	Note=Phosphoserine%3B by CDK5;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:21442427;Dbxref=PMID:23186163,PMID:21442427	
P12931	UniProtKB	Modified residue	187	187	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P05480	
P12931	UniProtKB	Modified residue	419	419	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14661060,ECO:0000269|PubMed:18936167,ECO:0000269|PubMed:19307596,ECO:0000269|PubMed:26936507,ECO:0000269|PubMed:6273838;Dbxref=PMID:14661060,PMID:18936167,PMID:19307596,PMID:26936507,PMID:6273838	
P12931	UniProtKB	Modified residue	419	419	.	.	.	Note=Phosphotyrosine%3B by FAK2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P12931	UniProtKB	Modified residue	530	530	.	.	.	Note=Phosphotyrosine%3B by CSK;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19369195,ECO:0000269|PubMed:19307596,ECO:0000269|PubMed:26936507,ECO:0000269|PubMed:7525268,ECO:0000269|PubMed:7929427;Dbxref=PMID:19369195,PMID:19307596,PMID:26936507,PMID:7525268,PMID:7929427	
P12931	UniProtKB	Lipidation	2	2	.	.	.	Note=N-myristoyl glycine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7525268;Dbxref=PMID:7525268	
P12931	UniProtKB	Alternative sequence	117	117	.	.	.	ID=VSP_012134;Note=In isoform 2. T->TRKVDVR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:2681803;Dbxref=PMID:2681803	
P12931	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_051699;Note=L->F;Dbxref=dbSNP:rs6018260	
P12931	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_041830;Note=A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs34881773,PMID:17344846	
P12931	UniProtKB	Natural variant	527	527	.	.	.	ID=VAR_076919;Note=In THC6%3B increased protein tyrosine kinase activity%3B increased autophosphorylation at Y-419%3B causes defective megakaryopoiesis associated with increased overall tyrosine phosphorylation in megakaryocytes. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26936507;Dbxref=dbSNP:rs879255268,PMID:26936507	
P12931	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Kinase inactive. Abolishes ubiquitination promoted by CBLC. K->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14661060;Dbxref=PMID:14661060	
P12931	UniProtKB	Mutagenesis	302	302	.	.	.	Note=Kinase active. Interacts with PDLIM4%3B when associated with E-307 and F-419. P->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19307596;Dbxref=PMID:19307596	
P12931	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Kinase active. Interacts with PDLIM4%3B when associated with E-302 and F-419. P->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19307596;Dbxref=PMID:19307596	
P12931	UniProtKB	Mutagenesis	419	419	.	.	.	Note=Loss of kinase activity. Loss of interaction with PDLIM4. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19307596;Dbxref=PMID:19307596	
P12931	UniProtKB	Beta strand	87	93	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	99	102	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	110	114	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	118	126	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Turn	127	129	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	132	136	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	137	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	140	142	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	146	148	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	152	154	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	158	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	167	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1SHD	
P12931	UniProtKB	Beta strand	174	179	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	181	183	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	187	195	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Turn	196	198	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	199	209	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	211	213	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2SRC	
P12931	UniProtKB	Beta strand	215	218	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	221	225	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	226	233	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	240	242	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	256	259	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	267	269	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	270	278	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	280	282	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6ATE	
P12931	UniProtKB	Beta strand	283	289	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Turn	290	292	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	293	299	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Turn	302	304	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2BDF	
P12931	UniProtKB	Helix	307	319	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	328	332	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	334	336	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	338	341	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	345	348	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6ATE	
P12931	UniProtKB	Helix	349	353	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	355	358	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	363	382	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	392	394	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	395	397	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	399	401	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Beta strand	403	405	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	410	413	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2SRC	
P12931	UniProtKB	Helix	417	420	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2SRC	
P12931	UniProtKB	Turn	423	426	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1Y57	
P12931	UniProtKB	Helix	429	431	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	434	439	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	444	459	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Turn	460	462	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	471	479	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	492	501	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	506	508	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Helix	512	520	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
P12931	UniProtKB	Turn	521	523	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FMK	
##sequence-region P46937 1 504
P46937	UniProtKB	Chain	1	504	.	.	.	ID=PRO_0000076071;Note=Transcriptional coactivator YAP1	
P46937	UniProtKB	Domain	171	204	.	.	.	Note=WW 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00224	
P46937	UniProtKB	Domain	230	263	.	.	.	Note=WW 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00224	
P46937	UniProtKB	Region	291	504	.	.	.	Note=Transactivation domain	
P46937	UniProtKB	Coiled coil	86	100	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123905;Dbxref=PMID:20123905	
P46937	UniProtKB	Coiled coil	298	359	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
P46937	UniProtKB	Compositional bias	3	49	.	.	.	Note=Pro-rich	
P46937	UniProtKB	Modified residue	61	61	.	.	.	Note=Phosphoserine%3B by LATS1 and LATS2;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:17974916,ECO:0000269|PubMed:18158288;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163,PMID:17974916,PMID:18158288	
P46937	UniProtKB	Modified residue	63	63	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
P46937	UniProtKB	Modified residue	105	105	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q2EJA0	
P46937	UniProtKB	Modified residue	109	109	.	.	.	Note=Phosphoserine%3B by LATS1 and LATS2;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:17974916,ECO:0000269|PubMed:18158288;Dbxref=PMID:20068231,PMID:23186163,PMID:17974916,PMID:18158288	
P46937	UniProtKB	Modified residue	110	110	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q2EJA0	
P46937	UniProtKB	Modified residue	119	119	.	.	.	Note=Phosphothreonine%3B by MAPK8 and MAPK9;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:21364637;Dbxref=PMID:20068231,PMID:23186163,PMID:21364637	
P46937	UniProtKB	Modified residue	127	127	.	.	.	Note=Phosphoserine%3B by LATS1 and LATS2;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000269|PubMed:17974916,ECO:0000269|PubMed:18158288,ECO:0000269|PubMed:20048001,ECO:0000269|PubMed:28169360;Dbxref=PMID:18669648,PMID:17974916,PMID:18158288,PMID:20048001,PMID:28169360	
P46937	UniProtKB	Modified residue	128	128	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
P46937	UniProtKB	Modified residue	131	131	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:24275569	
P46937	UniProtKB	Modified residue	138	138	.	.	.	Note=Phosphoserine%3B by MAPK8 and MAPK9;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:21364637;Dbxref=PMID:18669648,PMID:20068231,PMID:21364637	
P46937	UniProtKB	Modified residue	154	154	.	.	.	Note=Phosphothreonine%3B by MAPK8 and MAPK9;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000269|PubMed:21364637;Dbxref=PMID:18669648,PMID:21364637	
P46937	UniProtKB	Modified residue	164	164	.	.	.	Note=Phosphoserine%3B by LATS1 and LATS2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17974916,ECO:0000269|PubMed:18158288;Dbxref=PMID:17974916,PMID:18158288	
P46937	UniProtKB	Modified residue	274	274	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231;Dbxref=PMID:18669648,PMID:20068231	
P46937	UniProtKB	Modified residue	289	289	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163	
P46937	UniProtKB	Modified residue	367	367	.	.	.	Note=Phosphoserine%3B by MAPK8 and MAPK9;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000269|PubMed:21364637;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692,PMID:21364637	
P46937	UniProtKB	Modified residue	371	371	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:17525332;Dbxref=PMID:17525332	
P46937	UniProtKB	Modified residue	381	381	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P46937	UniProtKB	Modified residue	382	382	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P46937	UniProtKB	Modified residue	388	388	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
P46937	UniProtKB	Modified residue	397	397	.	.	.	Note=Phosphoserine%3B by LATS1 and LATS2;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17974916,ECO:0000269|PubMed:18158288,ECO:0000269|PubMed:20048001,ECO:0000269|PubMed:28169360;Dbxref=PMID:17974916,PMID:18158288,PMID:20048001,PMID:28169360	
P46937	UniProtKB	Modified residue	400	400	.	.	.	Note=Phosphoserine%3B by CK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20048001;Dbxref=PMID:20048001	
P46937	UniProtKB	Modified residue	403	403	.	.	.	Note=Phosphoserine%3B by CK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20048001;Dbxref=PMID:20048001	
P46937	UniProtKB	Modified residue	407	407	.	.	.	Note=Phosphotyrosine%3B by ABL1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18280240;Dbxref=PMID:18280240	
P46937	UniProtKB	Modified residue	412	412	.	.	.	Note=Phosphothreonine%3B by MAPK8 and MAPK9;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21364637;Dbxref=PMID:21364637	
P46937	UniProtKB	Alternative sequence	1	178	.	.	.	ID=VSP_045190;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P46937	UniProtKB	Alternative sequence	230	267	.	.	.	ID=VSP_039053;Note=In isoform 3%2C isoform 5%2C isoform 6 and isoform 7. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:22939869,ECO:0000303|Ref.3;Dbxref=PMID:22939869	
P46937	UniProtKB	Alternative sequence	328	343	.	.	.	ID=VSP_039054;Note=In isoform 2 and isoform 5. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12807903;Dbxref=PMID:12807903	
P46937	UniProtKB	Alternative sequence	328	328	.	.	.	ID=VSP_053483;Note=In isoform 7 and isoform 9. Q->QVRPQ;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:22939869;Dbxref=PMID:22939869	
P46937	UniProtKB	Alternative sequence	329	343	.	.	.	ID=VSP_039055;Note=In isoform 3 and isoform 8. AMRNINPSTANSPKC->VRP;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:22939869;Dbxref=PMID:22939869	
P46937	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_071125;Note=P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462371;Dbxref=dbSNP:rs1162286204,PMID:24462371	
P46937	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_071126;Note=S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462371;Dbxref=dbSNP:rs376161041,PMID:24462371	
P46937	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_071127;Note=M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462371;Dbxref=dbSNP:rs777949318,PMID:24462371	
P46937	UniProtKB	Natural variant	462	462	.	.	.	ID=VAR_071128;Note=G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24462371;Dbxref=PMID:24462371	
P46937	UniProtKB	Mutagenesis	61	61	.	.	.	Note=In YAP-4SA%3B prevents phosphorylation by LATS1 and LATS2%2C promoting retention in the nucleus%3B when associated with A-109%3B A-127 and A-164. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20048001;Dbxref=PMID:20048001	
P46937	UniProtKB	Mutagenesis	80	80	.	.	.	Note=No change in interaction with TEAD4. Reduced interaction with TEAD4 and transforming ability%3B when associated with A-84 and A-85. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123908;Dbxref=PMID:20123908	
P46937	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Reduced interaction with TEAD4 and transforming ability%3B when associated with A-80 and A-85. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123908;Dbxref=PMID:20123908	
P46937	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Reduced interaction with TEAD4 and transforming ability%3B when associated with A-80 and A-84. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123908;Dbxref=PMID:20123908	
P46937	UniProtKB	Mutagenesis	86	86	.	.	.	Note=Complete loss of interaction with TEAD1. M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123905;Dbxref=PMID:20123905	
P46937	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Complete loss of interaction with TEAD1. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123905;Dbxref=PMID:20123905	
P46937	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Complete loss of interaction with TEAD1. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123905;Dbxref=PMID:20123905	
P46937	UniProtKB	Mutagenesis	94	94	.	.	.	Note=Loss of interaction with TEAD1%2C TEAD2%2C TEAD3 and TEAD4. Loss of transcriptional coactivation activity towards TEAD1%2C TEAD2%2C TEAD3 and TEAD4 but no effect on its activity towards RUNX2 and ERBB4. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18579750,ECO:0000269|PubMed:20123905;Dbxref=PMID:18579750,PMID:20123905	
P46937	UniProtKB	Mutagenesis	95	95	.	.	.	Note=Complete loss of interaction with TEAD1. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123905;Dbxref=PMID:20123905	
P46937	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Loss of interaction with TEAD1. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20123905;Dbxref=PMID:20123905	
P46937	UniProtKB	Mutagenesis	109	109	.	.	.	Note=In YAP-4SA%3B prevents phosphorylation by LATS1 and LATS2%2C promoting retention in the nucleus%3B when associated with A-61%3B A-127 and A-164. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20048001;Dbxref=PMID:20048001	
P46937	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Loss of phosphorylation by LATS1. H->A%2CR%2CN%2CK;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17974916,ECO:0000269|PubMed:18158288;Dbxref=PMID:17974916,PMID:18158288	
P46937	UniProtKB	Mutagenesis	122	122	.	.	.	Note=Significantly decreased phosphorylation at S-127 and decreased interaction with YWHAB. H->L%2CY;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17974916,ECO:0000269|PubMed:18158288;Dbxref=PMID:17974916,PMID:18158288	
P46937	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Loss of phosphorylation by LATS1. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18158288;Dbxref=PMID:18158288	
P46937	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Reduced phosphorylation by LATS2%2C loss of phosphorylation by LATS1%2C loss of interaction with YWHAB%2C decreased interaction with ERBB4 and increased nuclear localization and transcriptional coactivation activity toward ERBB4. In YAP-4SA%3B prevents phosphorylation by LATS1 and LATS2%2C promoting retention in the nucleus%3B when associated with A-61%3B A-109%3B A-127 and A-164. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12807903,ECO:0000269|PubMed:17974916,ECO:0000269|PubMed:18158288,ECO:0000269|PubMed:20048001;Dbxref=PMID:12807903,PMID:17974916,PMID:18158288,PMID:20048001	
P46937	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No effect on phosphorylation but loss of interaction with YWHAB. P->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17974916;Dbxref=PMID:17974916	
P46937	UniProtKB	Mutagenesis	164	164	.	.	.	Note=In YAP-4SA%3B prevents phosphorylation by LATS1 and LATS2%2C promoting retention in the nucleus%3B when associated with A-61%3B A-109 and A-127. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20048001;Dbxref=PMID:20048001	
P46937	UniProtKB	Mutagenesis	199	199	.	.	.	Note=Loss of interaction with ERBB4 and loss of transcriptional coactivation function toward CTF%3B when associated with A-202. W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12807903;Dbxref=PMID:12807903	
P46937	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Loss of interaction with ERBB4 and loss of transcriptional coactivation function toward CTF%3B when associated with A-199. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12807903;Dbxref=PMID:12807903	
P46937	UniProtKB	Mutagenesis	397	397	.	.	.	Note=Loss of phosphorylation by LATS1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18158288;Dbxref=PMID:18158288	
P46937	UniProtKB	Mutagenesis	407	407	.	.	.	Note=Enhanced interaction with TP73. Y->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18280240;Dbxref=PMID:18280240	
P46937	UniProtKB	Mutagenesis	407	407	.	.	.	Note=No phosphorylation by ABL1 and partial loss of binding to TP73. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18280240;Dbxref=PMID:18280240	
P46937	UniProtKB	Beta strand	52	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RE1	
P46937	UniProtKB	Helix	65	73	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GEI	
P46937	UniProtKB	Helix	75	77	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GEI	
P46937	UniProtKB	Helix	86	88	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GEI	
P46937	UniProtKB	Helix	93	95	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6GEI	
P46937	UniProtKB	Beta strand	169	171	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1K9Q	
P46937	UniProtKB	Beta strand	177	181	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4REX	
P46937	UniProtKB	Beta strand	183	185	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1K9Q	
P46937	UniProtKB	Beta strand	187	191	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4REX	
P46937	UniProtKB	Turn	192	195	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4REX	
P46937	UniProtKB	Beta strand	196	200	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4REX	
P46937	UniProtKB	Helix	202	206	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4REX	
P46937	UniProtKB	Beta strand	233	235	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LAW	
P46937	UniProtKB	Beta strand	238	241	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LAW	
P46937	UniProtKB	Turn	242	244	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LAW	
P46937	UniProtKB	Beta strand	245	250	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LAW	
P46937	UniProtKB	Turn	251	254	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LAW	
P46937	UniProtKB	Beta strand	255	259	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LAW	
P46937	UniProtKB	Beta strand	261	263	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5YDY	
##sequence-region P13574 1 688
P13574	UniProtKB	Chain	1	688	.	.	.	ID=PRO_0000072262;Note=Protein STE12	
P13574	UniProtKB	DNA binding	57	167	.	.	.	.	
P13574	UniProtKB	Modified residue	29	29	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17330950,ECO:0000244|PubMed:18407956;Dbxref=PMID:17330950,PMID:18407956	
P13574	UniProtKB	Modified residue	214	214	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19779198;Dbxref=PMID:19779198	
P13574	UniProtKB	Modified residue	226	226	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17330950,ECO:0000244|PubMed:18407956,ECO:0000244|PubMed:19779198;Dbxref=PMID:17330950,PMID:18407956,PMID:19779198	
P13574	UniProtKB	Modified residue	289	289	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18407956;Dbxref=PMID:18407956	
P13574	UniProtKB	Modified residue	400	400	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17330950,ECO:0000244|PubMed:19779198;Dbxref=PMID:17330950,PMID:19779198	
##sequence-region P03437 1 566
P03437	UniProtKB	Signal peptide	1	16	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Chain	17	566	.	.	.	ID=PRO_0000440411;Note=Hemagglutinin;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Chain	17	344	.	.	.	ID=PRO_0000038885;Note=Hemagglutinin HA1 chain	
P03437	UniProtKB	Chain	346	566	.	.	.	ID=PRO_0000038886;Note=Hemagglutinin HA2 chain;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Topological domain	17	530	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Transmembrane	531	551	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Topological domain	552	566	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Site	345	346	.	.	.	Note=Cleavage%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Lipidation	555	555	.	.	.	Note=S-palmitoyl cysteine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Lipidation	562	562	.	.	.	Note=S-palmitoyl cysteine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Lipidation	565	565	.	.	.	Note=S-palmitoyl cysteine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Glycosylation	24	24	.	.	.	Note=N-linked (GlcNAc...) asparagine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Glycosylation	38	38	.	.	.	Note=N-linked (GlcNAc...) asparagine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Glycosylation	54	54	.	.	.	Note=N-linked (GlcNAc...) asparagine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Glycosylation	97	97	.	.	.	Note=N-linked (GlcNAc...) asparagine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Glycosylation	181	181	.	.	.	Note=N-linked (GlcNAc...) asparagine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Glycosylation	301	301	.	.	.	Note=N-linked (GlcNAc...) asparagine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Glycosylation	499	499	.	.	.	Note=N-linked (GlcNAc...) asparagine%3B by host;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Disulfide bond	30	482	.	.	.	Note=Interchain (between HA1 and HA2 chains);Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Disulfide bond	68	293	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Disulfide bond	80	92	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Disulfide bond	113	155	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Disulfide bond	297	321	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Disulfide bond	489	493	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_04072	
P03437	UniProtKB	Sequence conflict	14	14	.	.	.	Note=A->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P03437	UniProtKB	Sequence conflict	15	15	.	.	.	Note=L->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P03437	UniProtKB	Sequence conflict	160	160	.	.	.	Note=G->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P03437	UniProtKB	Sequence conflict	198	198	.	.	.	Note=I->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P03437	UniProtKB	Sequence conflict	240	240	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P03437	UniProtKB	Sequence conflict	477	477	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P03437	UniProtKB	Beta strand	27	35	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Beta strand	40	42	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Beta strand	50	53	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Beta strand	55	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Beta strand	65	68	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	70	72	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	74	76	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Helix	82	87	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Helix	90	95	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	101	105	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	116	118	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Helix	121	131	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	136	138	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Turn	144	146	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HA0	
P03437	UniProtKB	Beta strand	152	157	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	160	162	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	167	169	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	171	173	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	180	185	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	188	190	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	192	200	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Helix	204	211	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	212	215	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	217	221	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	226	229	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	239	241	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6N5E	
P03437	UniProtKB	Beta strand	245	253	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	258	265	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	267	275	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	282	285	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	290	292	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	296	299	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	302	304	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	308	311	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	318	320	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6E56	
P03437	UniProtKB	Beta strand	331	333	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Beta strand	337	339	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HA0	
P03437	UniProtKB	Turn	352	354	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Beta strand	366	373	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Beta strand	376	382	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Helix	383	449	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1QU1	
P03437	UniProtKB	Beta strand	455	457	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HTM	
P03437	UniProtKB	Helix	458	470	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1QU1	
P03437	UniProtKB	Helix	472	474	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Beta strand	475	479	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1QU1	
P03437	UniProtKB	Beta strand	485	487	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1KEN	
P03437	UniProtKB	Helix	491	499	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1QU1	
P03437	UniProtKB	Helix	504	515	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2VIU	
P03437	UniProtKB	Turn	516	519	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HGG	
P03437	UniProtKB	Beta strand	524	526	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1QU1	
##sequence-region P11436 1 346
P11436	UniProtKB	Chain	1	346	.	.	.	ID=PRO_0000204060;Note=Aliphatic amidase	
P11436	UniProtKB	Domain	13	260	.	.	.	Note=CN hydrolase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00054	
P11436	UniProtKB	Active site	59	59	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P11436	UniProtKB	Active site	134	134	.	.	.	Note=Proton donor;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P11436	UniProtKB	Active site	166	166	.	.	.	Note=Nucleophile;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P11436	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Loss of activity. E->Q%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11955282;Dbxref=PMID:11955282	
P11436	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Loss of activity. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11955282;Dbxref=PMID:11955282	
P11436	UniProtKB	Mutagenesis	134	134	.	.	.	Note=200-fold reduction in activity. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11955282;Dbxref=PMID:11955282	
P11436	UniProtKB	Mutagenesis	166	166	.	.	.	Note=Loss of activity. C->S%2CA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10359655;Dbxref=PMID:10359655	
P11436	UniProtKB	Sequence conflict	40	40	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P11436	UniProtKB	Sequence conflict	169	169	.	.	.	Note=G->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P11436	UniProtKB	Sequence conflict	317	317	.	.	.	Note=E->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P11436	UniProtKB	Beta strand	12	18	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	28	48	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	52	56	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Turn	59	63	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	69	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	79	81	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	82	94	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	97	105	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Turn	108	111	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	116	122	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	128	133	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Turn	139	141	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	156	158	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	160	165	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	166	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	172	180	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	184	190	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	197	211	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	214	219	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	221	223	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	228	230	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	234	236	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	242	245	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	253	259	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	260	269	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	275	278	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	284	289	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	303	310	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Helix	312	322	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
P11436	UniProtKB	Beta strand	325	328	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2UXY	
##sequence-region Q9UK59 1 544
Q9UK59	UniProtKB	Chain	1	544	.	.	.	ID=PRO_0000250358;Note=Lariat debranching enzyme	
Q9UK59	UniProtKB	Modified residue	128	128	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q9UK59	UniProtKB	Modified residue	464	464	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q9UK59	UniProtKB	Modified residue	474	474	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9UK59	UniProtKB	Modified residue	478	478	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9UK59	UniProtKB	Modified residue	479	479	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9UK59	UniProtKB	Modified residue	485	485	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q923B1	
Q9UK59	UniProtKB	Modified residue	499	499	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q923B1	
Q9UK59	UniProtKB	Modified residue	514	514	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:17081983,PMID:20068231,PMID:21406692,PMID:23186163	
Q9UK59	UniProtKB	Alternative sequence	1	232	.	.	.	ID=VSP_020631;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9UK59	UniProtKB	Alternative sequence	233	237	.	.	.	ID=VSP_020632;Note=In isoform 2. ALMQH->MIHIV;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9UK59	UniProtKB	Sequence conflict	308	308	.	.	.	Note=N->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9UK59	UniProtKB	Sequence conflict	496	496	.	.	.	Note=T->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
##sequence-region I6TAH8 1 498
I6TAH8	UniProtKB	Region	1	21	.	.	.	Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite	
I6TAH8	UniProtKB	Motif	1	18	.	.	.	Note=Unconventional nuclear localization signal;Ontology_term=ECO:0000256;evidence=ECO:0000256|HAMAP-Rule:MF_04070	
I6TAH8	UniProtKB	Motif	198	216	.	.	.	Note=Bipartite nuclear localization signal;Ontology_term=ECO:0000256;evidence=ECO:0000256|HAMAP-Rule:MF_04070	
##sequence-region P69222 1 72
P69222	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:376343,ECO:0000269|PubMed:9868784;Dbxref=PMID:376343,PMID:9868784	
P69222	UniProtKB	Chain	2	72	.	.	.	ID=PRO_0000095785;Note=Translation initiation factor IF-1	
P69222	UniProtKB	Domain	2	72	.	.	.	Note=S1-like;Ontology_term=ECO:0000255;evidence=ECO:0000255|HAMAP-Rule:MF_00075	
P69222	UniProtKB	Beta strand	11	16	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1AH9	
P69222	UniProtKB	Beta strand	18	26	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1AH9	
P69222	UniProtKB	Beta strand	31	36	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1AH9	
P69222	UniProtKB	Helix	40	42	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1AH9	
P69222	UniProtKB	Beta strand	64	67	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1AH9	
##sequence-region P19909 1 593
P19909	UniProtKB	Signal peptide	1	33	.	.	.	.	
P19909	UniProtKB	Chain	34	562	.	.	.	ID=PRO_0000005659;Note=Immunoglobulin G-binding protein G	
P19909	UniProtKB	Propeptide	563	593	.	.	.	ID=PRO_0000005660;Note=Removed by sortase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00477	
P19909	UniProtKB	Repeat	104	140	.	.	.	Note=1-1	
P19909	UniProtKB	Repeat	179	215	.	.	.	Note=1-2	
P19909	UniProtKB	Repeat	254	290	.	.	.	Note=1-3	
P19909	UniProtKB	Repeat	303	357	.	.	.	Note=2-1	
P19909	UniProtKB	Repeat	373	427	.	.	.	Note=2-2	
P19909	UniProtKB	Region	104	290	.	.	.	Note=3 X 37 AA repeats	
P19909	UniProtKB	Region	303	427	.	.	.	Note=2 X 55 AA repeats	
P19909	UniProtKB	Region	531	555	.	.	.	Note=5 X 5 AA repeats of [DE]-D-A-K-K	
P19909	UniProtKB	Motif	559	563	.	.	.	Note=LPXTG sorting signal;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00477	
P19909	UniProtKB	Compositional bias	69	111	.	.	.	Note=Ala-rich	
P19909	UniProtKB	Modified residue	562	562	.	.	.	Note=Pentaglycyl murein peptidoglycan amidated threonine;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00477	
P19909	UniProtKB	Helix	251	268	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1GJS	
P19909	UniProtKB	Helix	272	279	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1GJS	
P19909	UniProtKB	Helix	284	296	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1GJS	
P19909	UniProtKB	Beta strand	303	309	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3FIL	
P19909	UniProtKB	Beta strand	311	313	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2I2Y	
P19909	UniProtKB	Beta strand	314	320	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3FIL	
P19909	UniProtKB	Beta strand	321	323	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1FCL	
P19909	UniProtKB	Helix	324	337	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3FIL	
P19909	UniProtKB	Beta strand	343	347	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3FIL	
P19909	UniProtKB	Helix	348	350	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3FIL	
P19909	UniProtKB	Beta strand	352	356	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3FIL	
P19909	UniProtKB	Beta strand	373	379	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ON8	
P19909	UniProtKB	Beta strand	384	390	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ON8	
P19909	UniProtKB	Helix	394	407	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ON8	
P19909	UniProtKB	Beta strand	413	417	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ON8	
P19909	UniProtKB	Turn	418	421	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ON8	
P19909	UniProtKB	Beta strand	422	426	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2ON8	
P19909	UniProtKB	Beta strand	443	449	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1P7E	
P19909	UniProtKB	Beta strand	454	460	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1P7E	
P19909	UniProtKB	Helix	464	477	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1P7E	
P19909	UniProtKB	Beta strand	483	487	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1P7E	
P19909	UniProtKB	Turn	488	491	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1P7E	
P19909	UniProtKB	Beta strand	492	496	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1P7E	
##sequence-region Q08JA8 1 264
Q08JA8	UniProtKB	Domain	30	256	.	.	.	Note=APH;Ontology_term=ECO:0000259;evidence=ECO:0000259|Pfam:PF01636	
Q08JA8	UniProtKB	Active site	190	190	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000256;evidence=ECO:0000256|PIRSR:PIRSR000706-1	
Q08JA8	UniProtKB	Metal binding	195	195	.	.	.	Note=Magnesium;Ontology_term=ECO:0000256;evidence=ECO:0000256|PIRSR:PIRSR000706-2	
Q08JA8	UniProtKB	Metal binding	208	208	.	.	.	Note=Magnesium;Ontology_term=ECO:0000256;evidence=ECO:0000256|PIRSR:PIRSR000706-2	
